Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
AL049629.2		ENSG00000284969	"CD59 glycoprotein "		11	33698261-33722467	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in many"	16	"placenta: 65.2"	"Cell type enhanced"	"Detected in some"	23	"Ciliated cells: 5.3;Ductal cells: 8.2;Exocrine glandular cells: 12.5;Pancreatic endocrine cells: 27.1"									"Group enriched"	"Detected in some"	6	"memory CD8 T-cell: 1.6;T-reg: 2.5"	"Lineage enriched"	"Detected in single"	8	"T-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 19.4;HUVEC TERT2: 24.9;TIME: 30.6;U-2197: 26.0"									HPA026494	Uncertain		Uncertain	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA026494: AB_1846321"																		3.2	0.4	0.3	2.8	0.5	1.2	2.2	0.4	2.6	0.7	0.5	0.1	0.9	1.5	1.3	2.3	1.5	0.3	2.6	2.4	1.6		2.0	0.6	1.9	2.0	0.9	1.0	0.4	1.3	0.1	0.2	65.2	0.9	0.4	0.4	0.5	3.1	1.3	3.9	0.0	0.1	1.4	0.7	0.4	3.6	1.0	0.5	0.2	1.0	1.4	1.4	0.8	2.9	0.0	0.3	0.0	0.0	0.0	2.5	0.2	0.5	1.5	0.1	1.0	1.6	3.8	0.0	8.4	3.8	1.1	1.0	0.0	4.3	0.0	0.9	5.7	0.5	1.0	0.1	19.4	1.8	0.8	0.1	0.1	3.3	0.4	0.4	0.2	0.5	1.4	1.3	0.5	6.9	0.9	24.9	0.1	0.2	3.3	7.1	0.4	0.7	0.3	0.2	0.6	11.4	0.2	0.7	0.5	2.2	0.9	0.0	0.1	0.9	1.5	2.8	0.1	0.4	0.0	30.6	3.2	1.2	26.0	3.2	1.7	1.5	0.1	7.4	0.0	7.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.2											0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	5.3	3.4	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALKBH5	"FLJ20308, OFOXD1"	ENSG00000091542	"AlkB homolog 5, RNA demethylase"	Q6P6C2	17	18183078-18209954	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 130.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007196	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA007196: AB_1850461"	"unprognostic (1.07e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.94e-2)"	"prognostic favorable (3.75e-4)"	"unprognostic (6.54e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.22e-2)"	"unprognostic (4.68e-3)"	"prognostic unfavorable (5.69e-4)"	18.0	19.5	17.1	14.6	21.9	19.1	26.2	23.4	25.3	18.2	21.8	20.1	18.8	15.1	22.1	12.1	17.3	30.5	18.7	45.8	16.5	18.9	16.0	24.2	14.7	16.9	19.0	16.9	20.9	25.0	22.7	20.2	14.8	15.4	19.4	8.9	19.9	23.7	21.1	130.4	12.7	16.9	20.4	15.3	18.8	16.2	29.7	17.6	26.8	23.5	19.5	13.7	26.8	44.8	11.5	8.9	17.6	10.6	7.6	17.0	5.7	33.1	32.0	13.0	23.4	19.1	13.3	11.3	16.0	19.8	26.3	24.5	36.1	8.8	21.0	23.7	17.6	13.9	21.9	19.6	16.9	13.6	23.9	26.7	15.4	18.2	20.1	17.8	11.1	20.7	12.7	11.5	19.7	11.7	16.7	15.2	16.4	16.7	9.6	14.6	24.6	23.9	12.4	11.0	13.9	16.4	21.7	25.7	36.8	7.7	11.4	13.4	17.7	20.0	13.9	18.2	42.7	14.0	9.6	15.4	25.4	17.7	37.2	31.3	11.2	8.5	12.7	46.1	18.2	16.6	4.3	7.2	17.6	15.1	7.4	14.0	7.9	13.6	17.0	8.9	11.5	10.9	11.0	4.6	7.6	10.6	6.6	7.9	5.7	17.1	21.9	23.4	25.3	16.5	18.9	19.0	16.9	15.4	17.6	32.8	25.7	39.8	24.5	57.5	79.0	78.7	25.5	28.1	18.2	26.2	37.3	28.1	71.3	24.0	48.1	37.6	35.4	46.7	27.3	36.7	47.3	36.0	41.4	52.9	29.7	112.8	58.5	27.6	39.9	29.1	38.0	25.6	47.2	17.2	41.8	72.5	28.5	42.4	48.8	81.8	52.8	19.4	44.3	106.7	98.2	48.9	26.3	48.4	31.6	21.6
ALX1	CART1	ENSG00000180318	"ALX homeobox 1"	Q15699	12	85280107-85301784	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 13.9"	"Cell type enriched"	"Detected in some"	6	"Melanocytes: 30.4"	"Cancer enriched"	"Detected in some"	10	"melanoma: 16.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 6.9;HEK 293: 15.4;HUVEC TERT2: 11.3;SK-MEL-30: 18.7;THP-1: 12.2;WM-115: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001598, HPA018905"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA			"Nuclear bodies"	"Nucleoplasm, Golgi apparatus"	"HPA001598: AB_1078400, HPA018905: AB_1844783"	"unprognostic (4.92e-3)"	"unprognostic (8.09e-2)"		"unprognostic (1.09e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.24e-2)"		"unprognostic (2.05e-2)"	"unprognostic (9.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.55e-5)"		"unprognostic (8.97e-2)"		"unprognostic (1.43e-1)"	1.9	0.0	0.1	0.0	0.2	0.0	4.8	0.0	0.2	5.4	0.1	0.0	0.8	0.0	5.4	8.5	0.1	4.7	0.0	0.1	0.2	0.2	8.3	0.0	0.1	0.0	0.2	0.0	3.6	0.1	0.0	1.6	0.1	0.0	1.6	0.0	13.9	3.8	2.0	0.4	3.3	0.1	1.1	0.0	0.0	0.1	1.5	0.0	0.0	0.2	4.0	0.0	2.4	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.5	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	2.5	0.0	6.9	0.3	0.0	0.0	15.4	0.0	2.7	0.0	0.2	0.0	0.0	0.0	0.0	2.1	0.0	6.3	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	1.8	4.0	0.0	0.0	18.7	2.9	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.3	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	1.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	30.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0
ANO9	"PIG5, TMEM16J, TP53I5"	ENSG00000185101	"Anoctamin 9"	A1A5B4	11	417933-442011	"Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"intestine: 69.4"	"Cell type enhanced"	"Detected in many"	12	"Enterocytes: 72.1;Mucus-secreting cells: 39.0;Paneth cells: 37.1;Undifferentiated cells: 37.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 26.1"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	41	"B-cells: 2.2;NK-cells: 3.9;T-cells: 7.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.0;CAPAN-2: 21.2;HaCaT: 12.3;RPMI-8226: 14.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA039948, HPA040112"	Approved		Uncertain	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA039948: AB_2676765, HPA040112: "	"unprognostic (3.62e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.41e-2)"	"unprognostic (8.93e-2)"	"unprognostic (6.98e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.54e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.92e-1)"	"prognostic favorable (8.81e-4)"	0.7	0.1	0.1	17.4	0.2	0.9	1.4	0.1	0.2	1.4	32.1	0.1	1.3	21.5	0.8	4.7	6.8	1.2	6.2	0.4	0.2	0.1	4.8	0.4	5.8	6.3	0.4	0.1	0.5	5.6	0.0	1.6	0.7	0.3	2.6	5.4	0.6	6.2	0.6	0.1	14.4	69.4	0.5	0.5	4.8	4.4	0.4	0.1	11.3	2.2	6.1	17.2	3.4	2.7	2.2	0.1	0.0	0.0	3.9	7.9	1.5	2.0	0.3	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	1.9	21.2	1.5	1.1	0.0	0.0	12.3	0.0	5.0	0.0	1.7	0.0	0.0	0.3	2.9	0.0	0.3	0.0	0.0	3.4	0.0	0.8	0.0	0.0	3.2	0.1	1.3	0.0	2.4	0.4	0.1	0.0	4.4	0.0	0.1	0.0	14.8	3.2	3.0	0.9	0.1	0.2	5.2	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	5.6	2.2	6.8	3.2	0.1	1.0	3.9	2.9	0.0	3.9	0.0	0.0	7.9	1.5	0.1	0.2	0.1	0.2	0.2	0.1	0.4	0.1	0.3	0.1	0.0	8.9	12.7	4.0	4.6	0.0	2.2	5.1	0.0	3.4	3.5	0.0	0.1	0.0	9.2	0.5	0.0	72.1	0.0	5.6	2.6	0.5	2.7	0.0	0.0	0.3	0.0	14.9	0.6	0.0	0.0	0.0	0.2	3.3	1.8	39.0	0.0	8.6	37.1	0.0	2.6	0.0	0.0	1.0	0.1	0.0	5.5	0.1	10.1	37.3	3.9
ARHGAP15	BM046	ENSG00000075884	"Rho GTPase activating protein 15"	Q53QZ3	2	143091362-143768352	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 52.0;bone marrow: 33.5;lymphoid tissue: 94.4"	"Cell type enhanced"	"Detected in many"	8	"B-cells: 62.8;Early spermatids: 89.3;granulocytes: 83.5;T-cells: 90.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 18.2;HEL: 25.4;HL-60: 35.8;MOLT-4: 23.7;NB-4: 27.8;THP-1: 37.8;U-698: 28.4;U-937: 19.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA032125			Uncertain	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA032125: AB_10671370"	"unprognostic (1.59e-2)"	"unprognostic (2.40e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.99e-1)"	"unprognostic (6.62e-3)"	"unprognostic (6.14e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.32e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (6.95e-5)"	"unprognostic (4.40e-2)"	"unprognostic (2.12e-2)"	"unprognostic (4.58e-2)"	"unprognostic (6.94e-2)"	5.5	2.7	3.6	36.6	4.6	33.5	3.7	0.6	2.9	2.4	4.3	1.5	2.1	2.7	2.1	4.3	3.6	2.4	4.9	5.0	3.8	2.1	4.5	4.8	9.1	36.9	7.8	1.7	1.5	1.2	0.4	1.3	1.6	4.6	3.9	3.3	1.0	8.1	2.2	1.1	1.7	12.2	1.6	11.3	51.8	3.0	3.5	5.9	94.4	4.2	2.2	21.7	6.0	3.9	25.2	14.5	52.0	9.6	28.7	46.0	23.2	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.5	0.0	25.4	0.1	0.0	0.0	35.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	15.3	0.1	1.2	0.0	0.0	23.7	27.8	0.1	0.0	0.0	13.3	0.1	6.7	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.0	1.2	37.8	0.1	0.1	0.9	0.0	0.0	0.3	0.1	28.4	0.2	19.0	1.1	38.6	8.6	34.9	26.6	8.8	42.3	25.2	46.0	33.3	14.5	22.5	33.9	28.4	52.0	28.7	9.6	14.4	36.5	23.2	3.6	4.6	0.6	2.9	3.8	2.1	7.8	1.7	4.6	5.9	0.0	14.8	62.8	0.0	4.9	0.0	2.0	0.0	4.0	4.5	0.0	0.0	0.1	0.0	0.0	89.3	2.6	0.0	0.0	0.0	0.3	11.5	0.2	83.5	0.4	19.7	1.6	0.0	6.7	31.4	5.3	13.8	38.9	8.5	19.8	0.0	0.2	0.0	0.0	3.2	0.3	0.2	45.3	28.6	7.1	1.0	4.0	0.2	90.6	0.0	0.1
ARSA		ENSG00000100299	"Arylsulfatase A"	P15289	22	50622754-50628173	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation, Ichthyosis, Leukodystrophy, Metachromatic leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 87.0;Late spermatids: 100.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 39.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005554, CAB025183"	Enhanced		Uncertain	"Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA		4500000	"Golgi apparatus"	Cytosol	"CAB025183: , HPA005554: AB_1078220"	"unprognostic (1.55e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.07e-2)"	"prognostic favorable (2.96e-5)"	"unprognostic (4.66e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.76e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.73e-3)"	19.0	15.2	14.0	15.2	15.7	16.6	15.2	11.9	17.9	12.0	20.3	21.4	26.4	30.2	13.3	21.4	15.6	18.5	23.3	18.8	13.4	8.8	17.5	24.1	15.7	16.8	19.1	10.3	9.3	45.4	13.1	20.4	18.5	17.3	15.8	8.8	14.0	36.8	21.9	6.3	11.1	23.4	8.7	13.2	25.6	23.6	27.2	17.9	10.6	18.7	7.5	16.5	14.8	13.3	5.6	15.7	30.1	19.8	3.9	8.9	7.7	4.1	5.8	2.8	5.4	20.9	11.4	7.0	6.7	8.2	2.9	5.0	1.6	6.4	2.8	4.1	11.0	5.4	6.4	0.6	6.2	0.4	1.2	4.4	1.6	6.5	5.8	14.5	2.4	17.1	13.5	12.1	4.8	3.1	9.9	6.6	5.8	1.7	39.3	5.9	4.7	2.2	2.8	0.8	4.3	5.8	2.0	0.2	12.9	4.9	6.4	1.3	4.3	9.5	8.5	4.8	2.6	3.8	3.0	11.6	2.1	8.0	7.5	1.9	9.3	0.8	2.1	6.1	2.2	6.9	4.3	13.7	17.1	8.9	16.0	7.9	5.6	6.5	7.3	11.2	5.6	3.9	5.3	30.1	3.9	19.8	15.7	8.5	7.7	14.0	15.7	11.9	17.9	13.4	8.8	19.1	10.3	17.3	17.9	6.0	11.7	17.5	11.1	4.1	4.9	6.5	30.6	13.4	4.5	12.2	3.9	10.2	1.7	28.6	51.1	7.9	87.0	23.3	18.7	18.1	13.0	12.6	5.8	27.6	33.4	6.4	35.3	9.2	28.5	100.4	10.0	17.4	16.9	37.9	23.2	9.3	25.7	35.9	5.6	20.6	6.2	0.0	4.7	43.1	3.1	4.8	11.1	10.5	19.0	14.9
ATP6V0A1	"a1, ATP6N1, ATP6N1A, Stv1, Vph1, VPP1"	ENSG00000033627	"ATPase H+ transporting V0 subunit a1"	Q93050	17	42458844-42522611	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.2;parathyroid gland: 65.6"	"Cell type enhanced"	"Detected in all"	8	"Cone photoreceptor cells: 276.9;Rod photoreceptor cells: 349.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022144	Enhanced		Approved	"Nuclear speckles,Golgi apparatus,Vesicles,Cytosol"		NA	NA		21000	"Golgi apparatus, Vesicles"	"Nuclear speckles, Cytosol"	"HPA022144: AB_1845189"	"unprognostic (3.93e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.60e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.84e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (3.25e-1)"	"prognostic favorable (1.28e-4)"	"unprognostic (3.07e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (6.90e-4)"	9.4	15.6	19.3	9.3	46.1	9.9	9.1	55.8	66.2	8.0	11.6	25.8	5.1	17.9	11.4	11.1	9.6	9.7	12.2	9.9	23.8	32.8	20.3	11.3	12.7	6.6	23.6	24.8	11.4	9.3	65.6	23.6	11.2	43.3	9.9	11.3	19.7	8.2	10.7	28.9	14.7	12.4	11.7	23.7	11.1	8.8	9.8	13.1	5.2	16.3	6.7	7.8	6.7	6.9	6.3	9.1	14.2	10.5	0.1	2.8	4.2	6.6	13.8	8.5	15.2	14.2	12.4	4.9	4.7	8.8	10.1	13.3	8.8	15.0	1.2	8.7	9.7	13.9	14.5	13.0	8.0	11.8	10.3	13.6	10.7	10.4	6.9	8.8	4.6	19.6	9.1	11.6	16.2	6.9	12.6	7.1	5.0	38.9	42.3	15.0	5.7	1.8	4.1	5.4	8.8	0.1	0.1	8.8	18.6	11.7	5.3	23.4	12.4	7.3	6.7	14.0	11.5	16.3	7.0	4.2	8.6	0.3	12.6	5.6	17.2	23.4	2.5	11.5	0.1	10.0	12.1	10.5	8.0	0.8	3.4	1.2	3.5	0.6	0.1	9.1	6.3	1.0	0.8	14.2	0.1	2.4	4.7	2.8	4.2	19.3	46.1	55.8	65.9	23.8	32.8	23.6	24.8	43.3	13.1	17.9	46.6	27.3	45.1	17.5	158.7	19.5	30.6	6.7	14.8	14.0	276.9	26.4	10.0	14.7	2.4	19.2	44.6	46.7	15.8	13.4	33.9	38.7	23.1	33.6	46.0	90.6	81.5	19.6	33.1	3.1	16.1	25.8	38.8	3.6	23.1	51.9	17.6	38.6	22.3	28.4	349.7	6.5	48.9	38.7	18.5	17.7	83.5	4.4	19.5	10.7
ATR	"FRP1, MEC1, SCKL, SCKL1"	ENSG00000175054	"ATR serine/threonine kinase"	Q13535	3	142449235-142578826	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	"DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 35.3;Spermatocytes: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054320			Supported	"Nucleoplasm,Golgi apparatus"		No	No			Nucleoplasm	"Golgi apparatus"	"HPA054320: AB_2682448"	"unprognostic (1.47e-1)"	"unprognostic (8.90e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.23e-2)"	"unprognostic (2.25e-2)"	"unprognostic (6.42e-2)"	"prognostic unfavorable (8.39e-5)"	"unprognostic (3.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (1.23e-5)"	"unprognostic (1.94e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.43e-1)"	10.5	24.3	7.7	11.4	15.9	10.1	14.8	11.3	14.6	10.1	8.5	10.0	10.4	6.0	14.7	16.8	9.4	12.1	9.3	8.8	9.8	7.1	9.6	12.0	10.3	16.0	10.0	8.1	12.3	13.6	18.0	22.5	8.8	12.5	11.0	11.2	9.5	12.5	10.8	7.7	11.2	10.9	9.8	8.8	14.2	9.0	15.3	9.7	19.0	13.8	7.7	15.1	10.9	10.6	5.8	2.8	2.2	4.0	6.7	6.0	0.8	22.7	11.2	7.5	8.5	10.7	11.8	8.9	12.6	7.1	9.4	9.7	5.2	7.3	18.6	13.0	8.9	12.3	14.8	11.0	11.6	14.2	5.9	7.2	10.2	8.5	5.1	4.7	17.1	5.7	9.2	6.4	8.9	10.6	6.4	9.7	9.7	7.1	8.4	9.6	10.0	12.9	7.1	7.2	14.9	8.0	10.7	10.9	13.5	9.5	10.6	5.3	5.4	23.2	8.4	8.2	7.1	12.2	6.9	12.5	9.6	4.8	12.4	13.5	11.0	6.5	17.3	12.5	6.7	7.6	0.7	2.7	2.2	4.4	4.0	6.0	3.1	3.2	4.2	2.8	5.8	4.1	4.0	1.7	6.7	2.5	2.5	2.4	0.8	7.7	15.9	11.3	14.6	9.8	7.1	10.0	8.1	12.5	9.7	6.0	8.8	13.4	6.5	3.5	14.7	7.1	7.6	18.7	6.8	3.5	35.3	6.6	0.0	5.3	12.0	7.1	2.1	0.0	4.3	3.3	4.8	6.7	1.1	6.0	5.7	7.9	7.5	8.6	9.1	6.9	6.1	6.9	10.1	4.6	5.4	4.8	6.2	0.0	6.7	4.1	23.4	0.0	6.4	42.3	15.8	4.0	4.2	5.1	7.0	5.2
BARX2		ENSG00000043039	"BARX homeobox 2"	Q9UMQ3	11	129375940-129452279	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 49.8;lymphoid tissue: 36.4;salivary gland: 78.3;tongue: 40.7;vagina: 22.0"	"Cell type enhanced"	"Detected in many"	10	"Basal glandular cells: 99.1;Suprabasal keratinocytes: 72.1;Urothelial cells: 102.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"pons and medulla: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"HDLM-2: 60.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB033311, HPA064966, HPA068414"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Cytosol"	"CAB033311: AB_781574, HPA064966: , HPA068414: AB_2685984"	"unprognostic (4.25e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.22e-5)"	"unprognostic (3.85e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.43e-3)"	"unprognostic (4.80e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.35e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.39e-2)"	"unprognostic (3.48e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (3.06e-4)"	0.1	0.0	0.3	1.6	0.5	0.0	6.0	0.6	0.9	8.7	4.4	1.4	0.3	7.1	0.6	1.8	49.8	6.8	5.0	0.1	0.5	0.4	1.9	0.1	0.5	0.1	0.7	0.2	1.0	6.9	0.0	0.6	1.5	4.1	1.5	1.9	0.0	78.3	0.7	1.0	11.2	7.9	0.0	1.6	0.0	2.6	1.2	0.2	0.4	0.5	40.7	36.4	0.2	22.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.1	0.0	0.4	7.8	0.0	1.9	0.0	60.3	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.7	0.0	1.5	0.0	2.3	0.0	0.0	0.0	7.7	0.3	0.0	0.0	14.7	0.0	0.1	0.1	0.0	0.0	7.4	0.0	0.1	1.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.6	0.9	0.5	0.4	0.7	0.2	4.1	0.2	0.0	1.4	0.0	99.1	38.2	0.4	0.4	2.5	6.7	6.8	0.0	0.0	10.6	6.6	18.2	6.5	0.3	27.5	0.0	0.6	6.4	2.3	15.2	0.0	0.0	1.6	0.0	1.7	0.0	0.0	1.3	0.0	0.8	10.1	0.0	12.2	0.8	5.0	22.1	0.4	1.4	0.2	0.0	0.7	0.0	1.1	72.1	3.5	0.0	15.8	102.1
BDKRB2	BK-2	ENSG00000168398	"Bradykinin receptor B2"	P30411	14	96204679-96244166	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Cholangiocytes: 15.3;Ciliated cells: 13.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"cerebellum: 13.5;pons and medulla: 5.7"	"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 22.8;BJ hTERT+: 41.8;U-87 MG: 18.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA003551, HPA050841"	Approved		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	"Golgi apparatus, Vesicles"	"HPA003551: , HPA050841: AB_2681254"	"unprognostic (1.03e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.79e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.32e-3)"	"unprognostic (3.11e-2)"	"unprognostic (9.40e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.49e-2)"	9.0	1.2	1.5	3.7	1.0	0.0	4.7	13.5	1.1	12.2	9.0	1.3	4.4	5.6	8.5	12.7	14.9	5.1	21.1	4.3	0.8	0.7	12.1	0.7	2.2	0.4	0.9	0.3	4.7	6.8	0.9	1.1	2.9	5.7	6.9	9.2	0.9	3.1	11.3	2.7	4.0	10.3	11.3	1.3	0.4	4.2	3.2	0.0	0.6	3.6	13.9	4.4	16.7	13.5	0.0	0.9	0.0	0.0	0.0	1.2	0.0	0.7	2.7	0.0	4.9	7.4	22.8	0.0	2.4	41.8	1.4	1.7	0.1	4.6	0.0	0.1	3.8	1.6	6.5	0.0	1.0	1.2	0.5	0.0	0.0	0.5	0.0	3.6	0.0	0.0	6.9	3.3	4.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	8.8	0.0	0.0	1.0	0.0	1.4	0.0	1.5	0.5	0.8	6.9	0.0	1.0	0.4	0.0	0.0	0.1	0.1	1.4	0.0	0.1	0.0	0.0	18.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.5	1.0	13.5	1.1	0.8	0.7	0.9	0.3	5.7	0.0	3.0	1.9	0.0	0.5	8.1	0.0	0.5	15.3	13.4	9.1	8.7	0.0	0.5	6.6	10.2	0.0	4.2	8.9	0.0	3.5	1.9	6.1	0.8	0.0	0.0	0.2	0.0	6.8	3.1	0.0	0.0	0.9	0.6	5.0	0.0	5.0	0.0	4.5	4.5	1.1	0.0	0.0	0.0	2.0	0.0	0.0	5.1	3.3	0.0	0.7	2.4
C19orf38	HIDE1	ENSG00000214212	"Chromosome 19 open reading frame 38"	A8MVS5	19	10836575-10869790	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 58.7;bone marrow: 54.4"	"Cell type enhanced"	"Detected in many"	18	"Kupffer cells: 101.9;Macrophages: 32.6;monocytes: 24.4;Spermatocytes: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	19	"classical monocyte: 44.3;eosinophil: 26.1;intermediate monocyte: 48.7;myeloid DC: 26.2;neutrophil: 37.3;non-classical monocyte: 58.7"	"Group enriched"	"Detected in many"	19	"dendritic cells: 26.2;granulocytes: 37.3;monocytes: 58.7"	"Cell line enriched"	"Detected in some"	4	"U-937: 32.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA012150, HPA055027"			Uncertain	"Golgi apparatus,Plasma membrane,Cytosol"		No	NA			Cytosol	"Golgi apparatus, Plasma membrane"	"HPA012150: AB_10603448, HPA055027: "	"unprognostic (6.65e-3)"	"prognostic favorable (2.43e-4)"	"unprognostic (6.44e-4)"	"unprognostic (6.98e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.31e-3)"	"unprognostic (3.56e-1)"	"unprognostic (8.27e-2)"	"unprognostic (5.60e-2)"	"unprognostic (6.02e-2)"	"unprognostic (9.74e-2)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (1.75e-7)"	"unprognostic (2.31e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.11e-2)"	2.7	1.2	2.1	6.9	4.0	54.4	1.8	0.7	3.1	2.0	1.3	4.8	0.0	1.3	0.9	4.0	0.9	2.6	2.1	5.6	2.4	2.1	1.4	2.3	12.8	19.6	4.2	0.6	1.6	1.3	0.3	1.0	1.9	3.8	1.6	1.0	1.5	1.0	0.8	2.3	0.6	1.7	2.3	6.3	22.3	1.2	15.0	3.7	4.1	0.7	0.5	2.0	2.8	3.5	2.1	26.2	37.3	58.7	1.2	0.8	20.7	1.5	0.0	0.1	0.3	1.5	0.8	0.1	0.2	0.0	0.3	0.6	0.1	0.2	3.8	0.3	0.0	0.1	0.1	0.2	0.2	0.2	1.7	0.4	0.2	0.0	0.0	1.1	2.5	0.4	4.1	0.4	0.7	0.2	0.1	0.1	0.4	0.2	8.1	0.1	1.4	0.1	5.9	0.3	0.2	0.3	2.8	0.0	1.9	0.0	0.1	0.2	0.1	0.8	0.0	0.6	0.1	0.1	5.6	0.0	0.0	0.0	0.7	0.0	4.9	2.3	1.1	0.0	32.8	0.0	1.2	44.3	26.1	0.1	48.7	0.2	2.1	0.1	0.1	26.2	1.2	0.8	0.2	37.3	1.2	58.7	0.5	0.3	20.7	2.1	4.0	0.7	3.1	2.4	2.1	4.2	0.6	3.8	3.7	0.0	2.6	12.3	0.3	0.7	0.0	0.6	0.0	2.7	1.2	1.8	2.0	0.8	0.0	0.0	2.7	0.0	0.0	0.0	1.1	0.6	1.1	0.4	2.3	0.9	21.2	0.0	0.0	0.0	101.9	5.3	0.9	32.6	1.7	24.4	0.5	2.3	0.2	3.5	0.7	0.4	1.0	6.5	0.1	27.0	15.8	0.6	0.6	0.8	0.3	0.6
CD300C	"CMRF-35A, CMRF35, CMRF35A, IGSF16, LIR"	ENSG00000167850	"CD300c molecule"	Q08708	17	74541108-74546143	"CD markers, Predicted membrane proteins"	Immunity	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 46.8"	"Group enriched"	"Detected in some"	12	"granulocytes: 15.0;Hofbauer cells: 29.5;Kupffer cells: 28.1;Macrophages: 33.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"classical monocyte: 28.6;intermediate monocyte: 46.8;myeloid DC: 32.5;non-classical monocyte: 46.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 32.5;monocytes: 46.8"	"Cell line enhanced"	"Detected in some"		"HEL: 5.3;HMC-1: 26.2;THP-1: 4.9;U-937: 12.4"									"HPA014523, HPA060349"	Approved		Uncertain	"Golgi apparatus,Vesicles,Mitochondria"		NA	NA			"Golgi apparatus"	"Vesicles, Mitochondria"	"HPA014523: AB_1846293, HPA060349: "	"unprognostic (1.55e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.99e-3)"	"unprognostic (3.79e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.47e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.68e-2)"	"unprognostic (7.51e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.37e-3)"	"unprognostic (6.27e-2)"	"prognostic unfavorable (8.53e-5)"	"unprognostic (1.16e-2)"	"unprognostic (1.09e-1)"	9.8	2.8	3.6	9.0	4.6	10.9	1.8	0.4	2.9	1.2	1.7	2.9	0.0	1.5	1.4	1.9	1.0	1.9	2.8	3.4	2.0	1.7	1.9	2.1	11.2	12.3	5.3	1.3	1.1	1.3	0.5	1.2	3.8	3.9	1.9	1.8	1.8	1.8	0.7	1.1	0.9	2.3	4.1	7.1	14.2	1.6	0.9	2.7	0.1	1.6	0.1	1.4	3.5	1.1	0.4	32.5	8.4	46.8	8.6	0.1	10.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	2.4	26.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.7	0.0	0.0	0.1	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.9	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.7	12.4	0.0	8.4	28.6	1.4	0.1	46.8	0.1	0.4	0.0	0.0	32.5	0.3	0.0	0.0	1.0	8.6	46.4	2.1	0.0	10.7	3.6	4.6	0.4	2.9	2.0	1.7	5.3	1.3	3.9	2.7	0.0	2.2	0.0	0.0	0.3	0.0	0.0	0.0	1.4	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	15.0	0.0	29.5	0.0	0.0	0.0	28.1	0.0	0.0	33.8	1.7	1.8	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0
CD59	"16.3A5, EJ16, EJ30, EL32, G344, MIC11, MIN1, MIN2, MIN3, MSK21, p18-20"	ENSG00000085063	"CD59 molecule (CD59 blood group)"	P13987	11	33703010-33736491	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 285.5"	"Cell type enhanced"	"Detected in all"	4	"Urothelial cells: 1502.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 217.5;U-2197: 180.1"									"CAB001448, HPA026494"	Supported		Uncertain	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		98000000	"Golgi apparatus, Vesicles"		"CAB001448: AB_563604, HPA026494: AB_1846321"	"unprognostic (2.07e-2)"	"prognostic unfavorable (3.81e-5)"	"unprognostic (7.40e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (3.10e-5)"	"unprognostic (5.65e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.98e-1)"	"prognostic unfavorable (2.92e-5)"	"unprognostic (1.66e-2)"	"prognostic favorable (1.39e-10)"	"prognostic unfavorable (9.03e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.09e-1)"	96.7	41.0	36.7	26.3	44.3	23.8	76.0	25.9	32.7	44.8	36.9	24.0	57.9	16.5	45.4	132.8	68.4	53.2	67.6	90.5	35.6	38.4	100.0	61.0	86.4	39.8	39.7	25.8	39.3	52.3	60.6	48.0	285.5	68.7	47.4	37.7	51.4	114.8	62.6	70.6	43.4	25.0	52.4	32.9	26.2	54.7	28.1	23.1	16.1	85.9	57.7	40.0	51.2	63.4	13.5	20.5	42.8	4.8	17.7	60.4	11.1	16.8	15.8	4.7	13.8	109.9	86.2	2.7	96.0	107.2	24.1	28.2	7.3	50.7	1.3	17.2	103.4	28.7	19.0	8.6	95.8	33.8	26.8	13.1	1.7	56.0	11.0	30.0	10.1	5.8	40.0	24.2	20.4	98.3	66.8	146.8	5.9	11.8	39.0	151.5	15.4	4.7	4.2	2.6	31.1	82.5	1.8	14.6	13.5	72.7	28.8	3.2	4.4	33.4	15.5	17.6	13.9	11.8	1.0	217.5	55.4	13.3	180.1	33.3	17.3	33.8	1.6	47.6	0.0	96.2	30.5	4.8	42.8	11.3	1.6	14.4	13.5	24.0	12.7	20.5	10.6	15.7	9.3	28.4	17.7	0.9	10.5	60.4	11.1	36.7	44.3	25.9	32.7	35.6	38.4	39.7	25.8	68.7	23.1	253.1	215.4	44.4	795.7	254.1	47.4	262.5	430.6	580.9	208.1	230.3	31.4	513.5	139.3	1251.4	102.0	802.4	90.2	140.2	547.4	330.2	284.0	787.9	136.2	175.7	400.2	44.5	160.2	566.0	129.7	49.4	219.8	141.1	1204.5	272.3	85.9	184.1	823.9	122.8	192.3	162.3	45.0	271.7	576.8	86.8	27.6	248.5	699.7	62.8	98.2	1502.4
CDH9		ENSG00000113100	"Cadherin 9"	Q9ULB4	5	26880600-27121150	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 46.8"	"Cell type enhanced"	"Detected in single"	37	"Proximal tubular cells: 3.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"amygdala: 46.8;basal ganglia: 24.6;cerebral cortex: 23.7;hippocampal formation: 15.9;olfactory region: 15.6"	"Cell type enhanced"	"Detected in some"		"neutrophil: 8.3"	"Group enriched"	"Detected in many"	5	"B-cells: 4.1;granulocytes: 8.3"	"Cell line enhanced"	"Detected in some"		"K-562: 9.4;NTERA-2: 13.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA007167	Approved		Uncertain	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA007167: AB_1078489"					"unprognostic (1.49e-1)"								"unprognostic (2.27e-4)"					0.7	0.5	46.8	1.0	24.6	2.8	0.7	0.5	23.7	0.5	0.8	0.0	0.0	0.6	0.9	1.2	0.7	0.5	0.7	0.5	15.9	3.5	10.5	0.5	0.6	1.6	1.2	15.6	0.6	1.1	1.0	0.5	0.8	1.5	1.0	1.2	0.0	0.5	0.1	0.5	1.9	1.5	0.8	0.6	0.8	0.9	3.7	2.6	0.0	1.9	0.0	1.7	0.5	0.5	4.1	0.9	8.3	1.1	0.1	0.8	1.1	2.5	0.9	0.5	0.8	0.4	0.0	1.6	0.0	0.9	0.3	0.7	0.0	0.9	1.3	0.3	0.3	0.2	0.3	0.1	0.6	0.0	0.1	0.3	0.5	0.7	2.5	0.0	0.0	1.6	0.6	0.7	0.0	0.0	0.0	0.2	0.8	9.4	2.3	0.0	1.5	0.8	0.5	13.9	0.2	0.5	0.3	0.3	0.4	0.5	0.5	3.1	0.3	0.0	0.4	0.5	2.7	0.5	0.9	1.7	0.1	0.8	0.8	0.3	2.8	1.0	4.4	1.0	1.0	0.8	1.3	0.2	0.4	0.2	0.7	0.6	4.1	0.4	0.2	0.1	2.5	0.3	0.5	8.3	0.1	1.1	0.9	0.8	1.1	46.8	24.6	0.5	23.7	15.9	3.5	1.2	15.6	1.5	2.6	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CDK13	"CDC2L, CDC2L5, CHED, KIAA1791"	ENSG00000065883	"Cyclin dependent kinase 13"	Q14004	7	39949646-40099580	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059241	Uncertain		Supported	"Nuclear speckles,Golgi apparatus,Cytosol"		NA	NA			"Nuclear speckles"	"Golgi apparatus, Cytosol"	"HPA059241: AB_2683956"	"unprognostic (1.99e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.18e-3)"	"unprognostic (3.42e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.77e-2)"	"unprognostic (8.13e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.53e-2)"	16.9	15.3	16.0	29.0	14.5	26.7	20.4	23.3	18.2	16.6	18.3	16.4	14.2	11.3	20.3	17.7	20.9	18.1	20.2	13.6	14.3	11.3	14.7	17.5	19.6	21.9	16.5	15.1	24.2	15.3	26.3	15.3	14.8	12.0	15.5	15.5	14.9	17.6	14.5	19.4	16.7	16.3	16.4	11.5	17.4	14.5	20.2	15.7	31.2	23.1	14.6	21.5	18.5	23.6	14.0	3.9	7.9	3.4	5.0	5.0	1.4	15.7	9.4	16.4	15.6	14.8	14.5	11.3	12.6	13.7	11.6	14.6	9.8	10.9	28.6	7.4	13.2	20.4	19.2	13.4	11.1	17.1	14.0	9.9	12.7	11.5	8.8	14.2	19.3	13.9	8.5	14.9	13.2	17.7	13.3	13.6	13.3	21.4	19.8	12.0	8.1	15.3	13.7	23.7	11.1	11.0	17.0	10.9	11.5	10.9	16.0	11.7	17.0	16.0	34.7	11.4	22.2	14.2	24.1	16.1	16.0	15.3	10.3	17.1	16.4	13.8	23.6	11.7	17.5	20.4	7.9	2.7	4.4	5.0	2.2	3.4	7.6	4.8	3.7	1.5	14.0	4.9	4.9	7.6	5.0	3.4	3.9	4.3	1.4	16.0	14.5	23.3	18.2	14.3	11.3	16.5	15.1	12.0	15.7	41.7	63.7	28.9	17.1	19.1	42.3	25.6	30.6	34.8	47.8	29.6	66.8	11.5	6.6	19.1	10.7	22.5	15.9	0.0	13.4	7.5	19.4	16.3	16.2	20.7	11.6	35.0	18.0	20.3	23.2	7.0	24.2	18.3	13.5	15.4	17.7	26.6	24.2	10.5	16.6	11.1	68.4	6.5	15.6	31.4	31.5	22.8	10.2	22.5	18.8	21.7
CEP83	"CCDC41, NPHP18, NY-REN-58"	ENSG00000173588	"Centrosomal protein 83"		12	94306449-94459988	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Ciliated cells: 88.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038161	Approved		Uncertain	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA038161: AB_10674547"	"unprognostic (4.98e-2)"	"unprognostic (1.64e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.75e-2)"	"unprognostic (4.76e-3)"	"unprognostic (3.59e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (4.98e-4)"	"prognostic unfavorable (5.00e-10)"	"unprognostic (1.29e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.95e-2)"	6.8	9.8	10.1	11.3	10.5	8.4	9.7	11.8	10.1	8.7	7.4	7.6	7.0	5.5	12.3	12.7	6.7	16.2	6.1	19.0	9.0	6.6	8.2	6.3	7.1	7.7	6.2	7.7	11.0	12.2	9.3	12.1	6.3	8.9	6.8	10.3	7.8	10.0	8.5	7.3	6.3	5.4	11.0	6.3	6.9	6.3	22.3	7.3	10.6	9.7	9.4	8.0	6.7	9.2	7.6	8.5	1.9	3.5	5.7	6.6	2.0	5.7	6.4	10.9	10.3	4.8	6.5	9.4	10.1	3.3	7.3	7.6	7.9	4.8	15.0	2.2	3.0	4.7	8.1	13.1	7.7	11.4	8.6	9.5	8.8	6.7	8.0	4.8	14.4	6.1	4.2	6.5	6.1	18.8	4.4	6.9	12.2	11.3	6.1	7.6	5.7	9.8	24.0	12.5	9.8	11.9	13.5	10.3	15.0	6.7	7.2	11.4	4.7	8.5	10.1	6.9	10.2	6.8	9.1	4.0	8.7	5.4	4.3	7.9	8.1	9.0	13.6	3.6	15.3	8.2	0.6	3.5	1.9	5.8	3.5	5.2	6.6	5.8	4.4	7.7	7.6	6.1	5.4	1.4	5.7	1.5	8.5	6.6	2.0	10.1	10.5	11.8	10.1	9.0	6.6	6.2	7.7	8.9	7.3	14.9	12.5	10.7	13.1	0.0	11.9	22.3	0.0	88.3	21.6	3.5	13.7	5.5	1.7	4.2	27.1	6.5	3.8	0.0	2.9	8.9	4.9	7.3	25.5	4.9	5.0	4.8	14.3	1.8	4.0	10.1	10.0	5.1	0.0	19.8	8.2	4.3	2.8	3.5	6.0	3.7	10.0	0.0	6.4	39.4	22.0	0.0	2.7	5.1	10.3	10.2
CEP85	"CCDC21, DKFZP434L0117"	ENSG00000130695	"Centrosomal protein 85"	Q6P2H3	1	26234153-26279038	"Predicted intracellular proteins"	"Chromosome partition"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 87.8"	"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 26.8;Spermatocytes: 43.5;Spermatogonia: 37.7;Syncytiotrophoblasts: 34.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 15.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028252	Approved		Approved	"Nucleoli,Golgi apparatus,Centrosome,Cytosol"		NA	NA			"Nucleoli, Golgi apparatus"	"Centrosome, Cytosol"	"HPA028252: AB_1846142"	"unprognostic (1.08e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.74e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.30e-3)"	"prognostic unfavorable (4.39e-6)"	"unprognostic (3.72e-2)"	"unprognostic (5.30e-2)"	"unprognostic (8.24e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.33e-3)"	"unprognostic (5.41e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.60e-2)"	2.1	2.7	4.8	3.8	11.0	12.4	3.1	7.7	8.8	2.4	3.7	15.5	4.6	3.5	2.6	3.3	5.6	2.7	2.6	19.4	5.5	4.0	3.8	3.7	3.2	5.3	20.4	4.9	2.4	3.3	4.4	4.7	3.6	7.8	3.0	4.5	4.0	3.5	2.5	87.8	8.4	3.3	2.9	10.4	4.3	3.7	26.8	13.5	12.1	5.4	5.5	6.6	3.0	3.8	2.4	3.8	15.6	5.0	2.1	3.4	2.8	13.5	6.7	10.8	11.5	3.0	2.8	21.3	6.9	3.2	9.5	10.2	8.6	12.7	12.9	9.4	2.8	5.2	12.0	12.1	5.7	9.6	9.4	10.5	18.2	13.2	9.1	3.1	16.6	20.2	1.4	5.7	8.0	5.8	4.5	4.2	17.5	24.5	18.0	7.0	4.9	15.9	20.2	10.5	6.7	11.2	16.3	12.6	12.0	4.8	2.1	18.4	8.5	9.7	8.1	8.0	6.2	7.4	11.9	4.9	7.8	13.0	9.1	10.6	14.2	20.7	16.1	4.8	29.3	14.7	3.4	4.6	15.6	3.0	4.4	2.5	2.4	2.0	2.3	3.8	1.3	1.8	3.4	0.5	2.1	5.0	1.3	3.2	2.8	4.8	11.0	7.7	8.8	5.5	4.0	20.4	4.9	7.8	13.5	0.0	2.1	0.0	4.2	6.2	9.6	26.8	2.5	1.4	4.5	5.2	11.8	2.0	6.6	1.7	0.8	1.8	3.9	0.0	1.1	3.6	2.1	2.2	2.3	2.5	4.3	0.0	1.7	1.8	5.2	2.3	1.4	4.0	1.7	4.6	3.1	1.3	2.1	3.4	0.4	0.8	10.1	0.0	1.0	43.5	37.7	5.4	34.9	3.5	4.7	3.2
CHEK2	"bA444G7, CDS1, CHK2, HuCds1, PP1425, RAD53"	ENSG00000183765	"Checkpoint kinase 2"	O96017	22	28687743-28742422	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Li-Fraumeni syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Erythroid cells: 23.3;Spermatogonia: 20.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001878, CAB002030"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"CAB002030: AB_563660, HPA001878: AB_1078514"	"unprognostic (1.54e-1)"	"unprognostic (2.20e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.49e-3)"	"unprognostic (5.08e-3)"	"unprognostic (3.33e-3)"	"unprognostic (9.62e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (7.80e-9)"	"unprognostic (2.38e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.27e-2)"	"unprognostic (6.79e-3)"	5.6	8.3	2.5	13.0	7.0	13.7	5.6	0.7	5.6	6.6	9.8	2.5	4.8	6.8	4.8	10.9	10.0	4.3	6.0	6.0	4.1	2.3	5.3	6.5	7.9	10.1	6.7	1.6	12.9	6.7	1.2	4.2	10.1	5.1	8.3	10.6	8.7	7.0	5.8	2.2	6.3	8.5	5.4	5.0	9.8	5.8	9.7	3.6	13.1	7.5	4.8	13.7	6.2	6.7	11.8	8.7	6.5	8.4	2.9	4.4	3.7	14.9	4.8	13.7	17.0	3.9	19.5	8.8	7.4	8.7	9.8	14.4	12.1	10.2	17.7	6.3	5.2	10.6	14.4	20.8	13.6	11.5	12.6	16.0	23.3	9.2	20.2	3.8	14.7	17.1	8.2	6.3	12.6	11.2	6.0	10.8	14.2	14.0	15.5	9.2	21.0	11.8	23.7	19.3	18.5	12.2	25.6	9.4	20.6	6.1	6.2	8.1	4.6	8.3	14.7	8.2	10.6	10.1	13.6	3.7	7.9	9.5	6.9	3.9	9.4	16.5	34.6	7.5	15.5	10.0	6.5	3.7	1.2	1.1	8.4	2.3	11.8	2.2	2.1	8.7	8.4	4.4	2.8	0.3	2.9	4.1	7.0	2.8	3.7	2.5	7.0	0.7	5.6	4.1	2.3	6.7	1.6	5.1	3.6	8.9	4.5	7.5	4.5	5.7	1.0	1.0	0.0	2.7	4.5	1.8	0.0	10.5	0.0	1.7	4.7	2.2	2.0	23.3	1.2	11.7	8.9	2.3	3.5	0.9	8.4	0.0	1.2	3.1	2.1	0.5	5.8	6.6	1.7	2.8	4.7	0.6	1.3	3.5	4.2	3.2	1.2	0.0	2.8	2.5	20.2	1.9	2.9	4.3	7.9	3.4
CHRM4		ENSG00000180720	"Cholinergic receptor muscarinic 4"	P08173	11	46385098-46386608	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 11.7;intestine: 8.0;lymphoid tissue: 17.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RH-30: 5.0;SCLC-21H: 14.5;U-2 OS: 4.2"	"Group enriched"	"Detected in many"	6	"amygdala: 26.8;basal ganglia: 65.9;cerebral cortex: 30.5;hippocampal formation: 26.4;olfactory region: 36.4"	"Group enriched"	"Detected in many"	7	"amygdala: 5.5;basal ganglia: 15.3;cerebral cortex: 8.6;hippocampal formation: 7.6;olfactory region: 20.1"	"CAB022444, HPA072083"	Enhanced		Uncertain	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"CAB022444: , HPA072083: "	"unprognostic (7.11e-2)"	"unprognostic (3.79e-1)"	"unprognostic (5.31e-2)"	"unprognostic (7.38e-2)"	"unprognostic (8.63e-3)"	"unprognostic (1.38e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.96e-3)"	"unprognostic (4.08e-3)"	"unprognostic (5.02e-2)"	"unprognostic (3.83e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.56e-1)"	"unprognostic (5.08e-2)"	0.0	0.5	1.1	0.2	11.7	1.6	0.0	0.0	6.0	0.0	0.6			3.7	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.6	0.0	0.0	0.2	0.0	0.2		0.0	0.2	0.0	0.5	0.0		0.0	0.1		0.0	0.0	0.0	1.2	8.0	0.1	0.0	17.2	0.8	4.1			0.0		0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.7	0.3	0.1	0.2	0.0	3.0	0.0	0.1	0.2	0.1	1.5	0.2	0.3	0.3	0.0	2.6	0.1	1.8	0.1	0.0	2.2	0.3	0.5	0.2	0.0	0.2	0.5	0.6	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.6	0.2	0.0	1.1	0.2	0.2	0.6	0.1	0.2	0.0	5.0	0.0	0.0	0.1	14.5	0.4	0.4	0.1	0.1	0.3	0.1	2.4	0.0	0.4	4.2	0.0	0.1	0.8	0.6	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CLEC2D	"CLAX, LLT1, OCIL"	ENSG00000069493	"C-type lectin domain family 2 member D"	Q9UHP7	12	9664969-9699555	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 45.6;lymphoid tissue: 47.5"	"Group enriched"	"Detected in many"	5	"B-cells: 129.2;Early spermatids: 83.6;monocytes: 115.4;T-cells: 223.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	11	"gdT-cell: 37.8;MAIT T-cell: 23.0;memory B-cell: 15.9;memory CD4 T-cell: 37.3;memory CD8 T-cell: 41.3;naive B-cell: 24.6;naive CD4 T-cell: 39.4;naive CD8 T-cell: 45.6;T-reg: 31.5"	"Group enriched"	"Detected in many"	11	"B-cells: 24.6;T-cells: 45.6"	"Group enriched"	"Detected in many"	4	"Daudi: 27.8;HDLM-2: 21.7;Karpas-707: 13.2;U-698: 42.8"									"HPA017649, HPA047584"	Uncertain		Uncertain	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA017649: AB_1846912, HPA047584: "	"unprognostic (1.09e-3)"	"prognostic favorable (1.37e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.77e-4)"	"unprognostic (4.34e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (5.85e-11)"	"unprognostic (1.17e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.44e-1)"	"prognostic favorable (1.68e-7)"	3.8	1.0	1.1	47.5	1.1	7.8	3.7	0.8	1.0	2.9	6.0	0.6	1.4	1.7	3.0	7.0	3.6	3.2	3.0	3.3	1.2	1.1	2.6	1.3	10.4	28.3	1.7	1.2	4.0	1.5	0.2	1.3	1.7	1.1	4.5	2.1	2.5	9.8	3.2	1.2	2.4	11.2	3.2	2.5	21.3	2.7	5.7	1.0	44.7	2.8	2.7	29.4	8.2	2.5	24.6	0.4	1.1	0.4	3.1	45.6	19.2	0.5	1.0	1.5	0.1	0.2	0.6	1.7	0.7	1.0	0.3	0.9	0.8	0.9	27.8	0.1	0.7	0.4	0.3	0.5	0.1	0.5	21.7	0.4	0.8	0.7	1.2	2.5	0.7	0.7	1.0	0.7	0.2	0.9	3.4	0.0	0.5	0.2	13.2	0.6	1.8	0.3	2.4	1.4	0.1	0.2	6.0	0.6	0.8	1.4	1.5	0.3	0.5	0.4	1.2	1.2	2.9	0.2	0.7	0.2	0.5	0.7	0.4	0.5	1.8	0.4	42.8	1.2	1.3	0.8	1.1	0.4	0.2	37.8	0.2	23.0	15.9	37.3	41.3	0.4	24.6	39.4	45.6	1.1	3.1	0.2	0.3	31.5	19.2	1.1	1.1	0.8	1.0	1.2	1.1	1.7	1.2	1.1	1.0	6.0	26.8	129.2	29.8	3.7	0.6	6.9	2.5	10.7	11.4	1.8	3.9	9.1	6.6	2.1	83.6	9.8	0.4	0.0	1.7	5.4	7.0	13.2	18.6	2.1	8.0	4.8	0.0	12.3	20.8	15.6	7.8	18.9	1.7	115.4	2.5	3.7	2.3	2.0	9.2	1.9	2.1	19.4	6.6	4.7	5.1	4.3	4.0	223.7	3.0	25.3
COL8A2	"FECD, FECD1, PPCD, PPCD2"	ENSG00000171812	"Collagen type VIII alpha 2 chain"	P25067	1	36095236-36125220	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion"		"Corneal dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 39.4"	"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 9.8;Fibroblasts: 13.4;Hofbauer cells: 6.5;Melanocytes: 6.8;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"classical monocyte: 1.0;intermediate monocyte: 1.2;myeloid DC: 2.8;plasmacytoid DC: 2.4"	"Group enriched"	"Detected in many"	15	"dendritic cells: 2.8;monocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"BJ: 5.6;fHDF/TERT166: 4.1;HHSteC: 14.2;hTERT-RPE1: 18.1;THP-1: 4.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA049788	Uncertain		Uncertain	"Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA			"Golgi apparatus"		"HPA049788: AB_2680882"	"unprognostic (9.98e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.51e-2)"	"unprognostic (8.41e-3)"	"unprognostic (8.76e-2)"	"prognostic favorable (9.44e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (7.26e-4)"	"unprognostic (3.50e-2)"	"unprognostic (3.01e-1)"	"prognostic unfavorable (9.35e-5)"	"unprognostic (1.08e-2)"	"unprognostic (6.77e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.16e-3)"	4.4	1.2	1.7	8.1	3.4	0.3	7.2	6.0	1.3	9.6	4.8	4.5	1.0	1.4	5.2	3.1	6.4	3.4	6.3	11.1	1.7	1.4	1.1	0.4	4.8	2.9	3.8	0.9	4.2	1.8	0.1	3.7	13.7	7.6	5.5	2.1	39.4	6.5	13.4	1.4	4.6	1.8	16.3	4.8	7.5	9.6	1.9	2.5	1.9	7.7	4.7	3.5	10.1	5.5	0.0	2.8	0.1	1.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.5	1.0	0.1	5.6	1.6	1.5	0.9	0.2	0.1	0.0	0.8	4.1	0.0	0.3	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.1	14.2	0.0	0.0	1.7	0.1	0.7	0.0	18.1	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.4	0.0	0.1	0.0	0.5	0.5	0.5	0.0	0.2	0.4	0.0	4.5	0.1	2.3	0.3	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.1	0.0	0.2	2.4	0.0	0.2	1.7	3.4	6.0	1.3	1.7	1.4	3.8	0.9	7.6	2.5	0.0	2.6	0.0	1.6	1.9	0.0	9.8	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.3	0.0	0.7	0.0	0.0	0.2	0.2	13.4	0.7	2.3	0.0	6.5	0.0	0.0	0.6	1.9	0.0	2.8	5.1	6.8	0.0	0.0	0.3	0.4	0.0	5.6	0.0	0.0	6.5	2.3	0.0	0.1	1.1	0.7	0.0	0.0	0.4
CXXC4	IDAX	ENSG00000168772	"CXXC finger protein 4"		4	104468312-104494901	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"brain: 19.4;pituitary gland: 17.2"	"Cell type enhanced"	"Detected in many"	16	"Bipolar cells: 41.0;Cone photoreceptor cells: 29.5;Horizontal cells: 42.9;Intestinal endocrine cells: 98.1;Rod photoreceptor cells: 25.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.9;memory CD8 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	20	"T-cells: 1.9"	"Cell line enhanced"	"Detected in some"		"AF22: 7.2;AN3-CA: 10.0;Karpas-707: 9.3;RPMI-8226: 5.4;SCLC-21H: 12.5;U-266/70: 10.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036600, HPA036925"	Uncertain		Uncertain	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA036600: AB_10673659, HPA036925: "	"unprognostic (1.37e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.75e-2)"	"unprognostic (5.86e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.45e-1)"	"prognostic favorable (2.19e-4)"	"unprognostic (1.82e-1)"	"unprognostic (4.52e-3)"	"unprognostic (5.69e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.42e-3)"	2.2	4.3	10.3	0.9	12.0	0.6	4.3	17.5	19.4	2.4	2.5	7.4	0.8	5.4	1.9	5.3	1.0	6.7	1.5	5.3	9.9	14.4	1.7	2.7	2.3	0.7	7.9	9.9	5.6	5.8	3.2	17.2	1.4	10.2	2.1	2.9	7.9	7.5	2.1	1.3	0.8	5.5	1.8	5.3	1.4	4.3	4.9	13.3	0.0	7.1	0.1	0.7	1.6	1.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.2	7.2	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.6	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	9.3	0.0	0.0	2.7	0.0	2.6	0.1	0.1	0.0	0.0	5.4	0.0	0.1	12.5	2.3	0.0	0.6	0.0	3.1	0.3	0.0	0.0	0.0	1.7	0.0	0.1	10.2	2.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.9	0.0	0.8	0.0	0.1	1.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	10.3	12.0	17.5	19.4	9.9	14.4	7.9	9.9	10.2	13.3	0.0	5.4	0.0	0.8	0.2	41.0	12.8	0.0	14.7	2.3	0.0	29.5	0.1	0.0	0.1	0.2	1.6	0.9	0.0	2.9	0.0	0.4	0.5	0.0	2.4	0.1	42.9	98.1	1.3	0.3	0.4	0.3	0.0	1.7	0.0	4.3	13.3	2.1	0.0	10.3	0.7	25.3	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.8	0.4
DOCK4	"FLJ34238, KIAA0716"	ENSG00000128512	"Dedicator of cytokinesis 4"	Q8N1I0	7	111726110-112206411	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 44.7;Horizontal cells: 89.0;Ito cells: 40.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 6.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.4"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 19.2;HUVEC TERT2: 36.4;TIME: 31.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071516			Approved	"Nucleoli,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Nucleoli, Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA071516: AB_2686407"	"unprognostic (1.37e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.48e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.03e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.78e-2)"	"unprognostic (7.06e-2)"	"unprognostic (3.66e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.89e-2)"	"unprognostic (9.48e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.39e-2)"	10.7	6.5	16.5	10.0	28.2	2.3	6.8	11.7	28.2	9.1	4.4	21.0	2.0	2.8	7.9	4.4	4.4	8.7	7.9	6.9	22.2	10.1	7.3	13.9	25.5	3.7	18.2	12.4	14.2	5.0	4.7	4.0	10.8	12.2	6.5	4.9	1.7	4.4	3.9	6.7	3.5	3.2	10.7	20.3	3.2	3.1	3.5	21.8	0.0	5.8	2.7	3.6	5.7	5.2	0.2	0.3	6.4	1.2	0.1	0.1	0.2	0.0	1.7	4.1	3.3	3.4	5.0	2.3	0.4	4.5	0.8	1.3	0.0	0.0	0.3	3.4	1.0	0.9	0.2	0.6	3.9	3.5	1.2	6.7	0.1	2.8	5.7	2.4	0.5	0.2	2.6	0.4	19.2	9.9	1.2	36.4	1.6	0.0	10.3	1.7	0.4	0.8	0.2	2.2	0.5	7.0	0.2	3.0	1.6	2.8	0.1	0.9	3.2	2.5	2.1	2.5	3.8	0.3	0.1	31.4	3.2	1.5	6.1	1.3	0.4	0.1	0.3	0.3	0.8	7.1	0.2	0.7	0.1	0.0	1.2	0.0	0.1	0.1	0.0	0.2	0.2	0.1	0.1	6.4	0.1	0.2	0.3	0.0	0.2	16.5	28.2	11.7	18.2	22.2	10.1	18.2	12.4	12.2	21.8	44.7	5.0	0.5	3.6	4.6	26.2	11.6	2.5	12.0	21.6	3.5	21.6	0.2	0.0	1.4	2.4	32.2	0.7	0.0	0.3	0.2	6.0	9.4	2.3	14.9	13.6	89.0	10.5	40.5	15.6	1.1	5.2	17.3	8.5	8.2	0.7	4.4	1.0	9.9	7.8	1.1	10.3	12.9	3.3	0.7	1.7	2.4	0.0	0.0	0.8	1.6
DUX4		ENSG00000260596	"Double homeobox 4"	Q9UBX2	4	190173774-190185942	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"testis: 3.4"	"Group enriched"	"Detected in some"	21	"Early spermatids: 4.1;Late spermatids: 4.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.5;U-2 OS: 3.7;U-266/70: 8.0;U-266/84: 10.4;U-698: 2.4"									HPA058451			Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Nucleoli"	"Golgi apparatus, Cytosol"	"HPA058451: AB_2683722"																		0.0	0.4		0.0		0.0	0.0		0.5	0.0	0.0			1.0	0.1	0.0	0.0	0.9	0.0	0.0			0.0	0.0	0.5	0.1			0.1	0.5	0.3		0.0		1.1	0.0		0.5	0.1	0.0	0.3	0.0	0.0		0.0	0.3	3.4			0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	2.5	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.6	0.0	0.0	0.0	3.7	0.7	0.0	8.0	10.4	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM178B	LOC51252	ENSG00000168754	"Family with sequence similarity 178 member B"	Q8IXR5	2	96875882-96986592	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 18.2;lymphoid tissue: 13.3;testis: 29.5"	"Cell type enhanced"	"Detected in some"	17	"Extravillous trophoblasts: 6.9;Late spermatids: 5.1;Spermatogonia: 19.4"	"Cancer enriched"	"Detected in many"	5	"melanoma: 8.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.2;naive CD4 T-cell: 2.6"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.6"	"Cell line enhanced"	"Detected in some"		"K-562: 17.5;OE19: 4.8;RH-30: 4.8;RPMI-8226: 19.1;WM-115: 19.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA042516, HPA062110"	Uncertain		Uncertain	"Nuclear speckles,Golgi apparatus"		NA	NA			"Nuclear speckles"	"Golgi apparatus"	"HPA042516: AB_10806241, HPA062110: "	"unprognostic (2.47e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.04e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.28e-2)"	"unprognostic (9.02e-4)"	"unprognostic (4.70e-2)"	"unprognostic (8.55e-2)"	"unprognostic (6.49e-3)"	"unprognostic (1.49e-1)"	"unprognostic (5.13e-2)"	"unprognostic (9.82e-11)"	"unprognostic (6.93e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.63e-3)"	"unprognostic (1.08e-1)"	0.8	0.0	2.4	0.6	3.8	18.2	0.6	1.0	1.5	0.6	1.0	0.6	0.6	0.1	0.7	6.8	0.6	1.5	0.6	0.6	3.4	1.9	0.6	0.6	0.6	0.6	5.3	0.6	0.6	0.6	0.0	0.6	1.1	0.6	0.6	0.2	1.0	0.6	1.0	0.6	1.2	0.6	0.6	8.5	13.3	0.0	29.5	0.6	0.6	0.6	0.6	0.6	1.0	0.6	0.0	0.8	0.0	0.0	0.1	2.6	0.6	4.2	0.0	0.0	1.4	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.4	1.7	0.0	0.0	0.1	4.8	0.0	0.0	4.8	19.1	0.0	0.0	0.6	0.0	0.0	3.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	19.2	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.6	1.7	0.0	0.1	0.0	0.8	0.0	0.6	2.4	3.8	1.0	1.5	3.4	1.9	5.3	0.6	0.6	0.6	0.0	0.0	0.8	0.6	0.7	0.1	0.3	0.0	0.0	0.0	0.0	2.0	2.7	0.0	0.0	2.4	0.0	0.0	0.0	0.0	6.9	1.4	0.2	0.0	0.0	1.1	1.6	0.0	0.6	0.0	5.1	0.9	0.3	3.3	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	1.7	19.4	1.5	2.1	0.0	0.0	0.1
FCGR1A	"CD64, CD64A"	ENSG00000150337	"Fc fragment of IgG receptor Ia"	P12314	1	149782671-149792518	"CD markers, FDA approved drug targets, Predicted membrane proteins"	"Immunity, Innate immunity"	"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 35.6;epididymis: 33.2"	"Cell type enhanced"	"Detected in many"	21	"Hofbauer cells: 235.7;Kupffer cells: 121.8;Late spermatids: 48.6;Macrophages: 101.0"	"Cancer enhanced"	"Detected in many"		"glioma: 10.3"					"Group enriched"	"Detected in some"	7	"classical monocyte: 35.6;intermediate monocyte: 14.0;myeloid DC: 9.5;neutrophil: 25.5"	"Group enriched"	"Detected in many"	80	"dendritic cells: 9.5;granulocytes: 25.5;monocytes: 35.6"	"Cell line enriched"	"Detected in some"	5	"THP-1: 61.0"									HPA026910			Uncertain	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			Vesicles	"Golgi apparatus, Plasma membrane"	"HPA026910: "	"unprognostic (5.27e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.34e-2)"	"unprognostic (7.97e-2)"	"unprognostic (8.44e-3)"	"unprognostic (1.73e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.18e-2)"	"prognostic unfavorable (4.83e-8)"	"unprognostic (1.28e-1)"	"unprognostic (4.51e-2)"	"unprognostic (9.99e-2)"	"unprognostic (9.03e-2)"	3.9	2.4	6.7	14.1	4.4	5.0	0.7	0.3	3.5	1.1	0.3			0.0	0.1	33.2	0.3	0.7	2.4	0.7	5.3	4.9	1.0	1.1	8.9	3.4	10.1		0.3	1.0	0.5	1.2	10.8		0.4	0.3		0.7	0.2	0.0	0.0	0.1	5.5	14.3	7.0	0.3	0.9			0.3		0.0	3.3	0.0	0.2	9.5	25.5	35.6	0.0	0.2	11.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.4	61.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.5	35.6	0.4	0.0	14.0	0.2	0.2	0.0	0.1	9.5	0.0	0.0	0.0	25.5	0.0	2.8	0.2	0.1	11.2											0.0	1.9	3.5	0.0	0.1	1.5	1.2	2.5	1.4	2.3	0.0	2.0	2.1	0.0	0.0	28.2	0.1	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	235.7	0.0	0.0	1.3	121.8	48.6	0.3	101.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.7	6.5	0.0	0.7	0.4	0.0	3.4	0.0	0.0	0.0
FCGR1B	CD64b	ENSG00000198019	"Fc fragment of IgG receptor Ib"	Q92637	1	121087345-121096310	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 21.8;epididymis: 36.9"	"Group enriched"	"Detected in some"	5	"Hofbauer cells: 68.7;Kupffer cells: 38.3;Macrophages: 36.3;Sertoli cells: 19.4"	"Cancer enhanced"	"Detected in single"		"glioma: 1.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 19.2;neutrophil: 21.8"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"NB-4: 10.7;THP-1: 40.9"									HPA026910			Uncertain	"Golgi apparatus,Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA			Vesicles	"Golgi apparatus, Plasma membrane"	"HPA026910: "	"unprognostic (3.21e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.10e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.65e-1)"	"unprognostic (3.24e-10)"	"unprognostic (8.99e-2)"	"unprognostic (2.85e-2)"	"unprognostic (7.86e-3)"	"unprognostic (8.93e-2)"	4.2	2.3	6.6	13.2	6.2	3.9	1.3	0.8	3.2	0.8	0.5	3.0	0.2	0.5	0.9	36.9	0.5	0.8	1.5	7.4	5.0	4.2	1.0	1.1	4.8	7.9	8.9	0.2	1.1	1.9	0.4	1.5	8.1	6.4	0.6	0.6	0.4	1.3	0.5	0.2	0.0	0.4	4.2	11.3	6.8	0.5	0.5	6.2	0.4	1.8	0.2	0.4	1.5	0.2	0.0	5.2	21.8	19.2	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.1	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	40.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	19.2	0.2	0.0	11.3	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	21.8	0.0	6.2	0.1	0.0	5.3	6.6	6.2	0.8	3.0	5.0	4.2	8.9	0.2	6.4	6.2	0.0	1.3	0.8	0.0	0.0	0.8	2.0	0.0	0.0	1.2	0.0	2.0	0.5	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	68.7	3.2	0.0	0.0	38.3	8.2	1.1	36.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	19.4	0.0	0.4	0.2	0.0	0.3	0.0	0.0	0.0
GABRD		ENSG00000187730	"Gamma-aminobutyric acid type A receptor delta subunit"	O14764	1	2019298-2030758	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	25	"brain: 87.0"	"Cell type enhanced"	"Detected in some"	9	"Bipolar cells: 9.3;Ciliated cells: 8.1;Club cells: 11.4;Horizontal cells: 12.7;Spermatogonia: 13.5"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 87.0"	"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.9;HMC-1: 2.5;MCF7: 8.3;NB-4: 5.3;NTERA-2: 2.1;SH-SY5Y: 3.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA044371	Enhanced		Uncertain	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA044371: AB_2678916"	"unprognostic (4.28e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.95e-8)"	"unprognostic (6.34e-3)"	"unprognostic (2.66e-3)"	"unprognostic (1.04e-2)"	"unprognostic (3.44e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.99e-1)"	"prognostic unfavorable (4.12e-8)"	"unprognostic (1.72e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.16e-2)"	1.2	3.4	8.8	0.9	16.8	1.0	1.0	87.0	40.0	1.0	1.2	1.7	0.0	0.9	1.3	1.2	1.3	1.0	1.5	1.7	6.0	1.7	1.1	0.9	1.4	1.3	3.3	11.1	0.9	0.9	1.4	0.7	1.2	17.1	1.0	1.0	0.0	1.1	0.9	1.3	1.4	1.0	1.4	1.4	1.0	1.0	3.3	1.5	0.0	1.6	0.0	1.0	1.2	0.1	0.0	1.2	0.2	0.1	0.0	0.0	0.8	0.0	0.7	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.9	0.0	0.3	0.0	1.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	5.3	2.1	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	3.1	0.1	0.0	0.0	0.0	1.1	1.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.8	8.8	16.8	87.0	40.0	6.0	1.7	3.3	11.1	17.1	1.5	3.0	5.1	0.0	0.0	0.5	9.3	0.8	0.0	8.1	11.4	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.2	0.0	0.1	2.3	0.0	0.1	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.7	0.0	3.1	0.1	13.5	0.0	0.2	0.0	0.0	0.0
GAGE10		ENSG00000215274	"G antigen 10"	A6NGK3	X	49303669-49319844	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"ovary: 3.9;pituitary gland: 3.1;testis: 2.9"	"Cell type enhanced"	"Detected in some"	28	"Leydig cells: 1.1;Peritubular cells: 1.1;Spermatocytes: 1.4;Spermatogonia: 4.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 7.0;BJ hTERT+: 1.5;SuSa: 2.2;WM-115: 2.9"									HPA043232	Supported		Uncertain	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"					"unprognostic (2.81e-2)"					"unprognostic (2.26e-1)"						"unprognostic (3.97e-1)"		0.0	0.0	0.6	0.0	1.8	0.1	0.8	0.5	0.3	0.0	0.2			0.0	0.5	2.0	0.0	1.7	0.1	0.5	0.5	0.5	0.0	0.0	0.0	0.6	0.4		3.9	0.0	0.0	3.1	0.0		0.4	0.3		0.2	1.1	0.2	0.0	0.0	1.4	0.2	0.3	0.0	2.9			0.8		0.2	0.0	0.1	0.0	0.7	0.0	0.5	0.1	0.5	0.3	0.0	0.0	0.6	7.0	0.7	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	1.0	0.0	0.0	0.2	0.0	0.2	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.2	1.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.9	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.3	0.0	0.1	0.5	0.7	0.3	0.3											0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.4	4.9	0.1	0.0	0.0	0.0	0.1
GAGE12E		ENSG00000216649	"G antigen 12E"	A1L429	X	49551333-49558649	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	18	"testis: 9.6"	"Cell type enriched"	"Detected in some"	12	"Spermatogonia: 11.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 7.4;HeLa: 4.1;Karpas-707: 2.0;T-47d: 1.7;U-266/84: 4.4;WM-115: 2.0"									HPA043232	Supported		Uncertain	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA043232: AB_2678376"																		0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	9.6			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.1	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.6	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.7	0.0	0.0	0.5	0.3	0.0	0.0	0.7	4.4	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	11.5	0.0	0.0	0.0	0.0	0.0
GALNT17	"GalNAc-T17, GalNAc-T19, GalNAc-T5L, GALNTL3, ppGalNAc-T17, WBSCR17"	ENSG00000185274	"Polypeptide N-acetylgalactosaminyltransferase 17"	Q6IS24	7	71132169-71713600	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.9"	"Cell type enhanced"	"Detected in single"	28	"Collecting duct cells: 1.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.6;NTERA-2: 7.2;RPMI-8226: 8.0;SK-BR-3: 30.5;SuSa: 10.0"	"Low region specificity"	"Detected in all"							"HPA013624, HPA047986"	Approved		Uncertain	"Nucleoplasm,Nucleoli,Nuclear bodies,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"	"Nucleoli, Nuclear bodies"	"HPA013624: AB_1858787, HPA047986: "	"unprognostic (2.79e-2)"	"unprognostic (6.83e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.62e-1)"	"unprognostic (6.41e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (4.60e-4)"	"unprognostic (2.00e-1)"	"unprognostic (4.73e-1)"	"unprognostic (1.96e-2)"	"unprognostic (9.63e-3)"	"prognostic favorable (3.91e-4)"	"unprognostic (1.92e-1)"	"unprognostic (7.94e-3)"	1.8	7.8	8.2	2.1	13.9	0.5	1.2	25.7	42.9	2.3	4.9	1.7	1.9	0.8	7.9	4.6	8.9	4.4	2.7	19.4	13.2	4.6	2.3	0.6	3.5	0.5	2.1	12.0	22.3	9.4	0.6	4.1	0.7	4.5	9.1	1.4	1.2	1.7	8.3	1.9	0.8	1.5	12.3	1.2	3.3	1.1	3.8	0.8	0.3	9.4	0.0	1.8	10.3	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.5	0.0	0.0	30.5	0.0	10.0	0.0	0.0	0.0	0.0	2.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	13.9	25.7	22.5	13.2	4.6	2.1	12.0	4.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GAPT	"C5orf29, FLJ33641"	ENSG00000175857	"GRB2 binding adaptor protein, transmembrane"	Q8N292	5	58491435-58497090	"Predicted intracellular proteins"	"B-cell activation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"blood: 117.8"	"Group enriched"	"Detected in some"	9	"B-cells: 29.7;granulocytes: 52.1;Hofbauer cells: 15.1;Kupffer cells: 25.6;Macrophages: 34.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"eosinophil: 117.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 117.8"	"Cell line enhanced"	"Detected in some"		"HEL: 27.4;HL-60: 15.8;NB-4: 16.5;THP-1: 13.0;U-937: 45.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA011048, HPA011070"	Uncertain		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	"Golgi apparatus, Vesicles"	"HPA011048: , HPA011070: AB_1848887"	"unprognostic (9.79e-2)"	"unprognostic (5.67e-3)"	"unprognostic (2.39e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.36e-2)"	"unprognostic (8.09e-4)"	"unprognostic (4.32e-1)"	"unprognostic (1.23e-3)"	"unprognostic (4.14e-2)"	"unprognostic (9.47e-3)"	"unprognostic (7.28e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.52e-3)"	"unprognostic (3.74e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.40e-2)"	1.4	0.8	1.4	15.5	2.7	8.5	1.0	0.6	1.2	1.8	1.4	1.6	0.4	1.8	1.3	2.2	3.3	1.2	3.1	1.1	1.5	1.7	1.6	1.0	7.2	19.4	4.5	0.9	0.7	1.2	0.0	1.5	0.8	4.4	2.6	2.0	1.4	2.3	0.4	0.5	0.9	8.2	2.4	5.9	25.8	1.7	0.8	3.2	5.2	1.1	0.5	23.5	5.1	1.2	12.0	25.4	117.8	8.2	0.1	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.4	0.0	0.0	0.0	15.8	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	16.5	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.7	0.0	12.3	8.2	117.8	0.0	5.7	0.0	12.0	0.0	0.0	9.4	11.9	0.0	0.0	10.1	0.1	6.6	25.4	0.0	3.4	1.4	2.7	0.6	1.2	1.5	1.7	4.5	0.9	4.4	3.2	3.0	3.4	29.7	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.1	0.0	15.1	0.0	0.0	0.6	25.6	0.0	0.0	34.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0
GCGR	GGR	ENSG00000215644	"Glucagon receptor"	P47871	17	81804132-81814013	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Diabetes mellitus, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 68.8"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 60.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 10.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 3.9;MCF7: 6.1;SK-BR-3: 5.3;U-87 MG: 6.1"	"Region enriched"	"Detected in single"	5	"cerebellum: 0.9"	"Not detected"	"Not detected"			HPA071228			Uncertain	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA071228: AB_2686368"	"unprognostic (3.28e-4)"	"unprognostic (9.30e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.53e-4)"	"unprognostic (1.11e-1)"	"unprognostic (2.30e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.42e-2)"	"unprognostic (5.99e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.17e-3)"	"unprognostic (8.36e-3)"	0.2	3.9	0.1	0.6	0.3	0.0	0.1	0.1	0.3	0.2	0.2	0.1	0.1	0.2	0.1	0.2	0.2	0.0	0.1	0.1	0.1	0.0	11.4	68.8	0.1	0.1	0.1	0.1	0.1	0.5	3.9	0.1	0.1	0.5	0.2	0.0	1.4	0.3	0.1	0.1	0.9	0.2	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.2	0.6	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	3.9	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	1.6	0.0	5.3	0.0	0.0	0.0	0.6	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.3	0.1	0.0	0.1	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.8	0.2	0.6	0.0	0.0	0.0	3.5	2.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.2	0.1	0.0	0.0	1.3	3.7	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.0	0.0
GLYATL1	"FLJ34646, MGC15397"	ENSG00000166840	"Glycine-N-acyltransferase like 1"	Q969I3	11	58905398-59043527	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 113.8"	"Cell type enhanced"	"Detected in some"	31	"Distal tubular cells: 91.2;Hepatocytes: 198.3;Proximal tubular cells: 523.1"	"Group enriched"	"Detected in some"	8	"liver cancer: 14.1;prostate cancer: 13.3;renal cancer: 10.1"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"naive CD4 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 3.9;Daudi: 9.7;RPTEC TERT1: 3.3;U-2197: 2.5"									HPA039501	Supported		Uncertain	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA039501: AB_2676545"	"unprognostic (9.46e-3)"	"unprognostic (5.33e-2)"	"unprognostic (3.90e-5)"	"unprognostic (3.93e-3)"	"unprognostic (3.54e-3)"	"unprognostic (2.17e-1)"	"prognostic favorable (3.69e-4)"	"unprognostic (3.62e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.92e-1)"	"prognostic favorable (3.03e-5)"	"unprognostic (1.50e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.55e-2)"	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.8	0.1	0.1	0.1	0.0	0.0	0.1	27.7	113.8	0.1	0.0	0.2	0.0	0.2	0.2	0.9	0.1	0.0	0.5	2.1	0.0	0.5	1.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.3	0.0	0.1	1.0	0.0	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.4	1.3	0.0	0.5	0.2	1.1	0.9	3.9	0.0	9.7	0.0	0.7	0.8	0.0	0.0	0.0	1.7	0.0	0.4	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.6	2.2	0.0	0.2	0.0	0.1	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.4	3.3	0.0	0.2	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.0	1.2	0.1	2.5	1.7	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.5	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.3	17.8	0.0	0.0	14.0	0.0	0.0	91.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.8	0.0	198.3	0.0	0.0	0.0	1.8	6.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	523.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.1
GLYATL1B	GLYATL1P3	ENSG00000255151	"Glycine-N-acyltransferase like 1B"		11	59086307-59094786	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Group enriched"	"Detected in some"	7	"blood: 4.9;breast: 12.5;lymphoid tissue: 4.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"prostate cancer: 0.7"					"Group enriched"	"Detected in some"	17	"memory B-cell: 1.9;naive B-cell: 4.9"	"Lineage enriched"	"Detected in single"	24	"B-cells: 4.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.9;JURKAT: 2.0;Karpas-707: 2.2;T-47d: 3.2;U-2197: 2.5;U-266/70: 5.0"									HPA039501	Uncertain		Uncertain	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA039501: AB_2676545"	"unprognostic (1.39e-1)"	"unprognostic (3.46e-1)"						"unprognostic (1.44e-1)"			"unprognostic (1.25e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.21e-4)"	"unprognostic (3.45e-1)"		0.0	0.0		1.0		0.0	12.5		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	4.1			0.0	0.0	0.0		0.0		0.9	0.0		0.0	0.0	0.0	0.1	0.0	0.0		0.6	0.0	0.0			0.0		0.0	0.0		4.9	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	4.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.1	2.2	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	3.2	0.0	0.0	0.0	0.5	2.5	0.2	5.0	1.6	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H1F0	"H10, H1FV"	ENSG00000189060	"H1 histone family member 0"	P07305	22	37805093-37807436	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 158.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 85.2;U-2 OS: 110.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000843	Supported		Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus,Actin filaments"		Yes	No			"Nucleoplasm, Nuclear bodies"	"Golgi apparatus, Actin filaments"	"HPA000843: AB_1079062"	"unprognostic (1.29e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.31e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.85e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.95e-3)"	"unprognostic (4.86e-3)"	"prognostic favorable (7.68e-7)"	"unprognostic (3.40e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.73e-1)"	21.7	13.6	27.5	14.7	24.9	158.1	32.3	35.7	41.7	48.2	37.9	20.4	11.3	35.8	42.7	18.5	66.0	31.7	38.5	30.3	23.5	17.6	33.2	90.6	22.8	15.0	16.0	23.8	48.5	43.5	20.2	25.6	33.6	23.5	43.7	34.0	28.3	43.2	12.4	53.5	53.2	59.2	28.0	18.6	16.3	34.6	15.2	18.8	56.3	36.1	33.4	32.0	24.9	45.2	0.1	6.3	12.5	9.0	0.1	2.4	4.7	20.2	8.8	27.4	12.1	7.2	6.6	38.9	16.5	34.6	48.5	69.2	35.9	32.5	0.0	4.1	13.7	11.3	39.8	0.0	11.4	34.6	0.1	2.0	34.3	3.2	23.8	25.4	0.0	0.1	6.2	20.3	24.3	27.4	0.5	12.8	7.9	0.0	0.0	3.7	33.6	5.7	3.3	10.6	85.2	43.5	9.5	16.3	7.0	7.6	5.5	6.3	35.4	45.7	31.2	60.2	12.8	24.3	21.5	8.5	3.7	110.7	16.3	3.3	0.0	2.3	0.1	4.5	12.4	10.5	12.5	7.6	11.3	0.1	9.0	0.1	0.0	0.8	0.2	6.3	0.1	2.4	0.3	4.2	0.1	7.7	5.7	0.2	4.7	27.5	24.9	35.7	41.7	23.5	17.6	16.0	23.8	23.5	18.8	26.8	114.5	10.0	163.5	62.0	29.8	40.3	107.0	97.7	135.4	97.7	3.9	33.1	106.1	132.1	1.8	71.9	117.5	280.4	159.3	112.5	82.5	175.2	22.0	68.2	59.5	42.9	119.1	63.3	67.8	3.7	85.4	44.3	81.0	92.8	180.5	46.0	119.5	160.1	57.0	42.8	5.6	109.9	96.7	55.8	24.9	78.3	183.8	7.0	103.1	138.2
HMOX1	"bK286B10, HO-1"	ENSG00000100292	"Heme oxygenase 1"	P09601	22	35380361-35394214	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 209.8"	"Cell type enhanced"	"Detected in many"	15	"Hofbauer cells: 439.8;Kupffer cells: 915.4;monocytes: 247.9;Syncytiotrophoblasts: 419.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"classical monocyte: 17.7;intermediate monocyte: 40.5;non-classical monocyte: 53.4"	"Lineage enriched"	"Detected in many"	6	"monocytes: 53.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 108.8;GAMG: 71.3;U-138 MG: 63.5;U-87 MG: 61.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA000635, CAB017444"	Enhanced		Uncertain	"Golgi apparatus,Plasma membrane"		NA	NA		17000	"Golgi apparatus, Plasma membrane"		"CAB017444: AB_10617276, HPA000635: AB_1079089"	"unprognostic (3.12e-1)"	"unprognostic (1.00e-1)"	"unprognostic (9.42e-2)"	"unprognostic (6.94e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.47e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (7.56e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.91e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.54e-2)"	28.4	10.3	4.1	12.5	8.7	16.3	13.8	0.8	20.6	5.7	12.0	6.1	0.6	22.0	2.5	8.5	8.8	9.8	9.8	10.2	4.1	3.1	23.0	63.7	54.0	76.3	12.5	1.3	28.6	8.8	0.5	2.7	21.1	7.5	3.6	4.9	3.3	3.5	0.8	21.9	13.8	22.8	6.9	11.2	209.8	4.6	5.9	7.6	3.6	4.2	7.3	8.3	6.7	10.2	4.8	7.9	8.4	53.4	1.1	0.3	10.1	1.4	22.1	0.2	4.5	18.1	5.3	108.8	10.2	6.0	4.8	5.2	9.8	1.3	0.0	2.3	8.3	71.3	1.2	1.3	0.2	1.5	36.6	1.1	0.5	6.7	20.0	25.2	1.3	6.9	16.6	0.4	31.7	2.1	7.7	14.4	0.0	0.0	10.6	15.3	1.1	0.0	0.5	2.2	13.6	2.5	0.1	1.9	3.4	3.4	11.9	0.3	0.3	26.4	2.3	1.7	9.6	1.0	0.3	5.4	63.5	2.8	10.3	9.9	6.6	8.5	1.0	61.6	0.6	1.0	2.0	17.7	1.2	0.2	40.5	0.0	4.8	0.1	0.3	7.9	0.5	0.0	0.0	8.4	1.1	53.4	0.2	0.2	10.1	4.1	8.7	0.8	4.8	4.1	3.1	12.5	1.3	7.5	7.6	3.0	21.3	13.8	5.9	14.5	0.0	3.1	10.2	1.4	0.0	5.2	0.0	39.4	18.3	10.3	1.6	20.2	43.4	0.0	1.3	204.4	21.6	85.9	11.5	19.5	439.8	0.0	15.3	30.7	915.4	1.3	28.7	175.5	33.7	247.9	5.3	0.2	8.7	10.5	4.9	128.1	0.4	0.0	16.5	0.9	2.7	13.7	419.8	10.0	4.1	91.1
HSPB6	"FLJ32389, Hsp20, PPP1R91"	ENSG00000004776	"Heat shock protein family B (small) member 6"	O14558	19	35754569-35758079	"Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 356.8"	"Group enriched"	"Detected in many"	5	"Leydig cells: 251.7;Peritubular cells: 207.2;Smooth muscle cells: 65.1"	"Cancer enhanced"	"Detected in all"		"stomach cancer: 93.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 189.0;ASC TERT1: 79.8;HHSteC: 64.1;HSkMC: 74.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB001974, HPA044153, HPA054811"	Enhanced		Supported	"Nucleoli,Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA		86000	Cytosol	"Nucleoli, Golgi apparatus"	"CAB001974: , HPA044153: AB_2678836, HPA054811: AB_2682610"	"unprognostic (3.19e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.21e-3)"	"unprognostic (7.02e-2)"	"unprognostic (9.67e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.02e-2)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (3.32e-2)"	"unprognostic (6.65e-2)"	"unprognostic (5.61e-2)"	"prognostic unfavorable (1.43e-6)"	95.3	39.5	3.9	18.3	8.1	1.1	40.5	1.1	6.1	49.7	48.4	3.8	18.6	5.7	42.6	57.4	24.6	33.3	80.6	132.0	4.4	2.4	6.2	3.5	8.7	7.2	5.4	2.8	53.4	5.8	1.7	1.2	12.7	8.1	42.1	8.7	18.2	8.6	35.8	356.8	2.5	14.3	128.2	10.2	1.9	32.4	22.6	4.9	0.0	11.0	153.5	16.4	121.6	23.3	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.2	0.2	189.0	79.8	0.1	8.4	0.1	0.5	0.9	0.1	0.0	0.0	0.0	25.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	64.1	0.0	0.1	74.6	0.0	1.9	0.0	0.2	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	1.8	0.0	0.1	0.2	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.9	8.1	1.1	6.1	4.4	2.4	5.4	2.8	8.1	4.9	3.0	1.1	0.0	0.2	1.5	7.4	26.8	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.1	19.2	2.2	0.0	0.0	0.0	2.8	35.4	0.4	0.0	0.0	4.5	0.0	0.0	28.3	0.3	14.1	251.7	2.0	1.7	1.0	0.0	30.6	0.2	0.0	207.2	0.0	2.1	25.8	65.1	2.2	1.2	1.8	4.0	0.0	0.0	0.5
IFITM1	"9-27, CD225, IFI17"	ENSG00000185885	"Interferon induced transmembrane protein 1"	P13164	11	313506-315272	"CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiviral defense, Immunity, Innate immunity, Osteogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Club cells: 187.7;Leydig cells: 278.5;Sertoli cells: 271.7;T-cells: 358.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"eosinophil: 56.6;gdT-cell: 120.0;MAIT T-cell: 80.7;memory CD4 T-cell: 128.1;memory CD8 T-cell: 121.4;naive CD4 T-cell: 123.5;naive CD8 T-cell: 123.4;neutrophil: 106.8;NK-cell: 164.4;T-reg: 70.4"	"Group enriched"	"Detected in all"	7	"granulocytes: 106.8;NK-cells: 164.4;T-cells: 128.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 122.7;BJ hTERT+ SV40 Large T+ RasG12V: 219.9;HMC-1: 67.9"									"HPA004810, CAB017615"	Enhanced		Uncertain	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"CAB017615: AB_2264496, HPA004810: AB_1851419"	"unprognostic (1.03e-3)"	"unprognostic (6.79e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.57e-1)"	"unprognostic (9.06e-2)"	"unprognostic (7.58e-2)"	"unprognostic (3.03e-1)"	"unprognostic (6.21e-2)"	"unprognostic (5.53e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (5.77e-9)"	"unprognostic (7.29e-2)"	"unprognostic (6.29e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.82e-2)"	81.1	14.2	17.4	36.7	24.5	41.2	57.0	11.9	23.1	71.0	28.2	12.9	20.6	17.2	48.3	152.4	44.4	67.2	31.2	62.6	19.8	13.9	59.8	34.5	44.1	159.7	34.8	14.7	100.2	16.3	22.3	23.3	36.3	27.3	38.7	22.1	49.5	27.4	41.6	38.7	23.6	33.0	46.0	37.9	112.9	20.5	29.4	20.1	42.7	48.3	28.0	50.3	39.3	52.8	13.0	4.3	106.8	18.6	164.4	128.1	147.7	6.4	0.1	53.3	4.3	3.9	13.7	0.3	11.3	53.0	122.7	219.9	0.1	44.5	0.1	8.5	11.9	1.2	15.1	1.7	1.1	2.4	13.5	2.8	6.5	4.1	0.4	35.3	9.5	67.9	25.6	0.0	1.3	0.1	1.3	0.2	2.1	23.2	53.9	0.0	0.9	4.7	18.3	15.2	0.0	1.6	1.2	0.1	1.2	32.8	0.0	0.0	0.0	5.9	0.6	10.9	7.6	2.2	0.8	0.3	0.1	0.1	0.0	0.0	3.8	2.0	0.3	0.1	14.3	0.1	15.6	2.3	56.6	120.0	10.9	80.7	13.0	128.1	121.4	4.3	11.3	123.5	123.4	106.8	164.4	18.6	1.2	70.4	147.7	17.4	24.5	11.9	23.1	19.8	13.9	34.8	14.7	27.3	20.1	32.8	96.7	12.5	9.5	24.7	0.0	4.8	0.0	36.1	187.7	31.4	0.0	1.2	5.0	0.9	1.2	146.9	12.4	0.0	1.2	25.0	131.5	1.8	17.4	17.9	9.3	0.0	1.2	130.1	11.0	0.0	278.5	21.9	74.2	0.0	14.4	0.0	0.9	10.1	117.0	0.3	0.0	271.7	95.7	0.3	1.0	12.5	3.3	358.0	24.3	4.4
KCNJ12	"hIRK1, IRK2, KCNJN1, Kir2.2, Kir2.2v"	ENSG00000184185	"Potassium voltage-gated channel subfamily J member 12"	Q14500	17	21376197-21419872	"FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"brain: 39.4;skeletal muscle: 47.8"	"Cell type enriched"	"Detected in some"	7	"Horizontal cells: 84.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	7	"cerebellum: 39.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 3.6;HeLa: 5.9;PC-3: 6.3;SCLC-21H: 7.3;SiHa: 3.7;SuSa: 8.0;U-2197: 6.3"	"Low region specificity"	"Detected in all"							HPA027021	Approved		Uncertain	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA027021: AB_10602912"	"unprognostic (3.81e-3)"	"unprognostic (2.69e-2)"	"unprognostic (8.60e-2)"	"prognostic unfavorable (7.84e-5)"	"unprognostic (2.29e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.39e-2)"	"unprognostic (4.91e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.90e-2)"	"unprognostic (9.70e-3)"	1.2	1.3	1.9	0.9	2.9	0.7	0.9	39.4	5.8	1.2	0.8	1.1	0.5	0.5	0.8	1.4	1.5	2.1	0.7	5.1	0.9	1.4	1.2	0.5	1.3	0.4	1.3	3.4	0.7	0.5	10.6	0.7	0.7	4.0	0.9	0.6	1.7	0.6	0.9	47.8	6.0	0.6	1.0	0.9	1.3	0.9	1.3	0.9	0.0	1.0	7.5	1.1	0.8	1.5	0.0	0.9	0.0	0.5	0.0	0.1	0.0	0.0	1.1	0.4	2.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	3.6	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.2	5.9	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.1	0.1	0.0	1.5	0.0	6.3	0.0	1.0	1.6	0.0	0.0	7.3	0.4	3.7	0.0	1.5	8.0	0.0	0.0	2.8	0.0	0.5	6.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.1	0.0	1.9	2.9	39.4	5.8	0.9	1.4	1.3	3.4	4.0	0.9	0.0	0.0	0.0	0.0	1.3	0.8	12.5	0.0	0.0	0.0	1.8	0.0	0.0	1.7	0.0	0.4	1.4	0.0	0.0	0.0	0.0	2.1	0.2	0.0	0.0	0.2	84.2	1.2	5.5	0.0	0.2	6.9	0.0	0.0	0.0	0.4	11.2	0.0	0.0	3.9	0.6	1.4	0.0	0.5	0.5	1.3	1.9	0.1	0.0	0.6	0.0
KCNJ18	"KIR2.6, TTPP2"	ENSG00000260458	"Potassium voltage-gated channel subfamily J member 18"	B7U540	17	21692523-21704612	"Disease related genes, Predicted membrane proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	12	"lymphoid tissue: 3.5;skin 1: 8.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"cervical cancer: 0.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 1.0;HDLM-2: 2.1;HeLa: 1.7;RPMI-8226: 1.0;U-266/70: 3.3"					"Region enhanced"	"Detected in many"		"cerebellum: 75.1"	HPA027021	Uncertain		Uncertain	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA027021: AB_10602912"		"unprognostic (2.41e-1)"				"unprognostic (3.90e-5)"			"unprognostic (2.56e-1)"						"unprognostic (1.95e-1)"			0.0	0.0		0.0		0.0	0.4		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	8.1	0.0	0.0		0.0	0.0	0.3			0.0		3.5	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.1	0.4	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0
KIAA0141	DELE	ENSG00000081791	KIAA0141	Q14154	5	141923808-141942047	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036548, HPA061490"	Uncertain		Uncertain	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA036548: AB_10673356, HPA061490: "	"unprognostic (1.97e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.63e-1)"	"prognostic unfavorable (6.89e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.15e-3)"	"unprognostic (7.86e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.02e-1)"	"unprognostic (2.28e-3)"	26.2	35.7	17.9	28.5	21.0	31.0	27.4	39.6	26.8	24.8	27.2	28.1	33.5	27.3	32.9	29.0	23.5	26.1	29.4	66.5	17.9	16.2	27.0	35.2	28.9	35.6	21.7	25.8	26.2	28.4	25.2	25.2	28.2	22.0	26.2	28.6	23.1	22.1	38.8	40.9	20.1	24.6	27.5	23.2	43.0	26.0	19.0	21.2	19.9	26.9	26.5	24.8	27.6	24.9	10.2	26.2	8.8	28.8	10.9	12.3	10.7	10.0	13.6	20.0	29.3	15.8	21.0	13.3	13.2	21.5	23.1	25.7	19.5	23.7	23.8	15.2	14.3	13.4	15.7	12.0	27.7	12.9	13.6	10.6	14.4	15.8	15.1	20.1	20.4	28.5	25.5	13.9	20.2	16.6	20.8	24.1	5.1	9.1	32.5	11.9	13.1	5.4	11.2	7.7	12.5	21.2	18.6	13.3	26.4	16.7	15.0	11.3	14.3	15.3	24.1	31.2	13.6	31.1	18.4	19.3	17.7	10.8	9.2	11.7	9.1	9.7	14.5	14.4	16.4	19.4	7.7	20.3	6.5	10.4	26.4	9.8	10.2	8.4	10.2	26.2	9.4	7.2	9.2	8.8	10.9	28.8	10.6	12.3	10.7	17.9	21.0	39.6	26.8	17.9	16.2	21.7	25.8	22.0	21.2	11.9	27.4	12.8	15.2	7.2	7.4	0.0	28.1	14.7	10.3	0.0	27.5	22.7	0.0	0.0	0.7	29.7	19.2	0.0	0.0	11.4	12.3	13.8	18.5	25.9	24.6	33.4	20.8	28.3	26.1	1.1	14.7	18.7	15.1	0.0	20.9	4.8	0.0	10.5	8.5	0.0	19.5	12.9	7.2	3.0	5.5	9.4	21.5	15.2	25.0	17.2
KIF3B	"FLA8, KIAA0359, KLP-11"	ENSG00000101350	"Kinesin family member 3B"	O15066	20	32277664-32335011	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 100.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007119	Approved		Uncertain	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	NA			Nucleoplasm	"Nucleoli, Golgi apparatus"	"HPA007119: AB_1852498"	"unprognostic (1.74e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.14e-1)"	"unprognostic (9.01e-3)"	"unprognostic (9.30e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.44e-12)"	"unprognostic (2.41e-2)"	"unprognostic (2.68e-1)"	"unprognostic (5.11e-2)"	"unprognostic (4.42e-2)"	8.4	11.0	22.9	7.7	30.2	5.5	9.1	17.6	24.6	11.6	13.4	13.3	7.7	14.3	8.8	13.5	5.8	15.4	11.0	6.2	19.9	15.1	26.4	17.8	9.3	7.7	15.1	18.7	10.5	16.9	38.5	18.1	6.4	13.2	9.0	14.2	11.8	8.4	8.6	5.3	5.8	17.1	9.0	16.0	6.8	12.7	15.3	13.7	4.3	14.3	4.1	8.4	8.5	6.5	6.5	3.1	3.7	5.9	2.6	6.6	1.8	22.9	15.6	10.9	13.9	14.5	23.1	11.1	11.4	16.0	13.9	10.9	26.5	12.7	12.4	13.8	21.5	19.8	14.9	13.9	16.9	17.7	5.8	6.3	10.7	12.5	13.0	9.2	9.0	8.2	14.1	12.2	23.9	9.5	11.4	11.2	5.0	6.6	4.9	11.1	10.5	4.1	4.1	5.8	12.3	13.7	3.8	17.9	4.5	14.2	17.0	17.9	15.1	29.8	8.0	11.4	9.5	17.6	7.0	13.6	26.1	17.8	15.1	14.1	8.3	11.9	6.4	25.9	15.8	10.5	1.3	3.1	3.7	6.6	4.2	5.5	6.1	5.0	6.1	1.7	6.5	3.1	4.6	3.2	2.6	5.9	3.1	3.9	1.8	22.9	30.2	17.6	24.6	19.9	15.1	15.1	18.7	13.2	13.7	20.8	25.5	9.3	7.3	6.0	31.6	7.0	35.7	53.5	14.8	12.2	100.1	6.5	3.3	29.6	52.5	12.5	61.3	0.0	33.7	5.2	11.0	13.5	8.1	20.4	7.0	30.2	37.8	13.5	7.3	61.7	12.4	5.9	0.0	4.6	25.9	20.6	28.0	33.1	19.1	19.9	58.5	0.0	6.2	30.1	6.9	4.4	5.5	8.6	21.8	7.8
KLF5	"BTEB2, CKLF, IKLF"	ENSG00000102554	"Kruppel like factor 5"	Q13887	13	73054976-73077542	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 88.4;intestine: 88.1"	"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 1017.1;Suprabasal keratinocytes: 599.6;Urothelial cells: 1225.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"basal ganglia: 22.2"	"Cell type enriched"	"Detected in single"	18	"basophil: 16.3"	"Lineage enriched"	"Detected in single"	106	"granulocytes: 16.3"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 27.5;HaCaT: 31.5;HBEC3-KT: 27.5;hTCEpi: 39.3;OE19: 59.4;RT4: 33.2;SiHa: 28.0"	"Group enriched"	"Detected in many"	4	"amygdala: 5.6;basal ganglia: 9.3;cerebral cortex: 6.9;hippocampal formation: 8.8;hypothalamus: 4.3"	"Low region specificity"	"Detected in some"			HPA040398	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			Nucleoplasm	"Golgi apparatus, Vesicles"	"HPA040398: AB_10673267"	"unprognostic (7.90e-3)"	"unprognostic (5.11e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.82e-1)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (2.55e-4)"	"unprognostic (4.43e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.56e-3)"	"unprognostic (3.98e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.54e-2)"	2.3	1.5	4.1	24.3	22.2	12.9	8.1	0.7	1.2	19.6	74.4	0.4	4.3	28.7	4.8	3.7	88.4	8.3	48.4	1.3	1.4	1.2	3.9	1.2	12.8	0.1	0.9	1.1	5.0	3.5	0.0	7.3	22.8	4.3	17.6	32.9	1.8	26.4	5.4	10.0	59.4	88.1	4.1	2.4	0.8	17.9	12.2	1.4	3.0	20.7	64.4	61.8	23.4	34.1	0.0	0.0	16.3	0.0	0.0	0.1	0.0	5.3	7.4	0.0	0.1	0.2	0.4	8.5	3.1	7.3	1.4	1.7	6.9	27.5	0.1	16.7	2.7	0.5	31.5	9.6	27.5	2.2	0.2	2.5	0.1	15.7	0.6	2.0	2.5	0.4	2.0	39.3	0.4	15.4	1.4	0.0	0.9	0.3	0.5	6.3	1.8	0.5	0.1	0.3	59.4	10.6	0.4	7.0	0.6	21.8	33.2	0.7	0.3	28.0	4.5	1.9	3.6	0.6	0.6	0.0	1.9	5.7	0.0	1.3	0.9	0.4	0.9	2.7	0.5	2.3	16.3	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	4.1	22.2	0.7	1.2	1.4	1.2	0.9	1.1	4.3	1.4	151.8	97.6	0.5	1017.1	460.9	0.4	5.6	79.0	128.5	151.2	34.9	2.0	57.7	18.3	30.8	305.6	1.1	308.2	0.0	40.2	87.3	46.1	522.9	3.5	2.9	5.4	9.5	195.2	0.6	0.0	162.5	6.1	6.1	55.6	5.4	327.8	0.0	63.9	284.0	1.4	2.6	0.0	0.0	28.8	7.2	25.9	599.6	48.5	0.7	397.9	1225.4
LDLRAD1		ENSG00000203985	"Low density lipoprotein receptor class A domain containing 1"	Q5T700	1	54007299-54018186	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"fallopian tube: 64.2;lung: 16.1;ovary: 20.5"	"Cell type enriched"	"Detected in some"	15	"Ciliated cells: 499.2"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 3.7;Hep G2: 15.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052489	Enhanced		Uncertain	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA052489: AB_2681850"	"unprognostic (6.53e-3)"	"unprognostic (2.05e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (9.21e-4)"		"unprognostic (1.59e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.97e-1)"		"unprognostic (1.32e-1)"	"unprognostic (8.07e-3)"	"unprognostic (2.43e-1)"		"unprognostic (2.86e-1)"	"unprognostic (5.23e-1)"		"unprognostic (4.27e-2)"	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	0.1	0.1	0.0	0.0	0.6	2.1	0.4	64.2	1.1	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	20.5	0.1	0.0	1.5	0.1	0.2	0.5	0.0	0.0	2.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.8	1.1	0.0	0.0	0.0	0.8	4.8	0.0	0.0	0.7	0.5	2.1	0.4	0.4	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.1	3.7	0.0	1.9	0.0	0.1	0.6	0.0	0.1	0.0	0.0	0.1	0.3	0.8	15.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	1.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.6	0.3	0.0	0.1	1.0	0.0	0.1	0.8	0.1	0.0	0.3	0.2	0.1	0.1	0.4	0.0	0.1	0.3	0.0	0.2	2.1	0.4	0.3	0.4	0.2	0.3	0.5	0.3	0.4	0.1	0.7	0.4	0.5	2.1	0.4	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	6.0	7.4	0.0	0.2	0.0	0.0	0.0	0.0	499.2	34.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.6	4.7	0.0	0.1	0.0	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3
LRAT	LCA14	ENSG00000121207	"Lecithin retinol acyltransferase"	O95237	4	154626945-154753118	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Sensory transduction, Vision"	"Acyltransferase, Transferase"	"Disease mutation, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"retina: 82.4"	"Cell type enhanced"	"Detected in many"	6	"Cholangiocytes: 7.6;Early spermatids: 7.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 4.5"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	8	"NTERA-2: 16.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA070726			Uncertain	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Golgi apparatus"	"Endoplasmic reticulum"	"HPA070726: "	"unprognostic (3.64e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.75e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.38e-1)"	"unprognostic (9.15e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.65e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.03e-4)"	"unprognostic (4.49e-6)"	"unprognostic (6.11e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.98e-1)"	0.9	0.8	2.2	0.8	3.2	1.8	1.4	0.7	1.1	0.9	4.2	3.0	0.8	3.7	0.5	1.2	0.5	0.9	2.3	0.6	3.1	4.2	0.6	3.3	1.0	0.5	2.9	2.4	1.0	2.9	0.3	1.0	0.3	8.9	1.6	0.4	82.4	0.5	1.6	2.3	1.4	11.1	0.3	7.0	0.7	0.9	2.9	3.1	0.0	4.9	0.2	0.6	0.5	0.7	0.9	3.7	2.0	4.5	0.6	0.3	3.9	0.7	0.5	0.4	0.2	0.1	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.7	0.3	0.0	0.2	0.0	0.0	0.1	0.8	0.6	0.1	0.1	0.2	0.5	0.4	0.3	0.1	0.1	0.3	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.3	16.5	0.0	0.0	0.1	0.0	0.1	2.0	0.5	0.1	0.0	0.2	0.1	0.2	0.3	0.1	0.0	0.0	0.4	0.2	0.6	0.1	0.1	0.0	0.0	0.0	0.2	0.5	1.0	4.5	0.4	0.3	1.6	0.3	0.5	0.3	0.3	3.7	0.9	0.3	0.3	2.0	0.6	0.5	0.5	0.2	3.9	2.2	3.2	0.7	1.1	3.1	4.2	2.9	2.4	8.9	3.1	0.0	4.1	0.0	4.2	1.0	0.8	0.2	7.6	0.0	1.2	0.0	0.0	0.1	3.3	0.8	7.2	0.2	2.0	0.0	0.7	0.1	0.3	2.4	0.0	2.0	0.1	0.0	0.0	1.8	0.0	1.6	0.0	0.0	5.0	0.0	0.7	3.7	1.4	0.0	0.0	0.3	0.9	0.0	0.1	4.8	4.5	1.0	0.2	0.7	0.3	0.6
MARF1	"KIAA0430, LKAP, LMKB, Marf1, PPP1R34"	ENSG00000166783	"Meiosis regulator and mRNA stability factor 1"	Q9Y4F3	16	15594386-15643166	"Predicted intracellular proteins"	"Differentiation, Meiosis, Oogenesis"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 20.8;Alveolar cells type 2: 26.6;Ciliated cells: 32.1;Club cells: 34.2;Collecting duct cells: 22.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 12.0"	"Group enriched"	"Detected in many"	4	"B-cells: 6.4;granulocytes: 12.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017992	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA017992: AB_1852921"	"unprognostic (2.33e-1)"	"unprognostic (6.44e-3)"	"unprognostic (8.84e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.13e-3)"	"unprognostic (2.35e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.47e-2)"	"unprognostic (6.93e-2)"	"unprognostic (8.44e-3)"	"unprognostic (1.35e-1)"	"unprognostic (6.94e-3)"	"unprognostic (3.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.74e-2)"	"unprognostic (7.94e-2)"	12.2	9.1	22.4	12.3	17.7	16.7	11.2	25.9	40.0	16.9	17.2	12.0	7.6	8.9	15.2	7.1	10.7	15.1	11.0	8.8	20.7	15.4	13.0	9.0	10.8	17.2	15.1	18.4	20.8	12.0	18.8	12.0	9.3	16.5	12.8	12.8	9.1	12.4	12.8	20.4	11.9	13.0	15.5	13.6	14.6	12.0	6.8	14.0	11.8	15.5	4.2	26.1	18.8	13.9	6.4	0.8	12.0	1.9	0.8	2.1	0.8	4.3	8.1	10.3	7.5	9.5	13.6	4.3	4.8	6.6	4.5	7.7	1.3	5.9	19.5	9.7	9.6	3.8	3.0	6.1	6.7	8.1	6.6	4.2	8.2	7.3	6.2	7.9	9.2	10.9	8.1	7.4	9.7	11.7	10.2	11.3	11.1	7.1	7.4	8.8	4.0	7.5	4.2	2.8	3.7	4.1	10.4	13.5	4.9	3.9	8.3	5.9	7.6	7.1	4.6	8.8	5.6	4.9	8.1	11.7	6.7	4.3	11.4	3.9	8.5	7.9	11.9	9.0	6.0	8.6	2.4	1.6	4.3	1.4	1.4	0.8	4.2	2.1	1.4	0.7	6.4	1.9	2.0	12.0	0.8	1.9	0.8	1.9	0.8	22.4	17.7	25.9	40.0	20.7	15.4	15.1	18.4	16.5	14.0	20.8	26.6	0.0	0.0	0.0	0.0	0.0	0.0	32.1	34.2	22.7	0.0	4.6	13.3	8.1	0.0	0.0	0.0	0.0	12.1	4.4	0.0	0.0	10.5	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	12.6	0.0	0.0	12.1	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0
MDGA1	"GPIM, MAMDC3"	ENSG00000112139	"MAM domain containing glycosylphosphatidylinositol anchor 1"	Q8NFP4	6	37630679-37699306	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 94.7"	"Group enriched"	"Detected in many"	5	"Bipolar cells: 31.7;Cone photoreceptor cells: 47.1;Horizontal cells: 54.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	17	"cerebellum: 94.7"	"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 3.1"	"Group enriched"	"Detected in many"	22	"B-cells: 1.1;T-cells: 3.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 13.8;HaCaT: 8.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031235, HPA050382"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA		490000	"Plasma membrane"	"Golgi apparatus"	"HPA031235: AB_10603017, HPA050382: AB_2681108"	"unprognostic (4.67e-2)"	"unprognostic (6.97e-3)"	"unprognostic (3.24e-1)"	"unprognostic (5.69e-4)"	"unprognostic (2.75e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.52e-5)"	"unprognostic (9.19e-3)"	"unprognostic (5.28e-3)"	"unprognostic (3.80e-3)"	"unprognostic (4.60e-2)"	1.5	3.7	3.4	3.1	2.4	0.0	1.0	94.7	5.1	3.0	1.3	1.5	1.0	0.0	3.0	1.5	1.8	2.1	3.4	1.2	5.0	2.0	0.8	0.5	3.5	3.4	1.7	2.4	8.4	2.6	6.6	2.6	0.5	5.4	1.5	1.1	3.4	0.7	1.2	0.9	6.7	1.5	2.6	4.1	3.9	1.2	1.4	1.3	0.6	1.1	1.7	2.7	1.1	3.1	1.1	0.0	0.0	0.0	0.0	3.1	0.4	0.1	3.8	6.9	2.6	13.8	5.6	3.0	2.7	2.7	3.4	3.9	0.7	0.0	0.9	0.6	1.7	3.6	8.9	0.5	0.0	1.1	6.9	4.0	0.0	0.5	0.0	0.6	0.0	0.9	1.0	0.1	1.4	0.0	8.0	0.0	0.1	0.1	0.0	1.2	0.1	0.0	0.5	0.0	0.1	0.4	7.3	2.4	0.0	0.8	4.2	6.3	0.0	1.5	0.4	3.3	0.2	3.2	0.6	0.5	3.7	1.2	1.3	5.0	0.0	0.1	0.0	5.8	1.1	2.4	0.0	0.0	0.0	1.4	0.0	0.4	1.1	1.2	0.8	0.0	1.0	3.1	0.8	0.0	0.0	0.0	0.0	1.8	0.4	3.4	2.4	94.7	2.7	5.0	2.0	1.7	2.4	5.4	1.3	8.9	0.3	0.0	1.7	2.1	31.7	5.2	0.0	2.7	1.2	3.5	47.1	0.1	0.0	0.6	1.9	1.0	0.0	0.0	0.0	1.2	2.4	1.5	0.0	0.0	0.1	54.0	1.7	1.8	0.0	0.0	9.5	0.0	1.7	0.0	0.0	2.3	0.6	0.0	4.6	0.1	1.3	0.0	3.4	2.3	1.0	2.6	0.6	0.5	0.0	3.8
MICAL2	KIAA0750	ENSG00000133816	"Microtubule associated monooxygenase, calponin and LIM domain containing 2"	"O94851, Q6ZW33"	11	12094008-12359144	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis"	"Actin-binding, Developmental protein, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 138.4"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 73.9;Late spermatids: 128.9;Peritubular cells: 106.1"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"cerebellum: 138.4;cerebral cortex: 39.8"	"Cell type enhanced"	"Detected in many"		"neutrophil: 12.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 40.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030437, HPA039895, HPA040438"	Approved		Uncertain	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"	"Nucleoplasm, Plasma membrane"	"HPA030437: AB_10601873, HPA039895: AB_2676731, HPA040438: AB_10672896"	"unprognostic (2.68e-2)"	"unprognostic (1.77e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (6.88e-4)"	"unprognostic (2.20e-2)"	"unprognostic (3.60e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.47e-2)"	"prognostic unfavorable (3.63e-5)"	"unprognostic (4.61e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.67e-1)"	4.1	3.3	15.4	7.3	15.1	6.8	2.9	138.4	39.8	6.6	14.7	2.7	2.9	7.2	14.7	7.7	11.5	5.4	11.1	24.8	22.0	6.9	2.9	3.9	12.8	2.3	5.6	17.9	3.9	4.4	0.7	2.4	5.0	5.5	3.3	15.1	2.8	2.9	8.4	14.6	9.3	10.8	22.7	7.6	2.6	5.9	24.6	0.6	0.0	4.5	1.9	2.2	7.8	3.2	0.2	5.5	12.2	6.7	3.7	3.5	2.1	11.8	6.3	0.3	1.4	1.6	3.0	7.5	18.9	21.4	7.4	11.6	13.2	8.5	0.3	4.1	13.2	21.2	8.4	2.3	30.4	18.4	13.7	1.5	11.2	1.2	0.9	14.2	2.1	1.4	5.3	5.4	32.6	31.9	13.8	16.9	0.8	19.5	0.5	11.9	0.7	0.1	1.0	0.4	8.4	5.9	0.1	7.5	7.9	1.5	14.9	6.1	0.5	6.2	17.3	1.2	4.7	1.7	0.6	30.1	40.3	15.2	6.6	16.4	0.4	0.9	0.4	24.5	3.0	0.8	0.1	6.7	0.5	2.8	1.7	3.5	0.2	1.7	1.7	5.5	0.2	0.2	0.9	12.2	3.7	0.5	1.0	2.1	2.1	15.4	15.1	138.4	39.8	22.0	6.9	5.6	17.9	5.5	0.6	38.7	29.6	4.2	6.7	9.0	2.8	28.1	7.6	5.3	11.4	3.5	0.0	2.1	0.0	9.6	73.9	7.1	31.5	23.3	12.4	9.5	4.5	7.0	1.1	17.8	3.0	0.0	21.7	11.1	11.1	128.9	19.5	8.9	5.0	8.2	10.0	0.2	29.0	14.1	106.1	0.6	1.6	12.9	27.6	0.9	0.9	8.3	1.9	9.2	9.9	9.7
MIF4GD	"AD023, MGC45027, MIFD, SLIP1"	ENSG00000125457	"MIF4G domain containing"	A9UHW6	17	75266228-75271227	"Predicted intracellular proteins"	"Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 67.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051222	Approved		Supported	"Nucleoli,Golgi apparatus,Cytosol"		NA	NA			Nucleoli	"Golgi apparatus, Cytosol"	"HPA051222: AB_2681393"	"unprognostic (1.05e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.82e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.36e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.15e-2)"	"prognostic favorable (2.70e-4)"	"unprognostic (2.18e-1)"	"unprognostic (9.20e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.12e-2)"	"unprognostic (7.31e-2)"	19.0	13.9	10.4	14.5	11.1	30.5	13.3	7.4	14.6	11.9	12.9	20.8	14.2	10.3	16.8	12.8	18.3	13.9	20.4	20.4	10.2	8.2	16.0	15.1	15.1	30.4	12.0	9.9	12.2	16.2	18.2	7.4	15.9	12.0	12.0	11.7	15.5	15.4	11.5	34.4	18.6	14.1	20.4	15.4	22.0	11.7	12.6	10.9	21.8	15.0	20.7	20.9	16.6	12.2	14.1	67.0	11.3	21.5	14.5	17.5	14.4	12.0	21.3	4.7	11.0	7.7	2.3	6.8	3.1	8.8	6.2	4.2	7.5	13.6	18.8	5.6	4.9	7.3	9.6	5.7	10.8	4.7	9.3	14.6	9.3	9.3	6.6	8.5	8.1	10.8	2.2	16.9	4.3	17.7	8.5	12.8	21.2	12.2	23.0	1.6	23.5	25.8	19.4	2.1	13.9	10.4	16.9	6.0	25.6	12.5	6.5	7.1	10.4	6.3	16.6	15.4	11.4	30.8	19.0	4.9	3.2	7.7	4.0	6.1	33.5	8.7	15.8	5.9	14.4	4.2	5.7	21.5	11.3	15.4	11.0	16.2	14.1	12.5	13.7	25.4	13.0	11.4	12.0	3.8	14.5	13.1	67.0	17.5	14.4	10.4	11.1	7.4	14.6	10.2	8.2	12.0	9.9	12.0	10.9	0.0	11.2	26.7	11.3	10.2	3.8	4.0	25.5	13.4	10.3	12.2	0.0	12.2	18.3	40.4	24.1	17.9	11.2	0.0	38.2	7.9	11.3	11.9	32.2	7.2	42.0	1.6	15.0	11.1	45.6	9.9	8.6	38.5	15.1	48.7	15.0	22.4	20.7	21.6	14.9	22.6	5.3	19.4	24.2	20.0	17.4	16.6	7.8	34.5	16.9	11.4
MPLKIP	"C7orf11, ORF20, TTDN1"	ENSG00000168303	"M-phase specific PLK1 interacting protein"	Q8TAP9	7	40126023-40134652	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA058457, HPA065463"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			Nucleoplasm	"Golgi apparatus, Vesicles"	"HPA058457: AB_2683724, HPA065463: AB_2685493"	"unprognostic (5.59e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.40e-2)"	"unprognostic (2.39e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.34e-3)"	"unprognostic (2.73e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.16e-3)"	"unprognostic (8.89e-2)"	"unprognostic (1.61e-2)"	"unprognostic (8.44e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.91e-2)"	"unprognostic (6.08e-2)"	13.7	15.2	11.6	9.3	12.7	8.7	14.8	13.9	12.1	12.7	14.5	12.6	9.5	11.9	11.0	13.6	12.9	10.0	9.3	9.3	11.8	11.4	20.5	52.1	8.7	13.3	15.0	8.8	12.0	17.3	10.1	16.1	13.8	10.4	11.5	11.6	11.1	14.4	10.5	10.1	11.3	13.4	9.2	11.9	12.7	10.8	11.0	12.0	25.5	19.2	7.9	12.8	11.3	12.6	53.8	41.9	52.9	38.0	30.7	45.0	40.9	24.1	7.1	13.3	16.7	13.4	15.8	14.7	8.7	10.3	13.9	14.1	9.7	11.8	19.7	12.9	9.0	26.5	29.7	8.0	16.3	17.4	15.1	29.0	15.0	10.5	20.4	16.1	17.8	14.4	14.8	22.6	9.9	12.9	13.9	16.7	21.6	39.3	15.1	14.1	12.4	18.0	60.4	18.4	20.2	24.2	26.4	9.2	25.9	15.4	5.7	19.4	24.1	14.3	13.6	20.9	19.5	17.5	26.7	15.1	7.5	22.7	9.1	13.5	24.6	29.1	33.4	12.8	30.6	22.1	43.4	38.0	52.9	28.0	34.3	31.3	53.8	35.9	32.8	39.4	47.0	40.0	35.1	20.4	30.7	31.5	41.9	45.0	40.9	11.6	12.7	13.9	12.1	11.8	11.4	15.0	8.8	10.4	12.0	47.6	34.6	54.8	74.2	97.8	44.2	15.9	53.5	53.5	39.8	55.8	23.6	94.3	99.5	60.1	107.2	61.3	51.0	0.0	47.7	63.7	58.5	51.4	49.7	109.9	60.4	50.9	46.7	45.4	55.0	29.2	70.2	56.9	55.6	52.3	57.8	42.0	52.6	70.6	51.9	148.0	42.4	51.8	48.1	54.9	49.5	117.2	80.0	48.0	77.3	91.3
MSH6	GTBP	ENSG00000116062	"MutS homolog 6"	P52701	2	47695530-47810101	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"	DNA-binding	"Cancer-related genes, Disease mutation, Hereditary nonpolyposis colorectal cancer"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009091, HPA028376, HPA028446, CAB070870"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	Yes			Nucleoplasm	"Golgi apparatus, Vesicles"	"CAB009091: AB_670083, CAB070870: AB_2144959, HPA028376: AB_10598909, HPA028446: AB_10602182"	"unprognostic (5.10e-2)"	"unprognostic (5.87e-3)"	"unprognostic (3.29e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (1.98e-1)"	"unprognostic (3.09e-2)"	"prognostic unfavorable (7.86e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.74e-3)"	"unprognostic (8.99e-2)"	"prognostic unfavorable (1.06e-7)"	"unprognostic (1.22e-1)"	"unprognostic (2.31e-1)"	"unprognostic (9.68e-2)"	"unprognostic (3.48e-2)"	13.0	20.5	9.7	13.1	18.8	13.6	13.0	20.5	13.1	17.9	13.3	17.6	10.7	6.1	28.2	11.0	12.4	18.3	8.4	8.6	11.4	8.8	9.5	14.6	11.0	21.7	23.9	9.6	43.2	27.6	16.2	17.3	14.9	15.0	14.6	10.3	8.7	12.0	13.2	10.4	10.3	10.5	22.1	14.9	11.6	11.1	25.1	22.0	40.4	13.4	10.4	25.8	14.2	16.4	8.4	8.4	7.6	9.8	9.7	15.1	5.7	27.5	20.6	38.3	9.1	11.6	12.2	17.3	15.3	13.5	15.9	16.7	15.1	9.6	45.5	23.0	16.6	21.9	11.6	34.5	19.5	20.8	19.8	17.2	29.1	16.3	15.3	7.1	29.2	10.7	9.9	6.2	16.2	10.8	14.9	9.9	1.1	25.3	16.7	15.5	19.9	31.1	13.8	33.6	18.6	9.5	73.8	50.2	20.5	9.7	17.9	21.5	23.3	21.3	10.2	9.3	35.1	12.2	10.3	6.0	18.5	22.6	14.0	19.8	15.7	21.2	76.2	15.6	18.7	11.3	7.6	5.8	4.9	8.4	9.8	10.4	8.4	9.5	8.3	8.4	8.1	15.1	7.6	3.9	9.7	9.3	4.2	9.5	5.7	9.7	18.8	20.5	13.1	11.4	8.8	23.9	9.6	15.0	22.0	26.8	18.4	9.7	20.1	22.3	26.4	6.9	0.0	28.1	31.8	7.0	33.4	24.9	3.3	12.8	25.7	15.3	2.6	0.0	8.4	16.9	17.4	11.4	17.3	8.5	11.1	14.3	4.6	12.3	5.1	11.5	23.6	12.1	3.3	7.2	7.9	27.0	8.8	3.5	21.2	5.3	29.7	6.5	17.2	40.0	40.2	15.3	8.0	13.3	9.3	10.7
NAA11	"ARD1B, ARD2, hARD2"	ENSG00000156269	"N(alpha)-acetyltransferase 11, NatA catalytic subunit"	Q9BSU3	4	79225694-79326050	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	166	"placenta: 32.1;testis: 30.5"	"Group enriched"	"Detected in some"	11	"Cytotrophoblasts: 16.7;Early spermatids: 21.1;Extravillous trophoblasts: 13.6;Late spermatids: 20.7;Spermatocytes: 14.4;Spermatogonia: 15.0;Syncytiotrophoblasts: 11.1"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"GAMG: 14.7;K-562: 8.8;U-266/70: 25.1;U-266/84: 8.0"					"Not detected"	"Not detected"			HPA035922	Approved		Supported	"Nucleoplasm,Golgi apparatus,Centrosome,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Centrosome, Cytosol"	"HPA035922: AB_10673490"					"unprognostic (7.37e-2)"							"unprognostic (7.58e-2)"		"unprognostic (1.36e-1)"	"unprognostic (1.20e-1)"		"unprognostic (4.67e-1)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	32.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	30.5	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	25.1	8.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	21.1	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	20.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	14.4	15.0	0.0	11.1	0.0	0.0	0.0
NEO1	"HsT17534, IGDCC2, NGN, NTN1R2"	ENSG00000067141	"Neogenin 1"	Q92859	15	73051710-73305206	"Cancer-related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Intestinal endocrine cells: 57.8;Peritubular cells: 59.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009320, HPA027804, HPA027805, HPA027806"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA		280000000	"Nucleoplasm, Plasma membrane"	"Golgi apparatus"	"CAB009320: AB_2150998, HPA027804: AB_10600771, HPA027805: AB_10601755, HPA027806: AB_10601006"	"unprognostic (1.90e-1)"	"unprognostic (2.38e-2)"	"unprognostic (7.60e-3)"	"unprognostic (3.76e-2)"	"unprognostic (5.44e-1)"	"unprognostic (3.83e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.30e-2)"	"unprognostic (5.51e-2)"	"unprognostic (8.05e-2)"	"prognostic favorable (4.39e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.75e-1)"	7.3	5.8	19.2	6.2	22.4	1.2	11.4	12.7	23.9	13.4	30.0	44.5	14.8	17.9	14.2	7.2	8.0	15.4	13.4	6.8	20.1	14.1	16.2	5.9	10.7	2.7	27.1	15.7	17.5	11.5	44.4	6.9	1.5	19.3	23.1	36.9	16.0	11.5	25.5	17.9	24.6	19.0	16.0	22.3	3.6	15.1	9.0	22.5	2.1	12.5	3.8	4.7	10.1	9.5	0.0	0.3	1.4	0.3	0.8	3.1	0.3	3.7	18.3	21.9	14.4	13.3	3.9	5.5	1.4	1.8	3.6	0.7	2.7	18.5	1.0	2.2	4.0	13.6	0.8	15.3	8.4	1.5	6.6	11.3	12.3	0.2	2.5	3.8	0.3	0.4	9.6	15.6	0.7	7.2	4.2	0.0	9.6	0.0	23.5	0.8	11.2	4.3	0.2	20.9	2.8	1.5	10.0	11.7	2.4	7.0	10.1	10.0	14.1	17.2	7.7	9.1	18.4	8.1	2.2	0.0	16.9	9.0	5.4	3.9	10.1	18.6	2.6	3.6	3.5	4.7	0.0	0.3	0.4	1.8	0.0	3.1	0.0	1.1	1.4	0.0	0.0	0.6	0.5	1.4	0.8	0.0	0.3	0.0	0.3	19.2	22.4	12.7	23.9	20.1	14.1	27.1	15.7	19.3	22.5	8.9	7.2	1.7	6.9	12.6	14.6	4.2	22.9	4.0	6.8	21.0	13.7	0.5	1.7	8.7	3.0	2.9	34.1	0.0	5.5	0.6	7.9	14.5	0.0	5.9	0.7	9.5	57.8	8.0	0.3	4.1	29.4	0.5	10.1	0.0	37.7	10.4	9.4	38.6	59.1	14.3	21.5	6.5	8.6	5.7	18.1	22.2	0.2	4.5	47.7	6.1
NKX2-1	"BCH, NKX2A, TITF1, TTF-1, TTF1"	ENSG00000136352	"NK2 homeobox 1"	P43699	14	36516392-36521149	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Congenital hypothyroidism, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"lung: 51.5;thyroid gland: 122.8"	"Group enriched"	"Detected in some"	6	"Alveolar cells type 1: 128.1;Alveolar cells type 2: 108.1;Club cells: 46.6"	"Group enriched"	"Detected in some"	39	"lung cancer: 30.9;thyroid cancer: 103.2"	"Group enriched"	"Detected in some"	6	"basal ganglia: 2.4;hypothalamus: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"SCLC-21H: 48.7"	"Group enriched"	"Detected in some"	5	"basal ganglia: 3.4;hypothalamus: 12.0"	"Group enriched"	"Detected in some"	13	"basal ganglia: 6.4;hypothalamus: 16.1"	"CAB000078, CAB053633, HPA074316"	Enhanced		Uncertain	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"CAB000078: , CAB053633: AB_442138, HPA074316: "		"unprognostic (3.79e-1)"		"unprognostic (4.25e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.79e-2)"		"unprognostic (1.26e-2)"				"unprognostic (2.23e-1)"		"unprognostic (1.18e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.18e-1)"	0.1	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	2.5	0.0	0.0	51.5	0.1	0.0	0.1	0.0	0.0	0.0	4.9	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.4	0.0	122.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	48.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.4	0.0	0.1	0.2	2.5	0.0	0.1	0.1	0.4	128.1	108.1	0.0	0.0	0.0	0.0	0.6	0.0	14.7	46.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
NOD2	"BLAU, CARD15, CD, CLR16.3, IBD1, NLRC2, PSORAS1"	ENSG00000167207	"Nucleotide binding oligomerization domain containing 2"	Q9HC29	16	50693588-50734041	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity"		"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 5.9;Basal keratinocytes: 5.3;Kupffer cells: 9.7;Macrophages: 13.7;Suprabasal keratinocytes: 13.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"classical monocyte: 15.3;eosinophil: 3.9;intermediate monocyte: 9.1;myeloid DC: 15.5;neutrophil: 6.3;non-classical monocyte: 5.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 15.5;granulocytes: 6.3;monocytes: 15.3"	"Cell line enhanced"	"Detected in some"		"HMC-1: 11.9;T-47d: 5.7;THP-1: 6.8;U-266/70: 15.7;U-266/84: 6.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA041985, HPA054494"	Enhanced		Approved	"Golgi apparatus,Cytosol"		No	NA			"Golgi apparatus, Cytosol"		"HPA041985: AB_2677780, HPA054494: AB_2682505"	"unprognostic (1.01e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.02e-3)"	"unprognostic (9.91e-3)"	"unprognostic (5.84e-2)"	"unprognostic (5.90e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.17e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.94e-3)"	"unprognostic (1.48e-2)"	"unprognostic (2.31e-9)"	"unprognostic (4.38e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-1)"	2.6	0.6	0.9	6.2	0.5	13.2	1.7	0.5	1.5	5.7	1.0	0.7	0.9	1.5	1.8	2.6	12.6	1.1	3.7	3.2	1.2	0.5	0.8	1.9	7.6	8.0	1.6	0.0	1.4	0.4	0.0	1.0	2.6	1.4	1.8	1.0	1.2	5.5	0.4	1.4	14.2	1.3	1.9	3.2	4.7	1.4	2.2	0.9	1.0	0.9	12.1	8.3	4.0	10.6	0.0	15.5	6.3	15.3	1.9	1.0	6.8	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	11.9	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.1	0.0	1.4	0.0	0.0	5.7	6.8	0.0	0.0	0.0	0.0	0.0	15.7	6.7	0.0	0.2	0.1	0.0	2.0	15.3	3.9	0.2	9.1	0.5	0.0	1.0	0.9	15.5	0.0	0.1	0.3	6.3	1.9	5.8	0.6	0.6	6.8	0.9	0.5	0.5	1.5	1.2	0.5	1.6	0.0	1.4	0.9	0.0	5.9	0.0	0.3	5.3	0.0	0.4	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.3	1.1	0.0	2.4	0.0	1.2	0.0	9.7	0.0	0.0	13.7	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.2	0.7	0.0	0.3
PCDH8	"ARCADLIN, PAPC"	ENSG00000136099	"Protocadherin 8"	O95206	13	52842889-52848641	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 20.6"	"Cell type enriched"	"Detected in some"	7	"Muller glia cells: 31.8"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"AF22: 23.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA010509	Uncertain		Uncertain	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA010509: AB_10601384"	"unprognostic (3.50e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.11e-4)"	"unprognostic (2.12e-2)"	"unprognostic (1.97e-2)"		"unprognostic (7.01e-2)"		"unprognostic (1.13e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.59e-1)"		"unprognostic (1.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.32e-1)"		0.8	0.9	11.5	1.1	18.6	0.8	0.8	0.4	20.6	0.9	1.0	1.1	0.0	0.9	1.0	0.8	0.8	0.8	0.8	0.8	18.2	4.8	0.8	0.8	0.9	0.8	3.6	8.4	0.8	0.8	0.8	1.4	0.8	0.8	1.7	0.9	0.8	0.8	0.8	1.4	0.8	1.1	0.9	0.9	0.8	1.2	2.3	2.5	0.0	1.4	0.0	0.8	0.9	0.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.8	0.0	0.0	1.7	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	18.6	0.4	20.6	18.2	4.8	3.6	8.4	0.8	2.5	0.0	0.0	0.0	2.5	0.1	4.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	31.8	0.0	0.0	0.4	0.0	0.9	0.0	0.0	1.4	0.9	0.0	0.0	0.0	0.0	1.3
PCGF5	"MGC16202, RNF159"	ENSG00000180628	"Polycomb group ring finger 5"	Q86SE9	10	91163012-91284331	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Late spermatids: 252.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA038349, HPA059071"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA038349: AB_10669523, HPA059071: "	"unprognostic (1.34e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.25e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.35e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.43e-2)"	"unprognostic (3.89e-1)"	"unprognostic (3.24e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (4.98e-4)"	"unprognostic (2.43e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.56e-2)"	"prognostic favorable (6.90e-4)"	16.0	30.1	28.0	15.0	25.1	6.3	14.6	19.4	24.5	15.9	21.8	18.6	16.9	21.0	15.4	14.7	16.1	15.4	15.7	32.5	24.0	27.5	29.0	31.1	17.2	25.8	27.9	20.5	19.3	19.3	25.3	16.0	18.9	21.0	17.5	17.5	12.4	19.6	18.4	24.5	13.6	30.9	24.4	29.7	20.9	17.3	14.1	24.1	31.6	29.4	13.5	18.4	20.4	21.2	6.1	3.0	8.0	9.9	7.3	7.4	4.0	16.0	7.1	5.9	2.5	8.6	13.5	4.1	9.1	18.8	8.3	11.7	1.0	9.5	21.2	4.2	11.4	6.8	3.1	6.3	6.2	14.7	24.4	4.7	9.9	4.8	10.8	11.4	7.7	15.9	6.1	11.6	6.1	8.7	17.1	6.9	9.5	5.2	12.0	12.8	2.9	17.4	1.9	0.8	3.7	4.0	8.7	10.9	5.7	15.2	2.5	2.8	4.0	4.4	4.8	7.6	2.2	3.8	3.5	17.7	9.8	6.9	6.0	10.7	20.9	12.8	19.2	13.8	5.6	3.0	8.0	2.2	3.8	4.2	5.6	7.4	6.1	6.2	4.2	3.0	5.8	6.3	6.1	3.1	7.3	9.9	0.8	3.4	4.0	28.0	25.1	19.4	24.5	24.0	27.5	27.9	20.5	21.0	24.1	6.0	20.0	51.8	43.3	30.6	19.5	72.2	22.9	29.4	25.0	27.9	15.7	14.5	41.4	31.0	102.3	34.1	68.0	23.3	55.8	3.0	35.8	48.1	22.0	52.5	45.3	47.7	20.7	36.2	58.8	252.4	18.1	52.4	40.5	61.3	57.3	64.5	45.4	44.6	28.0	48.1	18.3	12.9	47.6	57.4	13.2	27.4	4.7	39.9	44.6	47.4
PLAGL1	"LOT1, ZAC"	ENSG00000118495	"PLAG1 like zinc finger 1"	Q9UM63	6	143940300-144064599	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 95.0"	"Cell type enhanced"	"Detected in many"	7	"Fibroblasts: 117.4;Leydig cells: 128.3;Peritubular cells: 91.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 35.7;ASC TERT1: 29.1;RH-30: 36.3"					"Low region specificity"	"Detected in all"			HPA055706			Supported	"Nuclear bodies,Golgi apparatus,Vesicles"		No	No			"Nuclear bodies"	"Golgi apparatus, Vesicles"	"HPA055706: AB_2682893"	"unprognostic (4.74e-3)"	"unprognostic (8.35e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.74e-3)"	"unprognostic (5.09e-2)"	"unprognostic (1.95e-1)"	"unprognostic (9.32e-2)"	"unprognostic (6.17e-2)"	"unprognostic (3.49e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (4.94e-6)"	"prognostic unfavorable (6.61e-4)"	"unprognostic (4.69e-2)"	"unprognostic (5.17e-3)"	"unprognostic (4.93e-3)"	14.6	28.5	2.3	14.8	4.3	7.7	12.3	2.0	7.6	12.9	8.9	4.6	10.0	3.9	19.5	16.3	12.4	7.7	13.0	9.0	5.1	1.5	6.8	1.5	12.1	8.2	2.6	2.2	16.0	11.2	5.2	45.6	95.0	3.6	12.6	8.6	19.3	11.7	7.3	4.5	23.1	7.9	16.8	3.8	6.8	10.9	6.8	2.0	3.9	5.6	24.2	12.0	14.2	18.4	4.1	10.3	16.4	8.1	1.7	1.4	2.3	0.0	1.6	35.7	0.0	14.1	29.1	0.1	12.2	7.9	6.1	12.7	0.1	1.9	0.8	6.1	10.6	1.6	0.0	0.2	4.3	12.0	0.9	1.6	15.1	17.8	0.2	4.7	13.5	3.0	21.9	1.6	5.3	4.7	7.9	12.0	5.6	1.5	0.2	7.2	2.1	5.6	6.3	5.9	0.0	1.1	6.8	36.3	0.0	11.4	0.3	3.2	3.5	17.6	0.0	0.0	11.3	0.0	16.8	6.9	0.0	13.0	28.2	13.2	3.1	3.0	0.1	9.4	5.6	0.7	3.4	8.1	16.4	1.0	6.2	1.0	2.7	0.9	1.4	10.3	4.1	0.7	1.2	14.8	1.7	1.9	4.6	1.3	2.3	2.3	4.3	2.0	7.6	5.1	1.5	2.6	2.2	3.6	2.0	47.6	38.2	8.2	12.9	19.3	2.0	6.5	2.5	6.7	18.2	5.2	0.0	4.5	6.6	10.3	1.6	12.8	9.3	0.0	9.8	10.9	117.4	33.9	18.4	0.0	18.0	7.9	16.0	9.2	25.4	1.7	128.3	19.1	8.5	37.9	27.2	1.0	10.6	22.4	91.2	11.6	0.4	12.9	27.6	0.7	0.6	37.9	8.2	5.7	24.3	13.2
POLQ	POLH	ENSG00000051341	"DNA polymerase theta"	O75417	3	121431427-121546641	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 9.5;lymphoid tissue: 21.4"	"Cell type enhanced"	"Detected in some"	10	"Club cells: 3.4;Extravillous trophoblasts: 2.8;Spermatocytes: 7.0;Spermatogonia: 3.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 1.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 5.2"	HPA053359			Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	Yes			Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA053359: "	"unprognostic (1.59e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (5.46e-5)"	"unprognostic (2.70e-1)"	"unprognostic (6.23e-3)"	"unprognostic (3.09e-5)"	"unprognostic (8.55e-3)"	"unprognostic (1.09e-4)"	"unprognostic (2.86e-1)"	"unprognostic (5.59e-5)"	"unprognostic (2.06e-3)"	"unprognostic (0.00e+0)"	"prognostic favorable (1.04e-4)"	"unprognostic (1.76e-1)"	"unprognostic (6.01e-2)"	"unprognostic (5.76e-2)"	0.5	0.8	0.2	8.2	0.7	9.5	0.6	0.6	0.4	0.9	3.5	0.2	0.8	2.0	0.9	0.6	6.0	0.3	0.4	0.8	0.3	0.2	0.4	0.6	0.9	4.7	0.3	0.0	0.4	0.4	0.0	0.2	2.8	0.3	0.4	3.7	0.1	1.1	0.8	1.2	2.4	3.9	0.5	0.4	2.6	1.1	5.8	0.6	21.4	0.3	5.6	7.5	0.6	1.7	0.5	1.1	1.6	0.4	0.0	0.4	0.0	13.5	9.2	7.9	5.6	0.7	0.9	7.2	6.4	2.5	7.6	10.2	7.3	5.0	16.1	2.9	3.5	9.2	10.7	9.3	4.1	12.9	4.7	5.1	10.3	5.7	4.5	0.0	11.1	9.5	0.1	0.3	6.9	4.3	1.3	3.7	6.0	6.8	12.3	7.9	5.2	10.0	6.5	7.5	4.1	4.5	8.5	9.5	5.7	2.4	7.8	4.3	3.9	7.4	4.0	2.6	7.2	3.7	11.1	2.9	6.7	8.8	2.6	8.3	6.2	5.0	16.7	3.2	8.3	4.9	1.6	0.2	0.0	0.3	0.2	0.0	0.3	0.4	0.3	0.4	0.5	0.0	0.2	0.0	0.0	0.4	1.1	0.1	0.0	0.2	0.7	0.6	0.4	0.3	0.2	0.3	0.0	0.3	0.6	0.0	0.3	0.0	0.4	0.8	0.3	1.4	0.0	1.4	3.4	0.0	0.0	0.9	0.0	0.1	0.3	0.0	0.4	0.0	0.0	2.8	0.7	0.3	0.0	0.0	1.9	0.0	0.0	0.0	0.6	0.2	0.3	1.5	0.0	1.0	0.4	0.5	0.3	0.3	0.0	0.1	0.1	0.0	0.5	7.0	3.3	0.1	0.2	0.9	0.9	0.9
POMT1	LGMD2K	ENSG00000130714	"Protein O-mannosyltransferase 1"	Q9Y6A1	9	131502902-131523806	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 49.7;Spermatocytes: 57.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065252			Uncertain	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA065252: AB_2685445"	"unprognostic (2.00e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.67e-1)"	"unprognostic (7.97e-2)"	"unprognostic (5.35e-3)"	"unprognostic (1.14e-1)"	"unprognostic (9.76e-3)"	"unprognostic (2.84e-1)"	"prognostic favorable (3.90e-5)"	"unprognostic (8.36e-2)"	"prognostic favorable (4.68e-5)"	"unprognostic (2.41e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.12e-1)"	9.5	12.3	21.6	10.6	18.8	10.2	10.2	34.2	22.4	10.0	12.1	16.9	14.6	11.2	15.0	14.6	8.8	14.6	13.0	15.2	25.8	17.9	13.8	12.8	10.6	13.2	15.0	16.5	17.2	16.9	17.1	18.0	12.9	15.2	16.0	11.6	13.3	19.5	17.1	28.2	16.6	11.9	12.1	13.4	12.3	10.7	49.9	13.4	8.7	11.6	5.5	11.0	7.8	9.5	2.8	5.1	3.4	3.8	3.8	10.8	4.9	6.7	10.8	9.9	16.6	12.7	10.3	17.8	7.8	9.7	12.5	8.6	11.4	9.5	2.1	9.5	18.0	5.7	15.3	12.1	8.5	6.6	11.1	17.2	3.9	25.5	7.9	15.0	10.0	8.7	7.2	7.7	8.3	2.8	14.8	10.8	13.8	6.8	11.5	12.5	18.0	9.4	22.9	5.7	5.6	13.6	10.9	9.3	16.1	11.0	2.0	11.2	9.9	13.3	15.5	7.8	6.7	22.7	10.1	11.7	9.9	2.1	17.9	6.6	7.2	6.2	3.5	5.9	18.8	8.1	0.0	3.8	3.4	7.4	3.6	10.8	2.8	7.2	7.4	5.1	2.7	6.7	5.5	0.5	3.8	3.3	3.1	7.6	4.9	21.6	18.8	34.2	22.4	25.8	17.9	15.0	16.5	15.2	13.4	8.9	20.2	7.3	4.8	3.9	11.9	8.5	10.2	4.0	6.8	12.2	7.9	18.5	1.7	9.9	49.7	7.1	12.3	0.0	5.8	10.1	7.1	5.3	2.3	9.7	9.1	20.6	7.5	6.7	5.3	24.3	8.1	5.7	5.0	10.0	8.2	14.1	7.3	3.5	9.6	9.0	16.9	6.5	6.0	57.0	7.9	2.6	14.6	6.9	8.0	2.0
PPP2R3C	"C14orf10, FLJ20644, G4-1, G5PR"	ENSG00000092020	"Protein phosphatase 2 regulatory subunit B''gamma"	Q969Q6	14	35085467-35122517	"Predicted intracellular proteins"			"Cone-rod dystrophy, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	10	"Early spermatids: 382.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040835, HPA058834"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No			Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA040835: AB_10794152, HPA058834: AB_2683831"	"unprognostic (1.41e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.32e-3)"	"unprognostic (5.33e-2)"	"unprognostic (9.73e-2)"	"unprognostic (1.10e-3)"	"unprognostic (3.05e-1)"	"unprognostic (7.85e-2)"	"unprognostic (9.48e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.15e-3)"	"unprognostic (8.55e-2)"	"unprognostic (8.29e-2)"	14.5	12.5	19.1	15.5	23.8	26.4	12.2	17.9	22.1	12.9	13.8	11.4	9.5	14.1	10.9	11.0	8.9	10.0	12.5	14.8	17.9	11.4	10.1	10.5	12.1	18.9	28.4	17.2	12.6	9.5	11.3	30.8	12.7	20.6	11.8	14.7	6.8	10.2	9.7	20.0	6.5	15.3	14.5	22.8	21.5	13.1	46.8	24.1	18.9	8.7	7.5	16.4	14.7	10.4	12.2	12.7	32.1	19.2	13.9	14.7	11.4	15.6	8.6	14.9	13.3	9.8	19.8	11.2	12.6	10.7	14.9	18.3	6.8	11.3	16.8	5.0	12.0	6.1	6.7	6.7	4.8	22.2	18.4	7.8	9.4	4.6	24.9	14.4	17.4	18.5	15.2	4.5	11.2	6.9	8.0	20.2	9.9	9.9	17.1	21.4	11.3	18.3	16.3	13.5	9.2	10.0	18.2	11.5	13.8	5.2	9.1	16.1	14.0	15.5	11.2	20.3	7.1	7.4	20.8	17.1	16.3	7.0	13.7	14.4	15.3	20.1	34.2	8.3	16.7	18.5	20.0	15.0	32.1	10.7	19.2	11.7	12.2	10.8	13.8	12.7	11.0	9.6	11.7	28.1	13.9	16.4	8.1	14.7	11.4	19.1	23.8	17.9	22.1	17.9	11.4	28.4	17.2	20.6	24.1	14.9	24.8	50.1	18.1	10.2	15.8	23.0	25.5	22.7	12.5	19.2	3.9	16.4	28.2	26.6	382.3	29.2	28.5	23.3	31.4	21.7	23.5	24.4	33.4	19.2	53.2	7.9	30.0	26.4	42.9	134.4	26.2	49.9	27.0	72.1	21.2	18.8	38.8	20.3	28.7	31.1	19.1	32.3	31.1	103.4	61.7	11.8	29.1	39.5	20.2	26.5
PPP2R5C	"B56G, B56gamma, PR61G"	ENSG00000078304	"Protein phosphatase 2 regulatory subunit B'gamma"	Q13362	14	101761798-101927989	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"T-cells: 251.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027553	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA027553: AB_10602081"	"unprognostic (3.28e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.31e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.09e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.72e-1)"	25.5	29.4	52.6	37.7	45.3	48.1	27.4	25.7	38.9	27.8	31.1	25.6	30.1	22.4	24.0	29.2	32.7	22.3	25.4	48.4	49.3	35.6	25.5	38.1	34.5	53.8	44.7	32.4	28.4	25.6	27.6	35.3	19.5	27.5	23.1	33.3	26.6	28.9	27.8	30.5	28.9	31.7	27.7	45.5	36.8	25.4	27.6	29.5	51.4	29.6	28.3	52.1	33.2	21.9	20.1	24.9	35.3	25.3	16.8	60.5	20.9	21.0	14.5	24.6	23.7	22.3	31.5	23.8	19.9	26.4	25.0	24.0	14.5	36.8	57.7	19.3	25.8	17.6	22.2	22.4	21.1	32.6	25.9	10.6	16.7	17.2	14.1	16.5	25.6	35.9	20.7	27.4	17.2	16.0	22.3	22.4	31.5	34.7	24.4	23.8	32.1	25.7	28.3	14.3	42.5	24.2	21.8	27.7	14.2	24.0	24.0	19.3	36.1	27.0	17.9	33.7	18.0	32.8	19.7	22.1	15.8	15.1	60.7	19.7	34.1	51.0	96.2	23.7	19.0	17.5	20.1	19.8	18.2	60.5	24.3	38.9	20.1	39.7	47.5	16.9	17.8	28.6	44.1	35.3	16.8	25.3	24.9	39.7	20.9	52.6	45.3	25.7	38.9	49.3	35.6	44.7	32.4	27.5	29.5	77.4	85.3	74.9	37.2	52.1	31.6	113.5	48.4	68.3	52.4	34.9	55.0	41.1	39.7	33.2	55.5	45.2	45.9	46.7	40.7	39.2	41.8	41.7	66.0	70.6	61.7	25.4	45.5	59.5	108.0	50.8	48.6	71.4	81.0	136.1	71.3	33.5	39.8	66.8	42.8	53.6	38.0	38.8	46.4	23.7	25.4	61.5	43.8	251.6	58.7	59.3
PRIM1		ENSG00000198056	"DNA primase subunit 1"	P49642	12	56731596-56752373	"Predicted intracellular proteins"	"DNA replication, Transcription"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Erythroid cells: 70.0;Spermatocytes: 38.6;Spermatogonia: 82.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040010	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	Yes			"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA040010: AB_10805599"	"unprognostic (3.04e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.61e-2)"	"prognostic unfavorable (2.40e-8)"	"unprognostic (4.68e-2)"	"unprognostic (2.73e-3)"	"unprognostic (1.82e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.98e-3)"	"unprognostic (3.94e-1)"	"unprognostic (2.16e-1)"	"unprognostic (5.35e-2)"	"unprognostic (6.53e-2)"	5.7	5.2	6.7	9.8	9.3	26.0	10.1	16.0	10.6	6.0	8.2	6.7	5.5	4.5	6.2	4.9	9.6	6.2	3.1	4.0	7.6	4.6	4.5	8.2	5.4	11.1	9.2	4.6	9.7	10.7	7.9	12.3	5.0	7.9	5.2	11.1	5.3	7.0	4.3	6.3	7.9	8.3	6.1	11.8	10.2	6.3	17.0	10.8	28.3	5.1	6.8	13.2	5.6	6.9	8.6	6.3	3.5	6.2	5.3	12.7	4.6	12.2	10.6	14.7	9.0	1.7	2.6	17.3	10.4	8.5	18.5	17.3	11.4	15.8	24.1	8.7	4.8	7.4	12.4	17.7	11.3	20.4	12.0	11.0	31.8	6.8	10.9	0.5	38.9	13.5	1.1	2.1	16.4	7.1	2.8	6.6	28.1	29.9	38.1	10.7	9.1	22.2	14.8	16.3	8.8	13.3	25.0	25.8	20.8	4.4	9.3	15.0	13.3	12.4	6.0	5.6	11.2	19.4	14.9	3.0	9.6	22.8	10.0	13.1	13.9	27.7	13.6	6.0	16.5	12.7	1.4	1.4	3.5	7.8	3.4	9.0	8.6	10.5	7.5	3.4	8.2	12.7	10.0	0.0	5.3	6.2	6.3	9.1	4.6	6.7	9.3	16.0	10.6	7.6	4.6	9.2	4.6	7.9	10.8	6.0	5.0	11.5	11.9	3.4	4.2	2.4	2.5	8.1	6.8	7.0	5.9	7.0	0.0	4.4	5.0	5.8	1.3	70.0	6.4	22.0	3.3	2.7	3.5	4.3	10.3	19.1	1.2	3.7	7.3	2.5	6.6	7.2	3.3	9.0	2.9	5.6	3.4	0.0	4.6	1.6	11.8	12.9	3.9	38.6	82.6	3.4	3.8	10.5	8.5	2.0
RAB6C	WTH3	ENSG00000222014	"RAB6C, member RAS oncogene family"	Q9H0N0	2	129979664-129982738	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"parathyroid gland: 17.2"	"Cell type enriched"	"Detected in some"	9	"Cardiomyocytes: 8.7"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 4.5;HMC-1: 4.0;REH: 9.3;T-47d: 5.8;U-266/70: 3.9"									HPA059131	Uncertain		Uncertain	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA059131: AB_2683916"	"unprognostic (3.84e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.54e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.48e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.78e-1)"	1.7	3.3	5.1	1.4	6.2	1.1	9.9	1.3	10.3	7.6	2.0	4.0	1.3	1.1	3.3	1.4	2.2	1.6	1.5	1.5	7.6	5.3	1.4	3.8	1.2	1.2	5.2	4.9	1.5	4.2	17.2	1.6	2.8	8.6	7.0	1.3	2.1	2.0	2.8	1.7	1.2	4.4	1.3	5.3	2.7	1.3	4.0	1.5	0.8	1.5	0.9	1.3	1.2	1.5	0.2	0.3	0.8	0.5	0.6	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.1	0.0	0.0	0.0	9.3	0.0	0.9	0.0	0.0	0.1	0.8	0.0	0.8	0.2	1.1	5.8	0.0	0.0	0.0	0.7	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.9	0.4	0.3	0.2	0.2	0.4	0.3	0.1	0.1	0.2	0.2	0.6	0.5	0.2	0.4	0.3	5.1	6.2	1.3	10.3	7.6	5.3	5.2	4.9	8.6	1.5	0.0	0.0	0.0	0.2	0.7	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.4	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.5	0.8	1.0	0.5	0.0	0.0	0.3
S1PR2	"AGR16, DFNB68, EDG5, Gpcr13, H218"	ENSG00000267534	"Sphingosine-1-phosphate receptor 2"	O95136	19	10221433-10231331	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 75.1;Early spermatids: 83.7;Late spermatids: 119.0;Syncytiotrophoblasts: 57.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 23.7"	"Group enriched"	"Detected in many"	7	"granulocytes: 23.7;T-cells: 7.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 14.6;Daudi: 25.8;U-266/70: 19.3;U-698: 27.9;WM-115: 19.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014255, HPA014307"	Approved		Uncertain	"Nuclear speckles,Golgi apparatus"		NA	NA			"Golgi apparatus"	"Nuclear speckles"	"HPA014255: , HPA014307: AB_1847989"	"unprognostic (5.38e-3)"	"unprognostic (1.83e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.05e-3)"	"unprognostic (8.50e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (4.36e-10)"	"unprognostic (4.91e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.11e-1)"	"unprognostic (8.09e-2)"	17.1	2.3	1.4	13.7	1.3	0.9	7.2	0.9	1.5	13.3	4.1	1.7	3.9	1.8	8.3	9.2	6.4	7.9	6.5	6.1	1.3	1.5	2.4	9.5	11.2	10.6	1.3	0.0	12.9	2.6	3.9	2.2	31.3	1.7	9.8	2.5	3.2	9.4	5.7	3.4	4.0	3.9	8.7	1.7	2.2	4.2	21.8	1.0	2.0	3.3	6.3	15.6	8.0	12.0	0.3	1.6	23.7	1.9	2.1	7.4	1.2	1.4	0.2	1.7	3.4	9.4	11.5	14.6	2.1	4.4	1.0	2.0	0.9	0.8	25.8	2.5	4.0	1.1	0.8	0.6	1.0	0.7	2.6	1.3	0.6	0.6	0.6	3.1	0.7	0.6	6.3	0.5	1.9	0.6	2.7	0.1	1.3	0.6	5.6	0.6	1.2	0.3	1.2	1.7	0.4	0.8	1.8	0.7	0.9	0.8	1.2	1.2	2.3	1.2	0.7	1.8	1.4	0.6	0.6	0.2	3.5	1.1	7.9	0.6	19.3	9.1	27.9	1.3	1.3	19.1	23.7	1.9	0.4	4.9	1.5	5.9	0.2	6.2	4.6	1.6	0.3	2.6	2.6	0.5	2.1	0.6	0.2	7.4	1.2	1.4	1.3	0.9	1.3	1.3	1.5	1.3	0.0	1.7	1.0	0.0	1.4	0.0	3.5	0.0	0.6	0.4	0.0	0.0	1.2	1.8	2.0	75.1	0.0	3.1	83.7	1.5	0.0	0.0	2.7	13.9	15.8	4.2	0.0	5.9	12.5	0.0	2.4	4.9	0.6	119.0	20.4	4.8	0.0	4.6	0.1	7.1	2.3	0.0	12.4	0.5	0.4	12.9	2.0	1.2	1.1	0.0	57.2	1.5	0.0	2.6
SDCBP2	"SITAC18, ST-2"	ENSG00000125775	"Syndecan binding protein 2"	Q9H190	20	1309909-1329239	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 104.7"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 454.6;Pancreatic endocrine cells: 472.7;Paneth cells: 448.9;Urothelial cells: 654.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 11.2;OE19: 33.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA005804, HPA064490"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA005804: , HPA064490: AB_2732713"	"unprognostic (1.96e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.78e-3)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (3.17e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.20e-1)"	"prognostic favorable (3.37e-4)"	1.7	0.4	5.2	10.6	6.7	0.2	1.5	1.5	4.9	6.6	59.4	1.2	0.9	46.1	1.5	9.1	32.4	0.9	35.1	1.3	3.5	3.6	2.5	3.8	3.7	0.9	2.8	1.0	1.2	4.4	0.2	1.4	1.9	1.4	3.7	19.0	1.0	6.4	1.9	1.1	13.4	104.7	2.5	1.1	1.1	34.0	1.5	1.6	1.0	4.0	12.5	24.3	17.0	9.8	1.2	2.6	4.4	2.0	2.1	5.3	1.8	6.3	0.3	0.9	0.3	3.7	3.3	0.6	1.9	3.9	1.8	1.7	1.3	11.2	0.7	1.3	0.7	1.2	5.0	0.3	9.3	0.9	0.2	0.6	0.5	0.4	0.9	3.7	0.6	0.7	1.1	6.6	1.4	1.4	3.8	6.1	1.2	0.9	0.5	0.7	1.5	1.0	1.8	0.9	33.8	0.4	1.0	0.4	1.2	0.7	8.7	1.5	1.2	1.0	5.7	2.1	0.4	0.3	0.5	4.1	0.9	0.4	1.8	0.7	1.7	1.6	0.6	0.4	2.5	0.5	0.4	2.0	4.4	2.4	0.7	1.8	0.6	3.2	2.5	2.6	1.2	2.7	4.7	2.2	2.1	1.3	1.7	5.3	1.8	5.2	6.7	1.5	4.9	3.5	3.6	2.8	1.0	1.4	1.6	14.9	6.2	5.0	56.0	49.5	0.7	0.7	81.5	4.0	6.8	15.7	0.0	1.3	23.2	94.6	12.4	13.0	454.6	0.0	187.2	0.8	4.4	102.5	9.2	4.9	0.9	1.6	34.4	4.9	1.6	1.1	1.4	2.2	8.5	3.6	127.5	1.0	472.7	448.9	0.0	1.3	1.0	0.0	4.2	1.7	6.6	83.6	1.4	2.5	60.5	654.3
SDE2	"C1orf55, FLJ35382"	ENSG00000143751	"SDE2 telomere maintenance homolog"	Q6IQ49	1	225982702-225999331	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028467, HPA031255, HPA031256"	Approved		Supported	"Nuclear speckles,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Nuclear speckles"	"Golgi apparatus, Plasma membrane, Cytosol"	"HPA028467: AB_10599192, HPA031255: AB_10601462, HPA031256: AB_10603568"	"unprognostic (9.69e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (9.59e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.34e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.90e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.98e-2)"	"unprognostic (3.84e-2)"	25.6	11.2	10.7	13.3	12.8	33.6	21.6	10.8	11.5	12.3	10.6	17.9	9.0	11.0	15.1	11.5	14.3	12.8	13.4	12.2	10.8	11.0	11.9	17.9	16.2	13.9	14.1	9.8	16.2	14.2	15.6	13.9	14.5	12.5	12.9	11.6	11.1	12.0	11.2	20.9	18.0	12.9	12.7	13.5	14.4	11.5	14.1	14.4	33.9	15.8	11.0	14.1	15.6	16.9	8.2	7.8	17.9	7.2	12.5	11.2	6.3	8.5	6.2	10.1	10.7	7.1	7.9	12.6	9.1	8.7	12.5	9.6	9.0	9.8	12.5	14.3	7.7	4.9	11.0	12.6	7.9	15.3	9.5	10.3	13.8	5.3	8.2	13.0	13.5	16.8	8.7	11.5	13.3	16.9	7.1	8.6	15.1	25.1	15.2	9.2	2.5	18.8	10.8	14.0	13.2	6.6	15.9	13.0	16.2	7.5	6.0	9.1	15.1	10.4	11.4	17.1	8.5	11.2	16.7	8.4	10.7	7.6	13.8	19.9	9.1	6.5	15.5	11.0	8.4	21.1	16.3	6.0	5.5	8.2	6.2	11.2	8.2	8.3	7.9	6.7	7.1	8.6	8.0	17.9	12.5	7.2	7.8	6.4	6.3	10.7	12.8	10.8	11.5	10.8	11.0	14.1	9.8	12.5	14.4	26.8	23.5	17.7	14.0	38.7	5.2	7.3	2.5	13.4	25.0	8.7	0.0	7.6	13.3	5.8	47.5	16.2	11.3	23.3	6.1	8.4	15.4	11.4	34.6	17.9	9.7	14.3	16.7	12.9	16.1	12.7	9.2	13.9	18.6	5.4	10.7	11.4	8.2	10.7	6.0	9.0	7.7	6.5	17.3	15.1	13.9	51.7	11.9	15.0	9.8	16.6
SEC14L5	"KIAA0420, PRELID4B"	ENSG00000103184	"SEC14 like lipid binding 5"	O43304	16	4958317-5019158	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 29.4;heart muscle: 7.5;skeletal muscle: 11.0"	"Cell type enriched"	"Detected in some"	9	"Cone photoreceptor cells: 80.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.2;RPMI-8226: 4.2;SCLC-21H: 6.5;T-47d: 4.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041492, HPA041825"			Uncertain	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"		"HPA041492: AB_10794519, HPA041825: AB_10794526"	"unprognostic (1.90e-3)"	"unprognostic (4.08e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.68e-2)"	"unprognostic (7.33e-3)"	"unprognostic (8.71e-4)"	"unprognostic (6.87e-2)"	"unprognostic (1.56e-4)"	"unprognostic (1.01e-3)"	"unprognostic (7.12e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.45e-2)"	1.1	1.7	7.4	1.3	17.5	1.5	1.2	2.2	22.1	2.8	1.7	29.4	0.0	1.4	0.9	1.2	2.0	2.2	1.1	7.5	13.5	6.1	1.1	0.8	1.0	1.4	25.8	8.8	1.7	1.8	0.8	1.7	1.3	15.2	1.7	2.1	0.3	1.9	1.1	11.0	2.9	1.1	0.9	25.2	1.2	3.7	1.4	15.6	0.0	0.9	0.5	1.7	0.9	0.4	0.1	0.4	1.6	0.0	0.1	0.2	2.9	0.0	0.4	0.6	0.3	0.6	4.2	0.6	0.1	0.0	0.1	0.0	0.5	0.2	0.2	0.3	0.5	0.1	0.6	0.2	0.1	0.0	0.0	0.5	2.0	0.4	1.1	0.3	0.0	0.4	0.6	0.9	0.1	0.1	0.3	0.1	0.2	0.2	0.4	0.1	0.3	0.0	0.2	1.3	1.0	0.3	0.1	0.4	4.2	0.3	0.1	6.5	0.2	0.4	0.3	0.5	0.7	4.3	0.0	0.5	0.2	0.4	0.3	0.0	0.2	0.0	0.2	1.1	0.2	0.2	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	1.6	0.1	0.0	0.4	0.0	2.9	7.4	17.5	2.2	20.0	13.5	6.1	25.8	8.8	15.2	15.6	0.0	0.0	0.0	0.1	0.2	3.7	8.9	0.0	0.0	0.0	0.0	80.5	0.6	0.0	0.1	1.1	0.0	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.0	0.2	4.8	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	1.8	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.4	0.0
SELENOP	"SELP, SeP, SEPP, SEPP1"	ENSG00000250722	"Selenoprotein P"	P49908	5	42799880-42887392	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 248.3;liver: 403.8"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 416.9;Alveolar cells type 2: 429.0;Hofbauer cells: 658.5;Proximal tubular cells: 719.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 116.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Hep G2: 92.9;HSkMC: 81.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036287	Approved		Uncertain	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"	NA	NA	2220000000	2300000000	"Nucleoplasm, Golgi apparatus"		"HPA036287: AB_10794618"	"unprognostic (7.96e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.28e-3)"	"unprognostic (1.19e-3)"	"unprognostic (6.67e-2)"	"unprognostic (6.37e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (6.97e-6)"	"unprognostic (1.35e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.42e-1)"	53.8	31.4	17.5	13.5	54.6	2.2	41.1	11.9	24.0	34.9	56.8	52.8	24.2	40.9	22.3	39.0	20.5	26.2	44.4	26.6	27.6	17.5	57.5	403.8	55.0	30.4	106.2	16.1	49.1	15.3	18.2	21.4	62.7	63.6	30.5	48.5	27.1	19.5	41.2	16.4	18.1	248.3	16.1	137.1	87.1	21.6	19.6	70.3	6.3	24.5	14.7	11.3	30.0	33.0	2.2	3.6	2.2	0.7	2.7	2.4	1.4	0.1	0.3	1.4	0.1	7.7	2.1	1.4	0.6	1.9	0.0	0.0	2.0	11.0	0.3	6.9	0.2	0.2	0.3	0.0	0.0	0.0	0.4	8.9	0.5	0.0	92.9	4.7	0.5	0.0	81.3	0.1	0.0	0.0	0.3	0.0	0.3	1.0	2.2	4.0	0.2	0.1	1.1	5.4	3.1	0.1	0.2	0.3	15.9	2.1	1.3	0.3	0.5	0.5	2.8	0.2	10.6	21.7	0.1	0.1	0.5	0.3	0.9	0.1	1.5	0.2	0.3	0.3	1.0	0.2	0.3	0.6	1.8	2.2	0.6	2.4	1.6	1.6	1.7	1.2	2.2	2.4	2.0	2.2	2.7	0.7	3.6	1.5	1.4	17.5	54.6	11.9	24.0	27.6	17.5	106.2	16.1	63.6	70.3	416.9	429.0	0.0	0.0	0.0	0.0	0.0	0.0	96.4	187.7	118.7	0.0	169.8	167.5	38.5	0.0	0.0	0.0	0.0	45.9	18.4	0.0	0.0	24.4	0.0	658.5	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	1.8	0.0	0.0	47.6	0.0	0.0	719.9	0.0	0.0	0.0	0.0	0.0	0.0	94.4	0.0	0.0	0.0
SEMA6D	"FLJ11598, KIAA1479"	ENSG00000137872	"Semaphorin 6D"	Q8NFY4	15	47184101-47774223	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 40.8;placenta: 36.7"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 1: 47.6;Cone photoreceptor cells: 108.0;Enterocytes: 37.0;Horizontal cells: 74.7"	"Cancer enhanced"	"Detected in many"		"glioma: 8.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 13.4;SCLC-21H: 11.9;SH-SY5Y: 11.0;SuSa: 13.2;U-266/70: 8.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043109			Approved	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA		480000	"Plasma membrane"	"Golgi apparatus"	"HPA043109: AB_10793941"	"unprognostic (2.00e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.24e-1)"	"unprognostic (5.36e-2)"	"unprognostic (7.96e-4)"	"unprognostic (1.42e-1)"	"prognostic favorable (5.96e-5)"	"unprognostic (3.74e-2)"	"unprognostic (8.56e-2)"	"unprognostic (3.30e-3)"	"unprognostic (2.39e-4)"	5.3	1.9	10.3	3.7	16.7	0.8	5.3	5.4	17.1	5.3	14.7	15.3	4.3	18.9	2.1	2.9	2.0	5.2	4.0	8.3	10.3	11.2	14.2	3.0	8.2	2.2	14.0	13.6	25.0	14.8	16.2	6.1	36.7	15.9	4.8	12.0	10.0	4.4	8.5	15.6	3.1	40.8	3.4	12.7	2.5	3.4	2.6	11.0	0.2	6.3	1.5	1.1	3.1	9.6	0.5	0.0	1.9	0.6	0.0	0.8	0.0	0.0	0.0	2.2	0.0	1.3	1.1	0.2	0.5	13.4	0.3	0.0	0.3	0.1	1.8	0.0	3.4	0.0	7.0	2.8	0.9	0.0	0.9	1.6	0.0	4.1	0.0	3.6	0.0	0.1	1.0	7.3	0.0	0.4	0.0	0.9	4.8	0.1	2.9	0.4	0.7	2.2	0.5	4.2	0.0	0.0	1.3	0.0	2.0	1.0	0.9	11.9	11.0	0.1	0.9	3.7	13.2	0.4	0.0	0.0	6.2	0.3	0.2	0.0	8.8	0.0	2.0	1.6	0.2	1.6	0.0	0.6	0.0	0.5	0.0	0.0	0.5	0.3	0.8	0.0	0.0	0.1	0.2	1.9	0.0	0.0	0.0	0.0	0.0	10.3	16.7	5.4	17.1	10.3	11.2	14.0	13.6	15.9	11.0	47.6	1.0	0.0	4.0	1.8	3.3	9.4	0.0	0.0	3.4	10.4	108.0	14.7	5.0	1.0	0.1	6.7	37.0	0.0	0.2	1.2	6.7	0.9	3.5	0.8	2.3	74.7	16.7	4.9	0.0	0.0	21.6	0.0	8.5	0.0	2.6	14.3	0.4	6.0	12.7	0.2	2.0	0.0	12.2	0.7	5.1	1.0	3.9	0.0	9.8	1.4
SIGLEC11		ENSG00000161640	"Sialic acid binding Ig like lectin 11"	Q96RL6	19	49948985-49961172	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"lymphoid tissue: 11.3;ovary: 36.6"	"Cell type enhanced"	"Detected in some"	16	"Distal tubular cells: 16.6;Hofbauer cells: 6.3;Ito cells: 8.6;Kupffer cells: 19.6"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	15	"HEL: 15.4"									"HPA052132, HPA060278"	Approved		Uncertain	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA052132: , HPA060278: AB_2684240"	"unprognostic (1.07e-1)"	"unprognostic (2.85e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.93e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.79e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.95e-3)"	"unprognostic (5.38e-2)"	0.4	3.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.1		36.6	1.1	0.0	0.0	0.7		0.0	0.0		0.0	0.0	0.0	0.0	0.3	0.3	0.1	11.3	1.8	0.5			0.0		0.0	0.3	0.0	0.6	0.5	2.6	3.3	0.8	0.2	0.3	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.2	15.4	0.3	0.1	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.7	0.6	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.0	0.1	0.1	0.4	0.2	0.1	0.3	0.1	0.1	0.2	0.3	0.1	0.0	0.2	0.2	0.5	1.0	2.6	0.1	3.3	0.1	0.5	0.2	0.1	0.5	0.6	0.1	0.2	1.4	0.8	3.3	0.3	0.0	0.3											0.0	1.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	16.6	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.2	6.3	0.0	0.0	8.6	19.6	0.0	0.0	2.6	0.0	0.0	0.0	0.0	4.5	0.0	0.4	0.0	0.0	0.0	0.0	0.9	0.5	0.1	0.1	0.0	0.0	0.0
SIPA1L3	KIAA0545	ENSG00000105738	"Signal induced proliferation associated 1 like 3"	O60292	19	37907228-38208372	"Disease related genes, Predicted intracellular proteins"		"GTPase activation"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 68.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 4.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"A549: 29.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042072, HPA045480, HPA074988"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"HPA042072: AB_2677832, HPA045480: AB_2679342, HPA074988: "	"unprognostic (4.24e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.56e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.48e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.05e-2)"	"unprognostic (3.15e-1)"	"unprognostic (5.43e-2)"	"unprognostic (9.26e-3)"	"unprognostic (6.45e-2)"	"unprognostic (4.94e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.96e-2)"	6.2	6.2	10.8	15.3	11.9	5.4	10.0	18.1	13.2	9.8	18.3	13.0	13.9	31.1	6.7	6.4	9.0	9.3	7.6	11.1	15.8	7.7	12.4	6.9	10.5	11.4	10.5	7.8	6.0	17.1	7.4	7.8	3.4	8.5	9.7	12.8	11.2	14.1	9.1	11.4	19.0	29.7	6.2	8.7	12.2	16.4	8.1	12.4	11.7	18.2	6.7	20.2	10.0	11.8	4.6	0.9	1.1	3.5	0.9	1.4	0.3	16.8	29.9	3.7	4.7	2.2	2.2	2.5	7.3	6.2	4.8	4.6	10.2	9.8	9.6	6.3	6.2	4.1	3.8	3.4	13.7	5.4	3.2	1.6	2.6	2.8	3.2	4.3	1.8	2.8	1.7	7.2	9.0	19.3	7.2	5.5	2.8	1.9	2.1	8.4	5.2	2.4	2.5	3.0	13.4	8.0	5.3	3.0	1.4	10.7	14.5	8.9	4.8	8.0	13.8	1.1	2.1	9.2	1.7	11.6	8.1	2.8	24.8	11.2	2.8	4.7	3.3	10.4	2.4	10.4	0.2	0.4	1.1	0.5	0.7	0.2	3.0	0.4	0.5	0.2	4.6	0.4	1.4	0.3	0.9	3.5	0.9	0.3	0.3	10.8	11.9	18.1	13.2	15.8	7.7	10.5	7.8	8.5	12.4	6.0	8.5	13.9	4.5	10.6	18.9	5.1	22.9	10.7	10.3	22.7	13.7	1.6	3.3	6.9	4.1	4.5	68.3	0.0	13.1	1.1	2.2	6.5	2.3	20.2	2.9	31.8	24.2	6.2	4.9	6.4	2.0	5.3	5.0	5.4	41.5	2.3	12.5	30.2	1.8	17.1	5.9	6.5	2.8	1.4	4.7	14.1	0.7	3.2	27.0	4.6
SLC23A2	"KIAA0238, SLC23A1, SVCT2, YSPL2"	ENSG00000089057	"Solute carrier family 23 member 2"	Q9UGH3	20	4852356-5010293	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 55.6"	"Cell type enhanced"	"Detected in many"	12	"Bipolar cells: 215.7;Cone photoreceptor cells: 108.0;Horizontal cells: 81.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052825, HPA059314"	Approved		Uncertain	"Golgi apparatus,Vesicles"		NA	NA			Vesicles	"Golgi apparatus"	"HPA052825: AB_2681965, HPA059314: AB_2683975"	"unprognostic (3.83e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.64e-3)"	"unprognostic (8.05e-2)"	"unprognostic (2.09e-1)"	"prognostic favorable (3.35e-4)"	"unprognostic (6.22e-3)"	"unprognostic (2.08e-1)"	"unprognostic (6.36e-3)"	"prognostic favorable (7.14e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (6.08e-5)"	6.6	55.6	14.7	6.1	17.5	5.4	6.3	15.9	27.2	8.6	4.6	19.3	4.0	5.0	9.5	7.1	4.6	12.4	7.8	5.4	14.4	14.5	6.0	27.7	7.4	7.2	14.9	16.6	29.4	7.5	15.1	12.5	25.1	16.4	9.0	5.0	22.1	4.2	8.4	2.6	8.5	6.3	7.8	17.5	11.7	7.1	8.5	11.4	5.3	18.6	2.2	7.4	18.7	6.4	4.2	6.0	3.1	2.5	0.8	2.8	2.0	10.7	12.7	17.0	6.4	12.0	6.8	21.7	4.6	6.3	5.4	5.1	6.5	12.3	4.9	5.0	6.4	15.5	10.4	4.7	12.6	10.3	3.0	8.5	6.8	2.2	24.4	6.8	9.5	4.0	5.7	7.3	13.7	8.2	11.5	7.9	8.1	4.6	4.2	7.2	4.0	10.3	5.3	6.0	8.6	7.8	9.6	11.2	7.3	3.0	17.6	5.7	6.4	8.8	9.3	32.7	6.3	5.1	5.6	6.8	12.3	5.7	14.7	8.8	5.9	10.9	13.2	4.3	5.7	19.3	0.0	2.5	0.2	2.8	1.8	2.6	4.2	2.2	2.0	3.6	2.9	2.1	2.1	3.1	0.8	2.1	6.0	1.3	2.0	14.7	17.5	15.9	25.3	14.4	14.5	14.9	16.6	16.4	11.4	6.0	7.4	9.5	4.0	6.5	215.7	5.5	20.4	4.0	13.6	14.0	108.0	3.6	0.0	4.0	3.5	7.7	0.5	0.0	4.7	4.8	8.9	5.5	8.1	58.7	9.5	81.0	6.9	22.1	27.3	7.0	18.7	8.3	15.1	7.2	1.5	26.4	2.9	5.1	27.6	1.3	64.3	12.9	5.6	0.5	9.6	5.4	3.3	7.1	3.1	10.1
SMAD6	"HsT17432, MADH6, MADH7"	ENSG00000137834	"SMAD family member 6"	O43541	15	66702228-66782848	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 37.1"	"Cell type enriched"	"Detected in many"	6	"Ito cells: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 21.2;HaCaT: 12.6;HeLa: 17.4;U-2197: 12.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA061917			Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA			Nucleoplasm	"Nuclear bodies, Golgi apparatus"	"HPA061917: AB_2684637"	"unprognostic (1.20e-1)"	"unprognostic (7.43e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.50e-3)"	"unprognostic (9.59e-2)"	"unprognostic (4.50e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.55e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.33e-1)"	"prognostic favorable (5.45e-5)"	9.8	1.9	2.5	3.1	4.6	0.6	5.1	0.8	2.8	6.3	4.7	2.6	2.1	3.8	5.2	1.9	3.1	4.4	11.6	21.6	3.0	2.0	6.1	6.2	37.1	1.2	3.6	2.3	5.1	3.1	2.3	2.8	13.8	4.5	9.7	2.5	18.5	1.6	22.1	1.8	1.6	3.8	3.1	2.9	3.2	8.0	1.7	2.0	0.0	16.7	0.6	0.8	6.8	7.3	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.9	7.0	1.1	2.4	4.3	1.1	6.7	4.9	0.1	0.8	0.0	1.4	3.1	0.5	21.2	4.2	0.6	12.6	1.5	0.0	0.1	1.5	5.8	10.9	17.4	1.1	0.5	0.0	0.8	1.4	0.0	0.0	0.0	2.4	0.9	3.6	0.9	0.7	0.3	1.3	0.1	3.0	2.1	7.1	2.6	0.0	1.3	1.5	2.4	5.5	2.6	1.1	2.7	3.0	0.5	4.3	1.0	2.0	4.2	3.1	4.0	12.3	0.9	0.4	1.2	0.2	2.2	3.9	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.5	4.6	0.8	2.8	3.0	2.0	3.6	2.3	4.5	2.0	11.9	5.9	1.4	1.0	0.7	0.0	4.5	5.1	0.0	4.5	1.8	2.0	0.5	3.3	4.3	2.8	19.4	2.8	0.0	5.0	0.7	4.3	1.5	4.6	2.8	1.7	0.0	0.0	107.4	9.5	1.0	2.6	0.8	0.0	1.0	2.0	11.1	5.6	0.0	7.8	1.5	0.3	0.0	1.0	0.2	0.6	0.1	0.7	0.5	5.3	0.3
SOSTDC1	"DAND7, DKFZp564D206, USAG1"	ENSG00000171243	"Sclerostin domain containing 1"	Q6X4U4	7	16461481-16530580	"Predicted secreted proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 51.1;retina: 74.8;stomach 1: 32.3"	"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 24.9;Horizontal cells: 28.6;Melanocytes: 30.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 25.9"	"Region enriched"	"Detected in many"	9	"pons and medulla: 51.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.5;EFO-21: 11.2;HEL: 4.2;NTERA-2: 4.4;RPTEC TERT1: 20.8"	"Group enriched"	"Detected in many"	5	"basal ganglia: 9.4;hippocampal formation: 20.4;pons and medulla: 15.8;thalamus: 12.8"	"Low region specificity"	"Detected in many"			HPA042856			Uncertain	"Nucleoli,Nucleoli rim,Golgi apparatus,Vesicles"	"Secreted to extracellular matrix"	NA	NA			"Golgi apparatus"	"Nucleoli, Nucleoli rim, Vesicles"	"HPA042856: "	"unprognostic (2.08e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.17e-3)"	"unprognostic (5.59e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.41e-2)"	"prognostic favorable (8.69e-4)"	"unprognostic (2.59e-1)"	"unprognostic (2.62e-1)"	"prognostic favorable (3.22e-5)"	"unprognostic (7.01e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (8.72e-4)"	0.4	0.4	2.0	1.4	1.9	0.0	9.5	0.5	5.8	2.6	5.9	7.0	0.2	6.1	2.5	2.4	2.7	2.7	0.4	3.7	3.5	1.6	12.8	0.2	22.0	0.1	0.7	5.3	0.6	1.1	0.0	2.9	0.0	51.1	1.1	8.4	74.8	12.5	6.4	0.3	13.7	4.8	0.5	1.0	0.2	32.3	1.9	0.0	0.0	4.7	3.1	4.9	1.0	3.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	11.2	0.0	0.0	0.2	0.4	0.0	0.0	0.1	2.2	4.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	20.8	0.0	0.0	0.3	0.1	0.0	0.0	0.7	0.8	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.0	1.9	0.5	5.8	3.5	1.6	0.7	5.3	51.1	0.0	0.0	0.0	0.0	4.5	4.9	0.4	1.0	0.0	0.0	3.4	14.0	0.0	0.0	24.9	0.0	14.4	0.2	0.0	0.0	0.0	0.0	2.1	0.8	0.0	0.0	0.0	28.6	2.4	0.6	0.0	9.4	6.6	0.0	30.4	0.0	0.0	15.0	0.2	0.0	2.5	14.4	0.4	0.0	0.4	2.7	0.9	6.4	0.0	0.0	2.1	0.3
SPNS1	"HSpin1, LAT, nrs, PP2030, SPIN1, SPINL"	ENSG00000169682	"Sphingolipid transporter 1 (putative)"	Q9H2V7	16	28974221-28984548	"Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041995, HPA042988"	Enhanced		Approved	"Nucleoli fibrillar center,Golgi apparatus,Vesicles,Cytosol"		NA	NA			Vesicles	"Nucleoli fibrillar center, Golgi apparatus, Cytosol"	"HPA041995: AB_10959609, HPA042988: AB_10964587"	"unprognostic (3.54e-2)"	"unprognostic (4.57e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.66e-1)"	"unprognostic (7.86e-5)"	"unprognostic (1.01e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.02e-3)"	"unprognostic (8.85e-7)"	"unprognostic (1.48e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.12e-2)"	23.4	23.9	14.5	22.0	15.9	38.3	24.2	21.0	22.8	18.2	22.1	24.1	20.1	26.9	25.1	21.3	20.9	17.1	26.8	16.1	14.9	12.1	24.1	28.3	33.4	22.6	15.4	17.0	18.3	20.8	29.5	17.2	40.7	15.4	20.1	12.6	19.8	20.8	22.8	21.3	30.9	22.3	26.3	14.5	27.3	20.7	22.3	17.2	31.0	22.0	24.5	17.2	21.2	19.5	3.1	15.6	7.2	23.5	4.2	7.9	10.1	10.3	24.5	9.3	21.6	17.9	9.9	26.5	11.6	12.0	19.4	17.4	22.3	24.9	6.6	28.6	10.4	16.1	22.0	15.0	12.8	7.0	7.6	25.5	9.6	23.9	27.7	30.4	10.6	20.7	16.5	17.2	20.9	8.9	11.4	17.8	12.4	21.5	12.0	9.7	27.7	11.6	30.4	21.9	8.4	16.2	14.7	11.2	29.6	10.5	10.1	16.7	21.6	8.2	24.7	18.0	8.1	24.6	12.9	15.0	15.8	12.0	22.0	8.9	18.2	14.3	6.2	20.2	16.3	12.7	6.4	18.2	7.2	6.0	23.5	5.0	3.1	6.0	7.9	15.6	2.8	6.2	4.1	3.3	4.2	15.7	6.5	6.8	10.1	14.5	15.9	21.0	22.8	14.9	12.1	15.4	17.0	15.4	17.2	6.0	7.4	9.0	18.6	18.9	27.1	0.4	10.2	12.0	3.4	19.2	27.5	55.8	11.6	51.1	1.5	21.6	16.8	0.0	39.5	59.8	27.5	13.4	20.9	12.1	87.9	25.4	11.7	19.6	37.6	1.9	21.0	27.5	32.1	26.2	18.9	29.6	34.8	14.0	15.6	13.5	33.9	6.5	15.3	17.2	28.3	19.8	73.0	22.5	23.8	17.0
SRCAP	"DOMO1, EAF1, KIAA0309, SWR1"	ENSG00000080603	"Snf2 related CREBBP activator protein"	Q6ZRS2	16	30698209-30741409	"Disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Basal keratinocytes: 21.9;Suprabasal keratinocytes: 50.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA028929	Approved		Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA			Nucleoplasm	"Nuclear bodies, Golgi apparatus"	"HPA028929: AB_10601265"	"unprognostic (1.26e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.07e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.95e-2)"	"unprognostic (8.59e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.77e-1)"	"unprognostic (6.45e-2)"	"unprognostic (4.36e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.11e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.07e-1)"	13.5	15.5	15.4	17.1	15.6	23.6	13.6	24.8	18.1	14.8	16.3	20.4	14.0	14.1	23.6	12.0	13.0	15.1	16.0	11.9	11.5	9.3	10.5	9.3	11.6	13.9	18.2	10.8	17.2	17.8	31.2	18.2	16.3	13.0	14.1	10.3	17.5	17.2	13.4	23.5	14.8	18.0	13.4	12.6	16.0	15.9	22.4	14.0	20.5	17.4	10.1	15.1	21.4	12.7	3.2	2.3	6.2	3.2	1.7	2.4	1.5	13.8	27.4	16.5	16.8	13.0	9.3	17.8	10.5	9.7	12.1	9.7	13.0	10.2	28.8	14.5	13.3	8.3	13.9	17.1	13.1	10.0	18.6	39.3	18.3	24.0	11.1	5.8	21.2	22.2	9.7	6.5	18.1	14.9	6.2	12.3	9.7	28.1	16.3	8.8	17.1	18.1	8.4	17.2	5.8	12.3	25.3	13.0	16.5	3.8	16.0	16.0	16.6	11.7	15.3	4.5	5.8	17.3	12.0	19.8	17.2	12.6	9.7	14.0	18.6	15.7	21.2	13.8	11.2	13.1	0.7	1.8	6.2	2.4	3.2	1.9	1.8	1.3	2.4	1.3	3.2	1.3	1.1	5.4	1.7	0.8	2.3	2.1	1.5	15.4	15.6	24.8	18.1	11.5	9.3	18.2	10.8	13.0	14.0	3.0	3.0	1.9	1.7	21.9	7.6	1.4	2.5	0.0	2.3	1.8	7.9	2.0	0.0	1.0	0.8	1.7	4.7	0.0	2.7	1.1	1.7	2.4	2.3	2.9	2.0	7.9	10.9	1.8	0.3	0.5	2.6	1.7	10.1	2.8	2.8	2.9	1.5	1.7	1.1	0.5	5.5	0.0	3.9	4.7	5.1	50.8	2.1	4.3	2.7	2.5
STMN4	RB3	ENSG00000015592	"Stathmin 4"	Q9H169	8	27235323-27258420	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"brain: 132.2"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 43.7;Horizontal cells: 87.4"	"Cancer enriched"	"Detected in some"	27	"glioma: 14.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	26	"SCLC-21H: 45.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027765			Uncertain	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	Vesicles	"HPA027765: AB_1857607"	"unprognostic (1.52e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.19e-6)"	"unprognostic (1.22e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.57e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.31e-3)"	"unprognostic (9.84e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.37e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.15e-1)"	"unprognostic (7.63e-2)"	1.5	7.9	30.8	1.5	23.4	1.5	1.5	22.2	132.2	1.5	2.3	37.3	0.0	1.8	1.5	2.0	1.5	1.5	1.6	1.4	36.3	27.9	1.5	1.4	1.5	1.5	34.9	37.2	1.4	1.4	1.5	0.0	1.4	21.4	1.5	2.3	0.0	1.5	1.5	1.4	1.5	2.2	1.8	71.8	1.4	1.5	1.6	6.6	0.0	1.4	0.0	1.4	1.5	0.0	1.0	0.9	0.3	0.2	0.1	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.2	0.7	0.0	0.1	0.3	0.2	0.4	0.1	1.0	0.7	0.2	0.3	0.1	0.2	0.9	0.4	0.0	30.8	23.4	22.2	34.4	36.3	27.9	34.9	37.2	21.4	6.6	0.0	0.0	0.0	0.1	0.3	43.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	87.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	1.4	0.0	11.1	0.0	0.0	0.5	1.2	0.1	0.0	0.0	0.0	0.0
SUSD5	KIAA0527	ENSG00000173705	"Sushi domain containing 5"	O60279	3	33150042-33219215	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"Sertoli cells: 32.3;Smooth muscle cells: 13.0"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 1.9;neutrophil: 1.5"	"Group enriched"	"Detected in many"	9	"B-cells: 1.9;granulocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 14.8;HUVEC TERT2: 36.7;LHCN-M2: 14.2;TIME: 14.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA052788	Uncertain		Uncertain	"Golgi apparatus,Vesicles"		NA	NA		4300000	"Golgi apparatus, Vesicles"		"HPA052788: AB_2681948"	"unprognostic (1.81e-1)"	"unprognostic (1.52e-2)"	"unprognostic (5.84e-3)"	"unprognostic (5.52e-3)"	"unprognostic (1.39e-3)"	"unprognostic (4.05e-2)"	"unprognostic (3.72e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.10e-3)"	"unprognostic (6.45e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.89e-2)"	7.6	2.5	7.0	1.5	6.1	0.4	2.5	2.0	13.2	11.0	2.6	4.6	2.3	1.5	7.0	6.5	2.3	7.9	13.1	5.7	6.4	8.1	2.6	1.1	3.0	4.4	6.9	6.9	6.4	1.2	1.0	1.3	0.5	6.3	1.9	2.2	3.7	1.3	10.7	2.2	2.8	2.7	7.7	4.6	3.9	3.3	4.7	3.3	0.0	5.3	2.9	8.1	3.0	3.5	1.9	0.1	1.5	0.1	0.1	0.1	0.1	0.0	0.5	0.6	0.3	0.8	0.1	0.0	4.5	1.6	14.8	5.0	0.0	0.0	0.0	4.2	1.1	4.6	0.0	6.4	2.1	6.1	0.1	7.1	0.0	1.0	0.0	0.1	0.0	0.0	0.6	1.1	9.5	1.8	7.2	36.7	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	1.1	0.3	0.8	0.9	14.4	0.0	7.0	0.6	2.1	0.0	0.3	0.0	0.1	0.0	0.7	0.2	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.9	0.1	0.1	1.5	0.1	0.0	0.1	0.0	0.1	7.0	6.1	2.0	13.2	6.4	8.1	6.9	6.9	6.3	3.3	0.0	0.0	0.0	0.0	0.9	1.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	3.2	0.0	0.6	1.3	0.0	0.0	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	32.3	13.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0
TAF11	"TAF2I, TAFII28"	ENSG00000064995	"TATA-box binding protein associated factor 11"	Q15544	6	34877778-34888089	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA029326, HPA049127"			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA029326: AB_2672999, HPA049127: AB_2680645"	"unprognostic (4.02e-2)"	"unprognostic (5.36e-3)"	"unprognostic (7.41e-2)"	"unprognostic (5.18e-3)"	"unprognostic (6.65e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.56e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.68e-3)"	"prognostic favorable (5.87e-4)"	"unprognostic (2.91e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.89e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.87e-2)"	"unprognostic (4.92e-1)"	"unprognostic (3.32e-1)"	20.6	25.5	22.2	26.8	28.1	43.1	27.2	30.1	29.8	23.0	23.2	17.5	26.7	21.1	23.6	24.2	23.5	22.7	22.0	33.3	21.5	17.9	20.7	28.7	23.2	28.6	24.8	22.1	27.9	25.4	16.7	18.8	30.6	26.7	23.8	25.3	20.4	20.3	31.0	39.3	31.2	24.2	26.8	23.4	31.1	22.6	32.7	29.0	29.4	23.3	24.6	28.7	22.8	22.6	14.9	20.1	26.5	23.6	13.2	16.7	12.8	14.7	6.5	21.3	37.5	13.3	14.2	18.8	11.9	10.0	20.5	19.8	14.9	9.5	20.3	15.9	11.3	9.9	9.4	26.1	11.0	16.7	12.2	21.0	22.7	13.4	25.0	18.8	28.7	16.0	15.9	18.0	13.8	11.3	12.5	24.9	22.7	35.8	15.7	9.8	26.9	18.3	24.0	19.0	31.0	11.1	20.0	18.9	15.9	15.1	9.6	25.7	23.2	14.0	15.4	26.8	19.1	24.9	36.1	14.3	14.2	18.7	8.2	14.4	14.2	35.0	29.1	5.3	34.4	20.5	26.5	23.6	19.3	12.6	21.0	12.1	11.6	13.4	13.5	20.1	14.9	15.7	14.0	14.6	13.2	16.8	17.7	16.7	12.8	22.2	28.1	30.1	29.8	21.5	17.9	24.8	22.1	26.7	29.0	26.8	15.0	26.1	25.7	40.9	27.7	20.1	17.8	9.4	27.3	40.1	11.8	61.7	54.7	36.9	4.5	33.1	30.6	46.7	54.7	56.3	29.1	24.0	21.9	52.1	38.6	30.2	37.9	55.9	51.2	5.7	31.4	34.5	23.6	33.3	34.7	36.0	41.8	49.1	35.0	24.2	31.6	32.3	23.1	88.2	45.3	51.1	64.2	35.9	39.2	25.5
TFAP2D	TFAP2BL1	ENSG00000008197	"Transcription factor AP-2 delta"	Q7Z6R9	6	50713828-50772988	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	5	"brain: 4.4"	"Cell type enhanced"	"Detected in single"	24	"Horizontal cells: 1.6"	"Cancer enriched"	"Detected in single"	10	"lung cancer: 0.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HAP1: 5.2;U-2197: 1.6"	"Region enriched"	"Detected in many"	4	"midbrain: 14.1"	"Region enriched"	"Detected in many"	7	"midbrain: 16.3"	HPA048962			Uncertain	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			Nucleoplasm	"Golgi apparatus, Vesicles"	"HPA048962: AB_2680573"																		0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0			0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.1	0.0	0.0	0.0	0.0		0.0	0.0		0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMC8	"EVER2, EVIN2"	ENSG00000167895	"Transmembrane channel like 8"	Q8IU68	17	78130770-78142968	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 33.6;intestine: 23.2;lymphoid tissue: 52.9"	"Cell type enhanced"	"Detected in many"	7	"B-cells: 29.6;granulocytes: 40.4;Hofbauer cells: 25.4;monocytes: 26.2;T-cells: 39.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 15.7;HL-60: 20.9;HMC-1: 42.3;Karpas-707: 36.0;RPMI-8226: 22.2;U-266/70: 17.4;U-937: 17.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047387, HPA054429"	Uncertain		Uncertain	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA047387: , HPA054429: AB_2682485"	"unprognostic (8.54e-3)"	"prognostic favorable (8.45e-6)"	"unprognostic (1.32e-1)"	"unprognostic (2.33e-3)"	"unprognostic (3.59e-1)"	"prognostic favorable (4.19e-5)"	"unprognostic (6.38e-3)"	"unprognostic (6.47e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.06e-2)"	"unprognostic (4.27e-1)"	"prognostic unfavorable (1.96e-7)"	"unprognostic (6.24e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.89e-2)"	3.6	1.6	2.3	30.1	4.6	33.6	1.9	0.7	2.3	1.7	4.4	3.5	0.1	4.2	2.5	2.1	2.5	2.1	6.2	1.5	2.3	1.7	3.4	3.1	10.7	38.7	4.0	0.8	0.9	1.2	0.1	1.3	1.5	2.8	2.4	1.9	2.6	10.2	1.0	0.6	1.7	23.2	1.0	5.1	52.9	4.1	0.7	3.7	49.7	3.1	1.8	36.6	3.9	2.5	5.0	2.1	5.5	6.6	6.7	13.1	4.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	15.7	0.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.2	0.0	20.9	42.3	0.0	0.0	0.0	0.0	0.0	0.0	7.9	1.3	36.0	0.0	0.4	7.1	0.9	0.0	1.1	0.1	0.4	0.1	22.2	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	2.3	4.3	0.0	0.0	0.0	0.0	0.0	17.4	0.7	1.5	0.0	17.7	0.0	2.3	1.8	5.5	13.1	3.1	9.4	5.0	10.5	12.9	2.1	5.0	9.4	8.4	3.0	6.7	6.6	1.9	5.7	4.2	2.3	4.6	0.7	2.3	2.3	1.7	4.0	0.8	2.8	3.7	3.0	15.1	29.6	9.3	4.7	0.0	1.6	0.0	1.4	7.9	0.0	0.0	0.3	0.0	0.9	0.3	1.4	2.1	0.0	1.1	1.0	1.5	2.2	40.4	0.4	25.4	0.0	1.2	6.2	22.6	0.0	0.0	15.6	6.8	26.2	0.8	0.2	0.4	3.1	0.4	0.3	0.0	0.0	1.7	0.4	0.5	4.0	0.5	39.2	2.2	11.7
TMEM196	MGC42090	ENSG00000173452	"Transmembrane protein 196"	Q5HYL7	7	19719310-19773598	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 15.0;pituitary gland: 12.6"	"Cell type enriched"	"Detected in some"	10	"Bipolar cells: 51.1"	"Cancer enhanced"	"Detected in single"		"glioma: 0.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"ASC diff: 8.8;ASC TERT1: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043163	Uncertain		Uncertain	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA043163: AB_10794772"					"unprognostic (6.08e-3)"					"unprognostic (1.88e-2)"	"unprognostic (2.14e-2)"		"unprognostic (9.30e-2)"	"unprognostic (5.63e-2)"				0.7	3.7	8.0	0.6	8.6	0.4	0.4	0.3	15.0	1.2	0.6	0.3	0.0	0.4	3.8	1.5	0.5	1.2	0.4	0.4	3.6	10.1	0.6	0.4	0.4	0.4	2.9	7.4	0.4	3.0	0.7	12.6	0.4	5.0	0.5	0.5	0.5	0.4	0.4	0.4	0.4	0.4	1.0	1.4	0.4	2.6	0.5	2.8	0.0	0.4	0.0	0.4	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	8.8	8.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	8.6	0.3	7.3	3.6	10.1	2.9	7.4	5.0	2.8	0.0	0.0	0.0	0.0	0.0	51.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	1.8	0.4	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRPM1	"CSNB1C, LTRPC1, MLSN1"	ENSG00000134160	"Transient receptor potential cation channel subfamily M member 1"	Q7Z4N2	15	31001061-31161273	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel, Receptor"	"Congenital stationary night blindness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"retina: 99.0"	"Cell type enriched"	"Detected in some"	5	"Bipolar cells: 705.2"	"Cancer enriched"	"Detected in single"	179	"melanoma: 14.6"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	113	"SK-MEL-30: 16.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA014779, HPA071139"	Enhanced		Uncertain	"Golgi apparatus,Plasma membrane,Centriolar satellite"		NA	NA			"Centriolar satellite"	"Golgi apparatus, Plasma membrane"	"HPA014779: AB_2669090, HPA071139: "	"unprognostic (5.28e-2)"	"unprognostic (1.35e-1)"		"unprognostic (9.89e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.29e-3)"	"unprognostic (2.83e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.58e-1)"	"unprognostic (7.84e-2)"	"unprognostic (6.20e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.63e-2)"	0.1	0.0	0.4	0.0	0.6	0.0	0.1	0.1	0.3	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.2	0.3	0.1	0.1	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	99.0	0.4	0.0	0.2	10.4	0.0	0.1	1.9	0.0	0.0	2.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.4	0.6	0.1	0.3	0.7	0.2	1.6	0.0	0.3	0.1	0.0	0.0	0.0	0.0	3.8	705.2	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	30.8	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	12.7	0.0	0.0	0.0	2.4	0.0	0.0	150.1	0.0	0.0	10.0	0.0	0.0	0.0	0.6	18.1	0.0	0.0	7.9	3.8	0.9	0.8	0.0	0.0	0.0
TSLP		ENSG00000145777	"Thymic stromal lymphopoietin"	Q969D9	5	111070062-111078024	"Predicted intracellular proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Basal glandular cells: 24.2;Basal keratinocytes: 49.6;Club cells: 45.5;Early spermatids: 30.8;Late spermatids: 20.5;Suprabasal keratinocytes: 22.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 2.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.1"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 10.3;HHSteC: 11.7;hTCEpi: 6.9;hTEC/SVTERT24-B: 14.7;hTERT-HME1: 8.4;hTERT-RPE1: 26.0;U-87 MG: 9.5"									HPA056350			Uncertain	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	38400		"Golgi apparatus, Vesicles"		"HPA056350: "	"unprognostic (6.47e-4)"	"unprognostic (3.26e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.03e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.53e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.15e-2)"	"unprognostic (4.24e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.74e-3)"	5.1	1.7	0.7	2.0	1.1	0.2	19.1	0.5	0.8	5.4	4.6	1.4	6.6	1.5	4.2	0.7	14.1	1.1	14.1	18.7	1.4	0.8	1.6	17.3	4.6	1.8	1.2	1.7	1.1	0.8	0.2	1.5	0.4	2.3	16.4	1.7	1.0	3.5	6.8	2.3	1.7	2.7	12.6	4.6	1.0	2.6	7.9	1.1	0.3	4.1	3.2	2.3	10.0	6.0	0.0	0.0	0.0	0.5	0.0	2.1	0.3	0.0	0.0	0.0	1.2	1.6	10.3	0.0	0.0	1.5	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.3	0.5	0.0	1.6	1.8	0.1	0.0	11.7	0.3	0.0	0.2	6.9	14.7	8.4	26.0	0.0	4.3	0.1	0.0	2.1	0.0	1.6	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.9	0.0	0.7	0.0	0.0	0.6	0.0	0.0	2.7	0.0	0.0	9.5	0.2	0.4	0.0	0.5	0.0	0.9	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.5	2.1	0.0	0.0	0.0	0.0	0.0	0.3	0.7	1.1	0.5	0.8	1.4	0.8	1.2	1.7	2.3	1.1	0.0	1.9	0.0	24.2	49.6	0.0	5.2	0.0	2.7	45.5	0.0	0.0	0.0	0.0	0.1	30.8	4.7	0.0	0.0	0.0	0.0	2.1	4.0	0.0	8.3	0.2	0.0	0.0	4.9	0.0	20.5	0.6	0.2	3.3	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	3.1	0.3	0.4	22.0	0.0	0.0	0.0	2.1
UHMK1	"KIS, Kist"	ENSG00000152332	"U2AF homology motif kinase 1"	Q8TAS1	1	162497251-162529629	"Enzymes, Predicted intracellular proteins"		"Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071190			Approved	"Nucleoplasm,Golgi apparatus,Midbody"		Yes	No			"Nucleoplasm, Golgi apparatus"	Midbody	"HPA071190: AB_2686358"	"unprognostic (6.69e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.08e-2)"	"unprognostic (8.16e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.82e-1)"	"unprognostic (7.81e-3)"	"unprognostic (9.10e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.44e-2)"	"unprognostic (9.08e-2)"	"unprognostic (8.77e-2)"	"unprognostic (4.66e-2)"	21.6	22.0	23.5	18.9	26.2	30.1	23.5	10.8	30.5	14.3	16.3	17.2	30.8	16.3	11.5	12.9	16.0	12.9	12.1	11.4	27.0	31.8	27.9	32.4	16.9	24.3	30.6	20.3	12.1	11.8	25.0	12.5	16.5	33.4	14.7	17.4	14.1	15.9	22.9	30.6	11.5	21.8	9.6	20.5	21.3	16.8	10.4	14.1	23.0	17.1	11.7	24.1	16.1	12.8	5.7	4.3	4.5	9.2	5.9	8.5	4.0	21.1	9.9	5.2	12.7	14.9	11.8	11.7	28.0	15.3	23.0	16.6	6.4	13.3	17.3	24.5	20.9	11.2	12.3	9.9	15.5	37.1	23.7	7.2	17.1	12.3	5.8	11.5	24.9	20.0	12.1	16.4	22.6	21.7	16.1	13.2	12.0	14.9	24.1	39.4	8.9	13.2	6.6	6.9	15.9	13.4	8.5	23.3	14.4	15.3	21.9	9.5	8.8	24.7	23.0	18.0	7.5	19.9	28.0	20.5	26.3	14.9	18.1	39.0	25.0	34.7	20.5	21.9	12.2	23.8	4.5	3.3	3.7	8.2	8.6	8.5	5.4	6.2	6.8	3.6	5.7	6.3	7.1	2.0	5.9	9.2	4.3	4.9	4.0	23.5	26.2	10.8	30.5	27.0	31.8	30.6	20.3	33.4	14.1	17.9	32.1	50.1	25.7	26.2	21.7	29.4	56.0	41.5	50.0	50.6	11.8	22.6	48.0	23.2	35.7	30.8	40.7	0.0	20.2	32.6	19.3	44.8	45.0	71.0	27.6	22.3	32.1	35.0	64.6	34.6	19.8	51.7	27.0	44.1	35.0	13.6	28.8	34.8	18.4	49.4	21.6	0.0	27.3	23.4	22.0	21.5	18.8	52.2	31.1	52.1
WAPL	"FOE, KIAA0261, WAPAL"	ENSG00000062650	"WAPL cohesin release factor"	Q7Z5K2	10	86435256-86521815	"Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037874, HPA037875, HPA066141"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytokinetic bridge,Mitotic spindle,Centrosome,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Cytokinetic bridge, Mitotic spindle, Centrosome, Cytosol"	"HPA037874: AB_10697086, HPA037875: AB_10672396, HPA066141: "	"unprognostic (1.52e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.91e-2)"	"unprognostic (6.63e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.25e-1)"	"unprognostic (5.78e-2)"	"unprognostic (5.56e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.79e-1)"	15.3	15.4	16.0	15.5	16.9	19.8	15.6	23.6	15.0	13.4	14.0	12.1	6.8	12.5	16.0	8.7	20.4	12.6	11.2	13.3	15.3	8.2	14.5	23.1	17.5	19.3	14.8	11.5	14.8	13.6	18.1	18.2	19.0	13.4	13.9	13.1	9.4	14.9	10.6	34.4	20.4	16.0	16.0	16.4	18.2	13.5	28.1	16.4	39.2	15.9	9.4	22.4	15.1	15.9	5.2	6.2	14.3	8.7	3.9	7.7	3.1	20.2	9.5	16.7	22.0	13.3	14.2	14.7	17.8	22.0	15.2	16.6	20.6	17.9	30.8	12.1	15.9	13.4	19.1	18.9	15.3	23.4	20.0	12.4	18.6	15.2	22.6	15.2	37.6	21.5	11.1	17.9	19.4	32.7	17.3	16.9	18.0	19.5	18.6	17.3	17.3	23.4	14.1	14.8	12.7	9.6	16.7	13.5	12.2	13.1	18.0	6.5	12.6	15.7	10.6	19.3	17.3	23.2	20.1	16.2	14.6	17.4	12.8	23.3	18.3	25.4	32.6	13.4	26.9	10.3	14.3	4.7	9.4	4.7	5.3	7.0	5.2	6.3	6.5	6.2	4.8	7.2	5.7	7.3	3.9	8.7	4.7	7.7	3.1	16.0	16.9	23.6	15.0	15.3	8.2	14.8	11.5	13.4	16.4	77.4	51.5	21.9	40.4	0.0	47.2	0.0	12.7	25.4	38.7	15.7	19.6	36.2	18.3	52.5	61.6	29.2	15.6	70.0	46.0	25.0	22.4	50.1	23.3	41.2	35.6	52.4	17.5	28.8	48.6	27.3	29.7	49.5	0.0	56.9	31.7	45.3	46.8	37.1	30.4	26.7	127.3	64.7	0.0	125.1	82.8	0.0	63.6	38.9	32.2	54.7
ZNF143	"pHZ-1, SBF, STAF"	ENSG00000166478	"Zinc finger protein 143"	P52747	11	9460319-9528524	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Sertoli cells: 58.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003263, HPA003264, HPA074818"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus,Vesicles"		NA	NA			Nucleoplasm	"Nuclear bodies, Golgi apparatus, Vesicles"	"HPA003263: AB_1080672, HPA003264: , HPA074818: AB_2686715"	"unprognostic (2.30e-2)"	"unprognostic (2.12e-2)"	"unprognostic (5.51e-2)"	"unprognostic (9.72e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (1.76e-5)"	"unprognostic (4.87e-3)"	"unprognostic (2.57e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (1.20e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.06e-2)"	"unprognostic (7.55e-2)"	22.7	9.8	11.6	13.6	11.7	20.9	16.4	25.4	11.8	16.8	14.7	11.0	12.8	11.8	20.8	19.5	14.7	13.4	10.7	13.2	11.9	10.8	11.9	12.1	14.0	18.0	12.6	8.7	18.8	10.7	10.3	24.0	15.7	11.4	17.4	12.9	11.7	14.9	13.0	27.0	12.8	13.5	16.1	15.2	18.7	11.6	20.4	13.8	27.4	18.8	10.4	17.3	25.0	21.8	13.0	12.0	31.2	15.6	10.2	17.0	10.5	15.2	14.9	18.8	12.2	15.3	14.3	16.9	16.9	13.8	13.1	14.4	20.8	19.1	15.1	7.9	13.7	11.2	17.5	18.1	13.5	19.8	15.1	21.9	14.3	21.9	14.4	12.6	19.8	14.4	12.5	16.2	17.8	15.7	17.1	13.0	14.0	15.4	18.6	14.3	13.2	18.1	8.1	20.9	17.7	15.7	16.5	17.0	9.3	11.6	18.8	12.9	12.6	18.8	12.8	11.1	17.3	11.8	11.1	12.5	17.4	12.4	12.1	15.0	9.2	15.7	25.9	11.1	11.3	9.9	20.6	14.2	31.2	17.0	13.9	15.3	13.0	15.2	13.8	12.0	11.2	14.2	12.2	25.7	10.2	15.6	5.8	16.6	10.5	11.6	11.7	25.4	11.8	11.9	10.8	12.6	8.7	11.4	13.8	6.0	15.5	5.7	33.1	23.7	6.6	14.0	5.1	13.4	7.9	5.2	7.9	8.5	3.3	11.2	13.0	11.3	5.1	0.0	10.1	13.6	10.5	16.9	13.9	8.5	8.8	4.8	6.3	4.9	7.1	7.8	10.9	14.1	10.1	9.0	6.0	14.3	11.6	7.4	6.3	5.3	13.5	58.2	16.0	42.3	21.7	20.6	15.3	15.7	6.6	28.8
ZNF148	"BERF-1, BFCOL1, HT-BETA, pHZ-52, ZBP-89, ZFP148"	ENSG00000163848	"Zinc finger protein 148"	Q9UQR1	3	125225561-125375354	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001656, CAB017486"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"CAB017486: AB_794260, HPA001656: AB_1079995"	"unprognostic (2.40e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.94e-2)"	"unprognostic (5.94e-3)"	"unprognostic (5.66e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (2.88e-4)"	"unprognostic (6.36e-2)"	"unprognostic (7.97e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.63e-2)"	"unprognostic (2.72e-1)"	10.5	9.2	12.5	13.4	17.4	5.3	9.4	18.4	17.7	10.7	8.9	4.1	3.3	5.7	11.2	8.3	8.9	10.2	8.6	11.7	11.2	7.2	10.6	9.0	8.8	8.8	11.9	11.8	14.5	7.7	15.7	18.2	7.6	10.5	9.1	9.2	6.7	10.3	12.2	12.2	7.6	8.0	11.0	7.6	8.6	7.4	9.5	10.9	25.4	24.4	3.2	10.8	10.7	9.8	13.9	7.3	29.7	12.1	18.8	17.3	10.2	18.4	12.2	13.3	11.8	11.9	12.9	10.1	16.8	19.7	18.9	18.1	11.5	10.3	14.9	11.8	24.8	15.3	15.1	14.5	12.7	27.0	6.6	5.5	18.3	14.7	5.9	8.8	12.5	18.5	10.4	13.3	17.7	18.8	12.5	12.9	10.9	8.9	12.7	13.9	14.4	15.5	4.6	8.5	12.5	10.5	11.2	14.6	8.3	10.8	20.6	11.5	9.7	22.4	11.4	18.7	7.7	14.2	12.6	16.6	14.4	15.5	18.0	10.7	11.1	12.6	22.6	10.8	8.0	13.2	2.5	8.7	17.4	13.4	8.4	13.8	13.8	11.8	12.5	7.3	13.9	17.3	13.5	29.7	18.8	12.1	6.5	10.8	10.2	12.5	17.4	18.4	17.7	11.2	7.2	11.9	11.8	10.5	10.9	86.4	32.9	27.3	25.1	31.6	67.0	66.1	28.1	24.1	43.3	31.4	37.3	23.6	21.6	32.2	73.6	43.1	22.7	46.7	32.7	20.8	30.5	30.4	48.6	37.5	26.6	71.5	46.0	36.8	37.3	83.4	44.5	32.2	16.9	28.9	37.1	41.2	29.0	17.5	55.5	36.0	37.8	32.3	38.1	18.2	18.1	33.5	26.4	45.9	33.3	32.5
ZNF496	"MGC15548, ZKSCAN17, ZSCAN49"	ENSG00000162714	"Zinc finger protein 496"	Q96IT1	1	247297412-247331846	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 28.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055834			Uncertain	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA055834: "	"unprognostic (1.88e-3)"	"unprognostic (3.31e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.87e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.72e-3)"	"unprognostic (3.31e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.10e-2)"	"unprognostic (6.41e-2)"	"unprognostic (4.19e-1)"	"unprognostic (1.89e-3)"	"unprognostic (8.24e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.55e-1)"	10.1	6.2	6.9	6.4	8.2	6.3	8.7	11.4	13.5	17.8	10.8	15.1	4.7	4.1	16.1	11.4	7.2	16.8	8.7	9.6	6.3	5.8	8.1	4.7	8.7	6.8	6.3	6.2	21.7	20.4	12.7	7.0	10.6	7.3	10.1	6.3	14.5	8.1	12.3	16.6	5.9	6.7	13.0	7.1	9.6	9.2	21.1	7.8	22.4	14.1	7.0	7.5	12.8	8.5	1.5	2.7	0.3	1.0	2.7	5.5	1.8	12.0	11.1	11.7	14.3	4.7	12.0	14.8	5.7	14.1	12.7	11.5	6.0	11.3	3.4	9.8	9.2	4.8	10.4	12.0	10.9	12.8	9.3	2.9	11.2	7.8	6.8	12.7	13.6	5.8	12.7	11.5	9.9	23.9	14.2	15.0	16.4	19.8	8.8	7.8	7.7	13.4	9.4	23.6	5.3	16.6	12.8	12.9	4.6	7.8	14.6	10.1	22.2	7.6	8.6	11.3	11.2	9.0	16.9	10.3	9.3	13.2	4.1	17.6	9.8	7.8	9.9	3.9	0.9	10.0	0.0	1.0	0.3	2.1	0.7	3.4	0.8	0.9	2.3	2.7	1.5	1.9	5.5	0.3	2.7	1.0	1.6	0.3	1.8	6.9	8.2	11.4	13.5	6.3	5.8	6.3	6.2	7.3	7.8	0.0	2.7	1.5	3.6	3.3	6.8	7.6	2.5	4.0	5.7	1.8	2.0	4.1	1.7	3.8	8.3	5.7	1.0	0.0	5.0	5.0	6.6	4.8	3.5	1.8	5.0	3.2	4.7	7.4	4.7	28.7	5.2	2.0	3.3	3.6	2.0	1.5	4.4	2.9	6.7	2.4	6.9	6.5	6.6	14.0	8.3	3.0	3.5	1.7	3.4	3.9
ZNF682	BC39498_3	ENSG00000197124	"Zinc finger protein 682"	O95780	19	19997058-20039506	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 2: 13.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 12.0;AN3-CA: 18.0"									HPA055998	Uncertain		Uncertain	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA055998: AB_2683002"	"unprognostic (8.96e-2)"	"unprognostic (3.93e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.16e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.24e-3)"	"unprognostic (7.70e-4)"	"unprognostic (1.77e-3)"	"unprognostic (4.06e-7)"	"unprognostic (2.07e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (3.51e-4)"	4.1	4.9	11.0	5.2	14.1	4.1	7.6	13.6	12.9	5.9	5.3	10.3	8.5	3.5	5.2	8.1	5.3	6.9	5.3	7.1	10.5	7.6	6.3	6.9	8.1	7.9	12.5	6.5	4.6	4.9	4.6	12.0	6.7	9.4	11.0	5.8	4.3	3.3	16.2	6.7	13.9	4.6	5.6	9.7	6.7	5.4	5.6	12.4	6.5	17.4	4.6	9.6	6.2	4.8	5.7	2.2	7.6	1.0	2.2	6.4	2.1	0.0	0.0	12.0	18.0	0.9	1.3	0.5	2.5	1.2	4.3	6.9	2.0	2.5	0.1	4.4	3.6	1.2	2.2	4.9	0.4	4.8	0.0	5.1	0.0	0.1	1.3	1.7	0.0	4.3	1.8	1.4	2.4	0.0	0.6	0.0	4.7	0.0	0.1	3.2	3.7	6.8	1.0	6.6	0.0	1.6	4.3	6.2	0.1	2.2	7.8	6.6	7.1	0.0	2.3	0.0	6.8	4.5	2.4	0.0	6.3	1.0	10.6	4.3	0.0	7.0	1.1	0.0	0.0	2.0	7.6	0.7	1.4	4.0	0.8	3.0	5.7	5.8	3.1	2.2	4.3	6.3	6.4	2.4	2.2	1.0	1.9	6.2	2.1	11.0	14.1	13.6	12.3	10.5	7.6	12.5	6.5	9.4	12.4	8.9	13.7	4.2	2.2	3.1	5.5	9.5	5.1	1.4	6.8	3.5	0.0	6.4	5.0	3.4	1.1	3.3	1.0	0.0	6.4	5.4	2.4	2.4	2.3	2.6	2.3	3.2	1.2	4.9	4.1	0.5	1.7	2.5	1.7	0.0	3.5	3.8	3.6	0.0	4.2	3.0	2.0	0.0	2.0	4.4	4.1	3.0	2.1	7.5	2.6	1.6
ZNRF3	"BK747E2.3, FLJ22057, KIAA1133, RNF203"	ENSG00000183579	"Zinc and ring finger 3"	Q9ULT6	22	28883592-29057487	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 29.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036702, HPA036703"	Uncertain		Uncertain	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA036702: , HPA036703: AB_10672227"	"unprognostic (1.07e-1)"	"unprognostic (2.13e-3)"	"unprognostic (7.48e-3)"	"unprognostic (5.72e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.68e-2)"	"unprognostic (5.18e-2)"	"unprognostic (3.94e-1)"	"unprognostic (9.55e-5)"	"unprognostic (6.49e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.55e-2)"	4.6	11.8	16.8	2.5	14.7	1.0	4.5	12.2	18.1	7.8	5.7	7.7	21.8	5.1	8.3	22.2	5.9	8.1	3.8	4.3	22.0	5.0	13.6	7.5	8.7	1.2	6.1	17.7	10.0	5.4	16.3	4.2	8.0	8.1	12.0	5.9	4.9	12.1	13.4	5.6	7.6	4.7	7.8	8.9	2.2	6.4	6.7	10.5	0.0	6.9	1.9	1.5	5.7	4.9	0.2	0.4	1.5	1.0	2.0	0.5	0.1	3.7	8.9	8.3	2.3	1.5	1.8	15.8	2.3	1.1	1.8	1.7	13.4	2.1	0.0	3.6	1.2	3.3	6.4	5.7	3.5	2.2	4.9	5.8	1.5	1.6	29.2	1.4	4.3	1.5	1.8	3.3	2.9	2.9	1.5	1.6	2.7	3.1	2.1	2.5	3.5	0.1	2.2	3.0	4.7	3.6	4.4	5.4	3.4	7.7	5.5	13.8	5.1	4.0	4.0	2.3	2.7	2.7	2.0	1.5	6.9	6.0	5.4	3.7	2.8	3.9	5.2	3.0	2.5	3.6	1.0	0.2	1.3	0.2	1.0	0.4	0.1	0.2	0.1	0.4	0.2	0.1	0.5	1.5	2.0	0.2	0.3	0.1	0.1	16.8	14.7	12.2	18.1	22.0	5.0	6.1	17.7	8.1	10.5	11.9	17.6	0.0	4.4	11.2	3.7	6.2	5.1	6.7	6.8	12.2	0.0	23.0	1.7	4.7	12.1	5.2	1.3	23.3	2.1	1.5	4.7	6.0	0.0	16.1	2.9	1.6	8.1	1.8	1.0	11.0	10.0	0.2	0.0	0.0	8.3	6.6	4.0	0.0	12.0	9.8	4.1	0.0	4.4	3.4	2.9	6.6	6.4	0.7	14.1	2.0
